,Start Date,Start Price,End Date,End Price,Weekly Returns,Bin Label,News,Basics
0,2023-07-02,113.78477478027344,2023-07-09,107.4836654663086,-0.055377438028354264,D5+,"[{""date"": ""20230702044500"", ""headline"": ""Week In Review: CMBG Out-Licenses Two CAR-T Candidates To Janssen For $245 Million Upfront"", ""summary"": ""Two leading Chinese biotech companies join forces with Merck to develop next-generation immuno-oncology therapies. Click here to find out more.""}, {""date"": ""20230702051900"", ""headline"": ""Week In Review: CMBG Out-Licenses 2 CAR-T Candidates To Janssen For $245 Million Upfront"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230702080145"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of July 2"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read more.""}, {""date"": ""20230703081300"", ""headline"": ""The 3 Best Dividend ETFs to Buy for July"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230703092100"", ""headline"": ""Video: Dow Movers: MRK, GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230703133925"", ""headline"": ""Vera: Repurposed Molecule Program Does Not Impress"", ""summary"": ""Vera Therapeutics, Inc. is developing an old molecule it licensed from Merck. Trials conducted years ago produced unimpressive results. Read more on VERA.""}, {""date"": ""20230704045746"", ""headline"": ""Verve: Exciting Deal With Eli Lilly, But Still Neutral (Reiterating Hold)"", ""summary"": ""Verve Therapeutics announced a partnership with Eli Lilly & Co., focusing on in-vivo gene editing technology. Read why VERV stock is a Hold.""}, {""date"": ""20230705063150"", ""headline"": ""China extends squeezed-out foreign pharmaceuticals firms an olive branch"", ""summary"": ""China's Commerce Minister\ntold foreign pharmaceuticals firms they can expect more\ndevelopment opportunities during a roundtable on Wednesday, his\nministry said, as drugmakers bemoan government...""}, {""date"": ""20230705065300"", ""headline"": ""NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230705071100"", ""headline"": ""Analysts\u2019 Top Healthcare Picks: Merck & Company (MRK), PTC Therapeutics (PTCT)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230705090553"", ""headline"": ""Moderna strikes deal to develop mRNA drugs in China "", ""summary"": ""The deal is the biotech company's first agreement with China after the Asian nation repeatedly refused to accept mRNA vaccines from U.S.-based manufacturers. ""}, {""date"": ""20230705163400"", ""headline"": ""Merck & Co. Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. slid 0.55% to $113.70 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20230705204106"", ""headline"": ""Moderna announces China investment as country opens doors to foreign pharma"", ""summary"": ""China signals a warmer welcome for Western pharma giants just as Treasury Secretary Janey Yellen leaves for Beijing.""}, {""date"": ""20230706105000"", ""headline"": ""Broker Darlings of the Dow: Merck Ranks As a Top 15 Analyst Pick"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706105200"", ""headline"": ""Video: Dow Analyst Moves: MRK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706140705"", ""headline"": ""Voya Global Equity Dividend: 9.2% Yield, What's Not To Like?"", ""summary"": ""The Voya Global Equity Dividend CEF generates a big yield. Read if this fund is a good way to play defense in a volatile market.""}, {""date"": ""20230706163400"", ""headline"": ""Merck & Co. Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. slipped 1.72% to $111.75 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20230707002929"", ""headline"": ""US unit of India's Cipla recalls six batches of bronchospasm inhaler"", ""summary"": ""Indian drugmaker Cipla\nsaid on Friday its U.S. unit was recalling six batches\nof albuterol sulfate inhalation aerosol due to a container\ndefect.\n              The company is initiating a recall in the...""}, {""date"": ""20230707094930"", ""headline"": ""Simcha Therapeutics Announces First Patient Dosed in Phase 1/2 Study Evaluating ST-067 in combination with KEYTRUDA in Patients with Various Solid Tumors"", ""summary"": ""NEW HAVEN - Simcha Therapeutics , a clinical-stage immunobiology company pioneering first-in-class cytokine treatments in cancer, today announced that the first patient has been dosed in a Phase 1/2...""}, {""date"": ""20230707115200"", ""headline"": ""Merck & Co Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230707154000"", ""headline"": ""Merck, Walmart share losses lead Dow's nearly 100-point fall"", ""summary"": ""The Dow Jones Industrial Average is trading down Friday afternoon with shares of Merck and Walmart delivering the stiffest headwinds for the price-weighted...""}, {""date"": ""20230707163032"", ""headline"": ""12 Best Momentum Stocks to Buy Today"", ""summary"": ""In this piece, we will take a look at the 12 best momentum stocks to buy today. If you want to skip our analysis of the stock market and the latest news, and want to take a look at the top five stocks in this list, then head on over to 5 Best Momentum Stocks [\u2026]""}, {""date"": ""20230707163400"", ""headline"": ""Merck & Co. Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. slipped 2.46% to $109.00 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20230707200038"", ""headline"": ""Retirement Stocks: Here\u2019s Where to Invest $1,000 Right Now"", ""summary"": ""Finding a \u201cgood\u201d retirement stock suitable for all investors\u2019 portfolios is nearly impossible. Variables depend on your retirement account\u2019s tax structure, age, risk tolerance, and personal investment preferences. Still, a solid retirement plan is diversified across multiple industries and offers exposure to various investments. Investors optimizing their retirement stock picks should look for companies with solid historical performance, future potential, and investor-friendly financials. Divide""}, {""date"": ""20230707202031"", ""headline"": ""25 US Companies With The Highest Profit Margins"", ""summary"": ""In this article, we will be taking a look at the 25 US companies with the highest profit margins. If you wish to see the top ones, head straight to the 5 US Companies With The Highest Profit Margins. In the dynamic landscape of the United States business sector, several companies like JP Morgan, Apple, [\u2026]""}, {""date"": ""20230708090000"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - July 2023"", ""summary"": ""This is our monthly series where we highlight 5 companies that are large-cap, relatively safe, dividend-paying, with large discounts. Click for our exclusive list.""}, {""date"": ""20230709001953"", ""headline"": ""Merck: The Market Lacks Conviction To Take It Higher"", ""summary"": ""Merck's expensive valuation could discourage buyers from having the confidence in taking it higher. Click here to read my analysis of MRK stock.""}, {""date"": ""20230709110000"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
1,2023-07-09,107.4836654663086,2023-07-16,105.84675598144531,-0.015229379066685977,D2,"[{""date"": ""20230709001953"", ""headline"": ""Merck: The Market Lacks Conviction To Take It Higher"", ""summary"": ""Merck's expensive valuation could discourage buyers from having the confidence in taking it higher. Click here to read my analysis of MRK stock.""}, {""date"": ""20230709110000"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710014500"", ""headline"": ""B. Riley biotechnology analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710024858"", ""headline"": ""4 Factor Dividend Growth Portfolio - Cruising Towards A 20% Return"", ""summary"": ""The 4-factor dividend growth portfolio is a strategy that leverages the stock selection process of SCHD, with a few minor twists. Learn more about the strategy.""}, {""date"": ""20230710042800"", ""headline"": ""Affinity Asset Advisors, LLC Acquires Stake in Aeglea BioTherapeutics Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710081800"", ""headline"": ""Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials \u2013 What Other Viruses Could This COVID Treatment Target?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711071600"", ""headline"": ""Morgan Stanley Reaffirms Their Hold Rating on Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711090500"", ""headline"": ""Athinia\u2122 expands partnerships to include Tokyo Electron for real-time collaborative analytics of semiconductor fab equipment performance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711124400"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711154854"", ""headline"": ""Morgan Stanley Reiterates Merck (MRK) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20230711163400"", ""headline"": ""Merck & Co. Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. shed 1.15% to $108.70 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230711213325"", ""headline"": ""Joel Greenblatt\u2019s Return, Portfolio and Magic Formula"", ""summary"": ""In this article, we will discuss value investor Joel Greenblatt\u2019s portfolio, hedge fund returns, and his Magic Formula. You can skip our detailed analysis of Greenblatt\u2019s investment philosophy and his hedge fund\u2019s performance over the years, and go directly to read Joel Greenblatt\u2019s Top 5 Stock Picks. Joel Greenblatt, renowned for his expertise in value [\u2026]""}, {""date"": ""20230712010900"", ""headline"": ""Merck intensifies legal fight to halt Medicare drug pricing negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230712032900"", ""headline"": ""Merck (MRK) Shares Cross Below 200 DMA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230712060000"", ""headline"": ""ClearBridge Small Cap Growth Strategy Q2 2023 Portfolio Manager Commentary"", ""summary"": ""The growth rally expanded to smaller stocks in the second quarter. Click here to read the full fund letter.""}, {""date"": ""20230712092000"", ""headline"": ""Peering Into Merck & Co's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230712113000"", ""headline"": ""MilliporeSigma Invests $25 Million to Expand Cell Culture Media Production in Kansas"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230712125600"", ""headline"": ""Bernie Sanders Doesn't Own Individual Stocks But His Mutual Fund Holdings Include Stakes In Companies He's Criticized, Including Tesla"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230712163400"", ""headline"": ""Merck & Co. Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. shed 1.13% to $107.47 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230712171011"", ""headline"": ""Chamber of Commerce asks judge to block Medicare drug price negotiations before October"", ""summary"": ""The U.S. Chamber of Commerce asked a judge to block the landmark ability of Medicare to negotiate drug prices. ""}, {""date"": ""20230713021500"", ""headline"": ""Calliditas interim phase 2 data positive for head and neck cancer asset setanaxib"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230713103800"", ""headline"": ""See Which Of The Latest 13F Filers Holds Merck"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230713115000"", ""headline"": ""Big Pharma Ramps Up Fight Against Medicare Price Negotiations"", ""summary"": ""The U.S. Chamber of Commerce asked a judge to stop the federal government from putting into effect a law that will allow Medicare to negotiate the prices of...""}, {""date"": ""20230713120400"", ""headline"": ""3 Penny Stocks to Catapult You Into the Millionaires\u2019 Club"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230713163400"", ""headline"": ""Merck & Co. Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. shed 1.07% to $106.32 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230713200849"", ""headline"": ""15 Deadliest Cancers in the U.S."", ""summary"": ""In this article, we will discuss the 15 deadliest cancers in the U.S. To skip our detailed analysis and recent updates regarding cancer research and the oncology market, go directly to the 5 Deadliest Cancers in the U.S. Cancer stands as a pervasive, highly destructive, and agonizing disease, with a significant global impact. Cancer, also [\u2026]""}, {""date"": ""20230714024254"", ""headline"": ""My Dividend Growth Portfolio - Q2 2023 Summary"", ""summary"": ""In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. Read here for a summary of Q2 of 2023.""}, {""date"": ""20230714034100"", ""headline"": ""Merck initiated with a Hold at HSBC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714034500"", ""headline"": ""Why Are Dow Stocks Up Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714035503"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: June 2023 Review"", ""summary"": ""The significant dividend growth is attributed to rapid rise in interest rates over past 12-18 months, with cash position now yielding nearly 5%. Read more here.""}, {""date"": ""20230714094500"", ""headline"": ""Dow up 130 points on gains in shares of UnitedHealth, JPMorgan Chase"", ""summary"": ""The Dow Jones Industrial Average is trading up Friday morning with shares of UnitedHealth and JPMorgan Chase delivering the strongest returns for the index....""}, {""date"": ""20230714100800"", ""headline"": ""Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714124100"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714163400"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.96% higher to $107.34 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""20230714165437"", ""headline"": ""More Challenges Await AbbVie Following A Disappointing Quarter"", ""summary"": ""AbbVie Inc., one of the leaders in the global immunology market, will release its financial report for the second quarter of 2023. Click here to read more.""}, {""date"": ""20230714213534"", ""headline"": ""HSBC Initiates Coverage of Merck (MRK) with Hold Recommendation"", ""summary"": """"}, {""date"": ""20230715093100"", ""headline"": ""Why You Should Aim For $3 Million For Retirement (Gen X'ers And Millennials)"", ""summary"": ""Saving early and regularly, investing wisely, and budgeting expenses are keys to a wealthy retirement. Read why it's a good time for younger generations to look at retirement scenarios.""}]",{}
2,2023-07-16,105.84675598144531,2023-07-23,108.85432434082031,0.028414365008051945,U3,"[{""date"": ""20230717012200"", ""headline"": ""Merck & Co Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717074000"", ""headline"": ""MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717074120"", ""headline"": ""Wall Street Breakfast: Kicking Into Gear"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.""}, {""date"": ""20230717163400"", ""headline"": ""Merck & Co. Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. slid 1.65% to $105.57 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230717195500"", ""headline"": ""3 Ways Merck Supports the LGBTQ+ Community"", ""summary"": ""At Merck, our commitment to equality goes beyond the month of June.""}, {""date"": ""20230718041513"", ""headline"": ""7 Safe Stocks to Buy as Fed Gears Up for Disinflation"", ""summary"": ""While the Federal Reserve aggressively raised the benchmark interest rate to tame historically high inflation, much evidence indicates that the central bank hasn\u2019t done enough, thus bolstering the case for safe stocks for investing during disinflation. Fundamentally, the Fed\u2019s goal will be to facilitate a gentle deceleration of prices without sparking a recession. However, the initiative will be easier said than done. While the latest jobs report came in below economists\u2019 expectations, the unemp""}, {""date"": ""20230718052200"", ""headline"": ""3 Biotech Stocks for Getting Rich in 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718055900"", ""headline"": ""Merck price target raised to $113 from $102 at BMO Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718071300"", ""headline"": ""SARS-CoV-2 Is Not Done Yet \u2014 Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718115613"", ""headline"": ""J&J sues US govt to halt Medicare drug price negotiation plans"", ""summary"": ""Johnson & Johnson sued the\nU.S. government on Tuesday, becoming the latest drugmaker\nseeking to block enforcement of a program that gives Medicare\nthe power to negotiate drug prices.\n              The...""}, {""date"": ""20230718123900"", ""headline"": ""J&J becomes latest Big Pharma to sue over Medicare drug pricing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718163400"", ""headline"": ""Merck & Co. Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.36% higher to $105.95 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20230718164000"", ""headline"": ""Johnson & Johnson joins Merck, others, in fighting Medicare drug-price program"", ""summary"": ""Johnson & Johnson has joined companies such as Merck & Co. Inc. Bristol Myers Squibb Co. and other entities in suing the federal government over Medicare\u2019s...""}, {""date"": ""20230718173200"", ""headline"": ""Johnson & Johnson sues Biden administration over drug-pricing policies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719022900"", ""headline"": ""Johnson & Johnson Stock (NYSE:JNJ): Medicare Negotiations and Q2 Earnings in Focus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719032100"", ""headline"": ""Analysts\u2019 Top Healthcare Picks: Terns Pharmaceuticals (TERN), Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719033100"", ""headline"": ""5 Beaten-Down Healthcare Stocks With Potential for a Rebound"", ""summary"": ""Investors have fled healthcare stocks this year, ducking out of a trade that seemed a smart defensive play last year, as market conditions have changed.""}, {""date"": ""20230719054800"", ""headline"": ""Merck announces Phase 3 KEYNOTE-A18 trial met one primary endpoint"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719063400"", ""headline"": ""Merck succeeds in Phase 3 trial for Keytruda in cervical cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719065500"", ""headline"": ""Drug Pricing Negotiation Program: Johnson & Johnson Joins Legal Battle Against US Government"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719070600"", ""headline"": ""Merck Phase 3 Keytruda Study Hits Key Goal in Early Cervical Cancer >MRK"", ""summary"": ""By Colin Kellaher Merck &amp; Co. on Wednesday said a Phase 3 study of its blockbuster cancer drug Keytruda met one of its dual primary endpoints in certain...""}, {""date"": ""20230719072202"", ""headline"": ""Merck Phase 3 Keytruda Study Hits Key Goal in Early Cervical Cancer"", ""summary"": ""By Colin Kellaher \n\n\n  Merck & Co. on Wednesday said a Phase 3 study of its blockbuster cancer drug Keytruda met one of its dual primary endpoints in certain patients with early cervical cancer. \n\n...""}, {""date"": ""20230719084700"", ""headline"": ""Merck says Keytruda phase 3 trial meets primary endpoint"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719104500"", ""headline"": ""Merck Announces Phase 3 KEYNOTE-A18 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer"", ""summary"": ""RAHWAY, N.J., July 19, 2023--Merck Announces Phase 3 KEYNOTE-A18 Trial Met Primary Endpoint of PFS in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer""}, {""date"": ""20230719110000"", ""headline"": ""IYH: Healthcare Dashboard For July"", ""summary"": ""Pharmaceuticals/biotechnology is the most attractive subsector for value and quality scores. Fast facts on iShares U.S. Healthcare ETF, click for more on IYH.""}, {""date"": ""20230719110600"", ""headline"": ""Johnson & Johnson Stock Jumps on Earnings Beat. But Talc Worries Loom."", ""summary"": ""The company reports better-than-expected numbers, but ongoing litigation remains a concern for investors.""}, {""date"": ""20230719163500"", ""headline"": ""Merck & Co. Inc. stock remains steady Wednesday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. were unchanged Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230719173311"", ""headline"": ""Merck: Navigating Through Further Consolidation (Technical Analysis)"", ""summary"": ""Merck & Co., Inc. has shown a commendable performance over the past years, consistently surpassing the S&P 500. Click here to read an analysis on MRK stock.""}, {""date"": ""20230719180000"", ""headline"": ""Merck: Buy This Dividend Machine"", ""summary"": ""Merck (MRK) is a strong buy in healthcare, with steady growth, high profitability metrics, and a robust pipeline of potential drugs. Check here for more details.""}, {""date"": ""20230719212104"", ""headline"": ""12 Highest Yielding Dow Jones Dividend Stocks"", ""summary"": ""In this article, we discuss 12 highest yielding Dow Jones dividend stocks. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Highest Yielding Dow Jones Dividend Stocks. The Dow Jones Industrial Average, commonly referred to as the Dow, is one of the most [\u2026]""}, {""date"": ""20230720024800"", ""headline"": ""Check Out What Whales Are Doing With MRK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720062800"", ""headline"": ""Merck price target lowered to $116 from $118 at Truist"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720074031"", ""headline"": ""Merck Announces Phase 3 KEYNOTE-A18 Trial Met Primary Endpoint of Progression-Free Survival in Patients with Newly Diagnosed High-Risk Locally Advanced Cervical Cancer"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-A18 trial, also known as ENGOT-cx11/GOG-3047, investigating KEYTRUDA, Merck's anti-PD-1...""}, {""date"": ""20230720092900"", ""headline"": ""Johnson & Johnson (JNJ): A Comprehensive GF Score Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720093300"", ""headline"": ""GF Score Analysis: AbbVie Inc (ABBV)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720105200"", ""headline"": ""Johnson & Johnson, IBM share gains lead Dow's nearly 250-point climb"", ""summary"": ""Led by strong returns for shares of Johnson & Johnson and IBM, the Dow Jones Industrial Average is up Thursday morning. Shares of Johnson & Johnson and IBM...""}, {""date"": ""20230720132700"", ""headline"": ""Merck (MRK) Keytruda Advanced Cervical Cancer Study Meets Goal"", ""summary"": ""Interim data from a late-stage study, evaluating Merck's (MRK) Keytruda as a combination therapy, met one of its primary endpoints of progression-free survival.""}, {""date"": ""20230720142700"", ""headline"": ""Johnson & Johnson, Goldman Sachs share gains contribute to Dow's 150-point jump"", ""summary"": ""Buoyed by positive gains for shares of Johnson & Johnson and Goldman Sachs, the Dow Jones Industrial Average is up Thursday afternoon. Shares of Johnson &...""}, {""date"": ""20230720163400"", ""headline"": ""Merck & Co. Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. advanced 2.37% to $108.46 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""20230720201236"", ""headline"": ""J&J CFO: Medicare and Health Dept. are 'going after the wrong target' to reduce drug price inflation"", ""summary"": ""J&J became the latest big pharma company to sue the federal government over Medicare price negotiations. CFO Joe Wolk explains why.""}, {""date"": ""20230721033100"", ""headline"": ""Dow Jones Hits Milestone: 10th Straight Day In Green, Longest Winning Streak Since Early 2017"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721035000"", ""headline"": ""Dow Jones Hits Milestone: 10th Straight Day In Green, Longest Winning Streak Since 2017"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721054700"", ""headline"": ""Pfizer price target lowered to $42 from $43 at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721055809"", ""headline"": ""Truist Securities Maintains Merck (MRK) Buy Recommendation"", ""summary"": """"}, {""date"": ""20230721065500"", ""headline"": ""Merck announces CHMP opinion recommending approval of Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721065600"", ""headline"": ""Merck announces CHMP opinion recommending approval of gefapixant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721075900"", ""headline"": ""Merck gets EU nod for new therapies in cough and gastric cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721080300"", ""headline"": ""Merck Gets CHMP Backing for Expanded Keytruda Use in Gastrointestinal Cancers >MRK"", ""summary"": ""By Colin Kellaher Merck &amp; Co. on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval...""}, {""date"": ""20230721091200"", ""headline"": ""IN BRIEF: Merck & Co gets positive EU feedback for Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721093700"", ""headline"": ""IN BRIEF: Merck wins approval recommendation from EU for gefapixant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721101900"", ""headline"": ""Dow rallies nearly 100 points on gains in Intel, Merck shares"", ""summary"": ""Behind positive growth for shares of Intel and Merck, the Dow Jones Industrial Average is up Friday morning. Shares of Intel and Merck have contributed to...""}, {""date"": ""20230721103800"", ""headline"": ""UK shareholder meetings calendar - next 7 days"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721110850"", ""headline"": ""The Bristol-Myers Squibb Phenomenon: A Game Changer In The Pharmaceutical Industry"", ""summary"": ""On July 27, 2023, Bristol-Myers Squibb will release its financial report for the second quarter of 2023. Read more to see a detailed analysis on BMY stock.""}, {""date"": ""20230721115000"", ""headline"": ""Merck Receives Positive EU CHMP Opinion for KEYTRUDA\u00ae (pembrolizumab) Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Expressing PD-L1 (CPS \u22651)"", ""summary"": ""RAHWAY, N.J., July 21, 2023--Merck Receives Positive EU CHMP Opinion for KEYTRUDA\u00ae (pembrolizumab) Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive...""}, {""date"": ""20230721115200"", ""headline"": ""Merck Receives Positive European Union CHMP Opinion for Gefapixant"", ""summary"": ""RAHWAY, N.J., July 21, 2023--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of gefapixant, an investigational, non-narcotic, oral selective P2X3 receptor antagonist, developed for the treatment for adults with refractory or unexplained chronic cough. The CHMP\u2019s recommendation will now be reviewed by the European Commission (EC)""}, {""date"": ""20230721140000"", ""headline"": ""AbbVie: Loss Of Exclusivity Is A Natural End Process"", ""summary"": ""AbbVie has had some big shoes to fill due to the loss of exclusivity for Humira after 20 years of monopoly and $200B in revenues. See why ABBV stock is a Hold.""}, {""date"": ""20230721160625"", ""headline"": ""Growth Posted An Impressive First Half But Is Still Playing Catch-Up"", ""summary"": ""The Nasdaq has provided tremendous performance so far in the first half of 2023. Click here to read more.""}, {""date"": ""20230721163400"", ""headline"": ""Merck & Co. Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. rallied 1.78% to $110.39 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230721190228"", ""headline"": ""Merck Stock Not Likely To Be Saved By Dividends"", ""summary"": ""Merck & Co., Inc. has increased reliance on Keytruda and Gardasil. Click here to find out why MRK stock is rated as a hold.""}, {""date"": ""20230722013900"", ""headline"": ""Top 5 Momentum Stocks For Higher Profits In 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230722155130"", ""headline"": ""Unusual Put Option Trade in Merck (MRK)  Worth $1,260.00K"", ""summary"": """"}, {""date"": ""20230723054500"", ""headline"": ""Week In Review: Novartis In $1 Billion Deal For DTx Pharma"", ""summary"": ""Novartis signed a $1B agreement to acquire DTx Pharma. Click here for the latest weekly updates on biotech deals, financings, trials and approvals.""}, {""date"": ""20230723154424"", ""headline"": ""11 Best Healthcare Stocks Under $50"", ""summary"": ""In this article, we will be taking a look at the 11 best healthcare stocks under $50. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Best Healthcare Stocks Under $50. After the COVID-19 pandemic, many investors believed that the shining moment being enjoyed by healthcare and [\u2026]""}]",{}
3,2023-07-23,108.85432434082031,2023-07-30,104.86066436767578,-0.03668811503198055,D4,"[{""date"": ""20230723054500"", ""headline"": ""Week In Review: Novartis In $1 Billion Deal For DTx Pharma"", ""summary"": ""Novartis signed a $1B agreement to acquire DTx Pharma. Click here for the latest weekly updates on biotech deals, financings, trials and approvals.""}, {""date"": ""20230723154424"", ""headline"": ""11 Best Healthcare Stocks Under $50"", ""summary"": ""In this article, we will be taking a look at the 11 best healthcare stocks under $50. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Best Healthcare Stocks Under $50. After the COVID-19 pandemic, many investors believed that the shining moment being enjoyed by healthcare and [\u2026]""}, {""date"": ""20230724011500"", ""headline"": ""Analyst Cuts Nurix Therapeutics Price Target By 38%, Cites Lymphoma Data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724034700"", ""headline"": ""Russia Is Seizing European Company Assets \u2014 What US Businesses Are Still At Risk?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724094021"", ""headline"": ""Merck Receives Positive EU CHMP Opinion for KEYTRUDA Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use  adopted a positive opinion...""}, {""date"": ""20230724104700"", ""headline"": ""Moderna Is Fairly Valued, Balancing Declining COVID-19 Base Business with Promising Future Pipeline: Analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230724163500"", ""headline"": ""Merck & Co. Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. slid 1.45% to $108.79 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230725004610"", ""headline"": ""12 Best Low Volatility Stocks to Buy Now"", ""summary"": ""In this article, we discuss the 12 best low volatility stocks to buy now. If you want to see more stocks in this selection, check out the 5 Best Low Volatility Stocks to Buy Now. In the first half of 2023, global economic growth picked up pace, reaching 2.8%. Up to this point, the impact of [\u2026]""}, {""date"": ""20230725011100"", ""headline"": ""Merck declares $0.73 dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230725062200"", ""headline"": ""Big Tech Options Bets Die Down. XOM, MRK, LCID Stock Lead the Charge"", ""summary"": """"}, {""date"": ""20230725074600"", ""headline"": ""Data Vault Holdings, Inc. and p-Chip Corporation to Connect Platforms through Enabling IP Licensing Agreement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230725111216"", ""headline"": ""What Will be the Outcome of the Lawsuit Filed by Merck & Co. (MRK)?"", ""summary"": ""Baron Funds, an investment management company, released its \u201cBaron Health Care Fund\u201d second quarter 2023 investor letter. A copy of the same can be downloaded here. The fund advanced 9.22% (Institutional Shares) in the quarter compared to a 3.44% gain for the Russell 3000 Health Care Index (benchmark) and an 8.74% gain for the S&P 500 [\u2026]""}, {""date"": ""20230725115609"", ""headline"": ""Janux: Merck Deal, Loads Of Cash, Solid Early Data"", ""summary"": ""Janux Therapeutics is a small company with a deal from Merck & Co. and some solid early data. Click here for my look at JANX stock prospects.""}, {""date"": ""20230725121000"", ""headline"": ""Merck is Safeguarding the Environment Through Green Chemistry"", ""summary"": ""Merck & Co., Inc.""}, {""date"": ""20230725140121"", ""headline"": ""Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for"", ""summary"": ""Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""20230725140351"", ""headline"": ""20 Countries with the Highest Rates of Skin Cancer"", ""summary"": ""In this article, we\u2019ll take a detailed look at the 20 Countries with the Highest Rates of Skin Cancer. For a quick overview of the top five countries, read our article 5 Countries with the Highest Rates of Skin Cancer. Skin Cancer Statistics Worldwide Skin cancer, a malignancy that begins in the cells of the [\u2026]""}, {""date"": ""20230725163500"", ""headline"": ""Merck & Co. Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. shed 1.16% to $107.53 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230725165800"", ""headline"": ""Merck Announces Fourth-Quarter 2023 Dividend"", ""summary"": ""RAHWAY, N.J., July 25, 2023--Merck Announces Fourth-Quarter 2023 Dividend""}, {""date"": ""20230726015200"", ""headline"": ""Moderna On Cathie Wood's Radar Ahead Of Q2 Results: Ark Boosts Stake In COVID-19 Vaccine Maker By $12M This Week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726054800"", ""headline"": ""Merck, Moderna initiate Phase 3 study of V940 in combination with Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726065455"", ""headline"": ""Merck, Moderna begin late-stage study of mRNA cancer vaccine"", ""summary"": ""Merck, along with its\npartner Moderna, began a late-stage study to evaluate\ntheir experimental mRNA-based cancer vaccine in combination with\ncancer therapy Keytruda, the companies said on...""}, {""date"": ""20230726065500"", ""headline"": ""Merck and Moderna launch late-stage trial of V940 with Keytruda as treatment for high-risk melanoma"", ""summary"": ""Merck & Co. and Moderna Inc. said Wednesday they have launched a Phase 3 trial of Moderna\u2019s V940 in combination with Merck\u2019s Keytruda as a treatment for...""}, {""date"": ""20230726070500"", ""headline"": ""VTI ETF\u2019s Simple but Powerful Strategy is a Long-Term Winner"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726083000"", ""headline"": ""Moderna, Merck begin phase 3 trial on mRNA melanoma combo treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726092600"", ""headline"": ""Truist Financial Reaffirms Their Buy Rating on Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726104400"", ""headline"": ""UK shareholder meetings calendar - next 7 days"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726104500"", ""headline"": ""Merck and Moderna Initiate Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA\u00ae (pembrolizumab) for Adjuvant Treatment of Patients with Resected High-Risk (Stage IIB-IV) Melanoma"", ""summary"": ""RAHWAY, N.J. & CAMBRIDGE, Mass., July 26, 2023--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced the initiation of the pivotal Phase 3 randomized V940-001 clinical trial evaluating V940 (mRNA-4157), an investigational individualized neoantigen therapy (INT), in combination with KEYTRUDA, Merck\u2019s anti-PD-1 therapy, as an adjuvant treatment in""}, {""date"": ""20230726110900"", ""headline"": ""Individualized Cancer Treatment: Merck/Moderna's Personalized Skin Cancer Therapy Enters Late-Stage Of Development"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726121250"", ""headline"": ""Moderna/Merck begins late-stage study of skin cancer vaccine combination"", ""summary"": ""Moderna and its partner\nMerck said on Wednesday that they had begun enrolling\npatients in a late-stage study testing their personalized\nmRNA-based skin cancer vaccine in combination with...""}, {""date"": ""20230726151900"", ""headline"": ""Merck (MRK) to Report Q2 Earnings: What's in the Cards?"", ""summary"": ""Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda when the company reports Q2 earnings.""}, {""date"": ""20230726163500"", ""headline"": ""Merck & Co. Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. shed 0.36% to $107.14 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20230726200412"", ""headline"": ""Lightning Round: Merck is doing a teriffic job at reinventing itself, says Jim Cramer"", ""summary"": ""'Mad Money' host Jim Cramer weighs in on stocks including: Palantir, Tri Pointe Homes, Transmedics, Cheesecake Factory, Copa Holdings and more.""}, {""date"": ""20230726203646"", ""headline"": ""Cramer's Lightning Round: Move on from Rocket Lab"", ""summary"": ""\""Mad Money\"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.""}, {""date"": ""20230727015200"", ""headline"": ""GF Score Analysis: AbbVie Inc (ABBV)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727054800"", ""headline"": ""Merck: V1166 met key immunogenicity, safety endpoints in two Phase 3 trials"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727073512"", ""headline"": ""Merck and Moderna Initiate Phase 3 Study Evaluating V940 in Combination with KEYTRUDA for Adjuvant Treatment of Patients with Resected High-Risk Melanoma"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, and Moderna, Inc. , a biotechnology company pioneering messenger RNA  therapeutics and vaccines, today announced the initiation...""}, {""date"": ""20230727091228"", ""headline"": ""20 Countries With Highest Rates Of AIDS"", ""summary"": ""In this article, we will be taking a look at the 20 countries with the highest rate of AIDS. If you are not interested in reading the details, head straight to the 5 Countries With Highest Rates of AIDS. AIDS, or Acquired Immunodeficiency Syndrome, remains a pressing global health concern, and its impact varies significantly [\u2026]""}, {""date"": ""20230727094036"", ""headline"": ""Starpharma: Patience Needed, But A Lot To Like"", ""summary"": ""The news on Starpharma share price is challenging as a significant shareholder exits. Read more about SPHRF here.""}, {""date"": ""20230727104500"", ""headline"": ""Merck Announces V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Met Key Immunogenicity and Safety Endpoints in Two Phase 3 Trials"", ""summary"": ""RAHWAY, N.J., July 27, 2023--Merck Announces V116 an Investigational 21-valent PCV Specifically Designed for Adults Met Key Immunogenicity & Safety Endpoints in Two Phase 3 Trials""}, {""date"": ""20230727121100"", ""headline"": ""Merck pneumococcal vaccine outperforms PCV20 in Phase 3 trials"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727121100"", ""headline"": ""Merck Releases Encouraging Data From Two Late-Stage Studies For Pneumococcal Conjugate Vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727123400"", ""headline"": ""Ligand says Merck reports V116 met key endpoints in two Phase 3 trials"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727163500"", ""headline"": ""Merck & Co. Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. slid 1.75% to $105.27 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""20230728010400"", ""headline"": ""Catalyst watch: Amazon earnings, jobs report and will Apple talk AI?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728010900"", ""headline"": ""Catalyst Watch: Amazon earnings, jobs report, and will Apple talk AI?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728013800"", ""headline"": ""Earnings week ahead: Amazon, Apple, Pfizer, Starbucks, Uber and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728020000"", ""headline"": ""Drugmakers Want to Crush Medicare\u2019s Pricing Power. They\u2019ll Probably Succeed."", ""summary"": ""The industry has launched a legal war against a new law that would let Medicare negotiate prices. The odds are in Big Pharma's favor.""}, {""date"": ""20230728031100"", ""headline"": ""The Dow Breaks 13-Day Winning Streak, Fed Raises Interest Rates To 2001 Levels And AI Is The Buzzword For Big Tech Earnings: The Week In The Markets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728044108"", ""headline"": ""20 Countries With Highest Rates of Cancer"", ""summary"": ""In this article, we\u2019ll take a detailed look at the 20 countries with the highest rates of cancer. For a quick overview of the top five countries, read our article 5 Countries With Highest Rates of Cancer. Cancer, a pervasive and devastating disease, leaves a profound global impact. Also known as malignant tumors or neoplasms, [\u2026]""}, {""date"": ""20230728050937"", ""headline"": ""13 Safe Stocks To Invest In"", ""summary"": ""In this article, we will be taking a look at 13 safe stocks to invest in. To skip our detailed analysis of current recession concerns in the US and more, you can go directly to see the 5 Safe Stocks To Invest In. The Federal Reserve\u2019s July interest rate hike of 25 basis points that [\u2026]""}, {""date"": ""20230728055000"", ""headline"": ""Merck reports Phase 3 KEYNOTE-756 trial met one of dual primary endpoints"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728063100"", ""headline"": ""Dividend Roundup: Wells Fargo, Visa, IBM, Hasbro, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728063600"", ""headline"": ""Merck succeeds in Phase 3 trial for Keytruda in new breast cancer indication"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728072400"", ""headline"": ""Merck Phase 3 Keytruda Study Hits Key Goal in Early High-Risk Breast Cancer >MRK"", ""summary"": ""By Colin Kellaher A late-stage study of Merck &amp; Co.'s blockbuster cancer drug Keytruda met one of its dual primary endpoints in certain patients with...""}, {""date"": ""20230728074002"", ""headline"": ""Merck Phase 3 Keytruda Study Hits Key Goal in Early High-Risk Breast Cancer"", ""summary"": ""By Colin Kellaher \n\n\n  A late-stage study of Merck & Co.'s blockbuster cancer drug Keytruda met one of its dual primary endpoints in certain patients with high-risk, early breast cancer. \n\n  The...""}, {""date"": ""20230728100000"", ""headline"": ""FOCUS-Drugmakers go under the skin, skirting early US Medicare price negotiations"", ""summary"": ""Injectable versions of some widely-used cancer drugs including Johnson & Johnson's blockbuster multiple myeloma treatment Darzalex are likely to be excluded from new U.S. government price negotiations for years, drugmakers told Reuters, protecting billions in revenue.  J&J, Merck & Co, which is testing an injectable version of its top-selling immunotherapy Keytruda, and Halozyme Therapeutics, which licenses the critical new ingredient, hyaluronidase, for subcutaneous drugs, all told Reuters they believe the reformulation qualifies the medicines to be treated like new drugs.  President Biden\u2019s signature Inflation Reduction Act (IRA) allows the government Medicare health program for the first time to negotiate prices for some of its most costly drugs, starting at a minimum discount of 25% to a drug's price.""}, {""date"": ""20230728101454"", ""headline"": ""Drugmakers go under the skin, skirting early US Medicare price negotiations"", ""summary"": ""Injectable versions of some widely-used cancer drugs including Johnson & Johnson's blockbuster multiple myeloma treatment Darzalex are likely to be excluded from new U.S. government price negotiations for years, drugmakers told Reuters, protecting billions in revenue.  J&J, Merck & Co, which is testing an injectable version of its top-selling immunotherapy Keytruda, and Halozyme Therapeutics, which licenses the critical new ingredient, hyaluronidase, for subcutaneous drugs, all told Reuters they believe the reformulation qualifies the medicines to be treated like new drugs.  President Biden\u2019s signature Inflation Reduction Act (IRA) allows the government Medicare health program for the first time to negotiate prices for some of its most costly drugs, starting at a minimum discount of 25% to a drug's price.""}, {""date"": ""20230728104500"", ""headline"": ""Merck Announces Phase 3 KEYNOTE-756 Trial Met Primary Endpoint of Pathological Complete Response (pCR) Rate in Patients With High-Risk, Early-Stage ER+/HER2- Breast Cancer"", ""summary"": ""RAHWAY, N.J., July 28, 2023--Merck Announces Phase 3 KEYNOTE-756 Trial Met Primary Endpoint of pCR Rate in Patients With High-Risk, Early-Stage ER+/HER2- Breast Cancer""}, {""date"": ""20230728122014"", ""headline"": ""Unveiling AbbVie's Hidden Risks: Cautionary Notes For Investors"", ""summary"": ""AbbVie's Q2 2023 financial results exceeded expectations, driven by strong sales of innovative drugs Skyrizi and Rinvoq. Click here to read more.""}, {""date"": ""20230728125200"", ""headline"": ""Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. advanced 1.02% to $106.34 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230728205500"", ""headline"": ""S&P 500 Earnings: Forward S&P 500 EPS Estimates Have Firmed"", ""summary"": ""Roughly half of the S&P 500 has reported their Q2 \u201923 financial results, and the forward estimate has firmed up a little bit.""}, {""date"": ""20230729060200"", ""headline"": ""Wall Street Breakfast Catalyst Watch: Jobs Report, AAPL, MRK, SBUX Preview"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230729070700"", ""headline"": ""Bristol-Myers Squibb's Bright Future Unfolds Beyond Q2 2023 Turmoil"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230729111357"", ""headline"": ""11 Best Magic Formula Stocks to Buy Now"", ""summary"": ""In this article, we will take a look at the 11 best magic formula stocks to buy now. To see more such companies, go directly to 5 Best Magic Formula Stocks to Buy Now. Magic Formula investing strategy was first described by legendary value investor Joel Greenblatt in his 2005 book entitled The Little Book [\u2026]""}, {""date"": ""20230730122700"", ""headline"": ""AstraZeneca's Q2 Earnings Exceed Expectations, Astonishing Investors (Rating Upgrade)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230730192428"", ""headline"": ""7 Dow Stocks to Buy as Recession Fears Roll Back"", ""summary"": ""With the Dow Jones soaring on fading recession fears, its holdings are also becoming far more attractive, too. In fact, here are seven of the top Dow stocks to buy immediately. Dow Stocks to Buy: Merck (MRK) Source: shutterstock.com/CC7 From a pure potential perspective, Merck (NYSE:MRK) stock offers a lot to investors. Past returns might not be an absolute indicator of future performance. However, they tend to be a reasonable indicator given that strong firms usually tend to continue to do well""}]",{}
4,2023-07-30,104.86066436767578,2023-08-06,103.53931427001953,-0.012601008258188884,D2,"[{""date"": ""20230730122700"", ""headline"": ""AstraZeneca's Q2 Earnings Exceed Expectations, Astonishing Investors (Rating Upgrade)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230730192428"", ""headline"": ""7 Dow Stocks to Buy as Recession Fears Roll Back"", ""summary"": ""With the Dow Jones soaring on fading recession fears, its holdings are also becoming far more attractive, too. In fact, here are seven of the top Dow stocks to buy immediately. Dow Stocks to Buy: Merck (MRK) Source: shutterstock.com/CC7 From a pure potential perspective, Merck (NYSE:MRK) stock offers a lot to investors. Past returns might not be an absolute indicator of future performance. However, they tend to be a reasonable indicator given that strong firms usually tend to continue to do well""}, {""date"": ""20230731022700"", ""headline"": ""Noteworthy Monday Option Activity: MRK, LC, BLMN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731033600"", ""headline"": ""Merck looks to continue streak of EPS beats with Q2 results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731071547"", ""headline"": ""5 things to know before the stock market opens Monday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""20230731093427"", ""headline"": ""3 Pharma Stocks to Buy for Their Promising Progress"", ""summary"": ""Identifying promising pharma stocks is no small feat in the dynamic and competitive realm of pharmaceuticals. The industry is replete with businesses boasting robust pipelines, each vying for a breakthrough that could potentially revolutionize healthcare. Today\u2019s article sheds light on three high-potential pharma stocks that hold strong promise for the future. These companies are among the cream of the crop regarding R&D pipeline size as of 2023, demonstrating a powerful blend of innovation and""}, {""date"": ""20230731095200"", ""headline"": ""Notable earnings before Tuesday's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731104429"", ""headline"": ""Merck Announces Phase 3 KEYNOTE-756 Trial Met Primary Endpoint of Pathological Complete Response Rate in Patients with High-Risk, Early-Stage ER+/HER2- Breast Cancer"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced that the pivotal Phase 3 KEYNOTE-756 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, in combination...""}, {""date"": ""20230731111600"", ""headline"": ""Earnings Extravaganza: Another One-Third Of S&P 500 Companies Report This Week, Including Amazon, Apple"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731114000"", ""headline"": ""Merck Q2 Earnings Preview: Analyst Expectations, Jim Cramer's View, And The Spotlight On Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731121800"", ""headline"": ""Notable companies reporting before tomorrow's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.29% higher to $106.65 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""20230731180242"", ""headline"": ""Stock futures are little changed as Wall Street's busiest earnings week continues: Live updates"", ""summary"": ""The major averages ended July's trading on a positive note.""}, {""date"": ""20230801004300"", ""headline"": ""GLOBAL BRIEFING: Australian central bank pauses rates; HSBC profit up"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801033600"", ""headline"": ""Merck & Co. Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801034100"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801034600"", ""headline"": ""Bank of America Securities Remains a Buy on Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801045200"", ""headline"": ""These Stocks Are Moving the Most Today: ZoomInfo, Harmonic, Arista, Nikola, Zebra, Norwegian, and More"", ""summary"": ""ZoomInfo tumbles after cutting its outlook, Harmonic issues a disappointing forecast, Arista Networks soars after issuing revenue guidance above estimates,...""}, {""date"": ""20230801053000"", ""headline"": ""Merck reports Q2 adjusted EPS ($2.06), consensus ($1.97)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801053400"", ""headline"": ""Merck sees FY23 adjusted EPS $2.95-$3.05, consensus $2.60"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801053500"", ""headline"": ""Merck Non-GAAP EPS of -$2.06, revenue of $15B beats by $560M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801054700"", ""headline"": ""Merck posts narrower-than-expected loss and sales top estimates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801055200"", ""headline"": ""Nasdaq, S&P 500 Futures Pullback After Strong July; Why This Analyst Recommends Staying Fully Invested"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801062800"", ""headline"": ""Merck raises sales guidance despite buyout impact on bottom line"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801063100"", ""headline"": ""Merck Earnings Top Expectations. More M&A Could Be Next."", ""summary"": ""CFO Caroline Litchfield said sales of the company\u2019s cancer treatments and vaccines were growing and more M&A could be on the horizon.""}, {""date"": ""20230801063240"", ""headline"": ""Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal"", ""summary"": ""Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S.""}, {""date"": ""20230801063800"", ""headline"": ""Merck: Q2 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801064114"", ""headline"": ""Merck : Q2 Earnings Snapshot"", ""summary"": ""RAHWAY, N.J.  \u2014 RAHWAY, N.J.  \u2014 Merck & Co.  on Tuesday reported a loss of $5.98 billion in its second quarter.\n  On a per-share basis, the Rahway, New Jersey-based company said it had a loss...""}, {""date"": ""20230801065100"", ""headline"": ""Wall Street Breakfast: Rally On"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801065500"", ""headline"": ""Merck reports Q2 Keytruda sales grew 19% to $6.3B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801065903"", ""headline"": ""Merck : 2Q23 Merck Earnings Presentation"", ""summary"": ""Merck\n      \n      \n        Q2 2023 Earnings\n      \n      \n        August 1, 2023\n      \n    \n    \n      \n        \n          Agenda\n        \n      \n      \n        \n          \n         ...""}, {""date"": ""20230801071100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Neurocrine (NBIX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801073749"", ""headline"": ""Caterpillar, Merck rise premarket; Pfizer, JetBlue and ZoomInfo fall"", ""summary"": ""Investing.com -- U.S. futures edged lower Tuesday, with investors digesting more corporate earnings as well as key job openings data.""}, {""date"": ""20230801074900"", ""headline"": ""Merck & Co second quarter revenue up; profit falls acquisition costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801075354"", ""headline"": ""Merck CEO Rob Davis on Q2 results: We continue to see phenomenal growth"", ""summary"": ""Merck chairman and CEO Rob Davis joins 'Squawk Box' to discuss the company's quarterly earnings results, which reported second-quarter revenue that topped expectations on strong sales of its blockbuster cancer drug Keytruda and HPV vaccine Gardasil, but posted a quarterly loss due to its acquisition of the biotech company Prometheus Biosciences earlier this year.""}, {""date"": ""20230801075700"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801081106"", ""headline"": ""Stocks making the biggest moves premarket: Uber, Gap, Caterpillar & more"", ""summary"": ""Despite missing Wall Street's revenue expectations, shares of Uber rose more than 4% after the ride-hailing giant offered rosy guidance for the third quarter. ""}, {""date"": ""20230801083200"", ""headline"": ""Merck Swings Into Q2 Loss On Prometheus Biosciences Acquisition Charge, But Raises FY23 Revenue Outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801095204"", ""headline"": ""Trending : Merck Posts Narrower-Than-Expected 2Q Loss"", ""summary"": ""9:35 a.m. ET -- Merck is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. Merck posted a narrower-than-expected loss for the...""}, {""date"": ""20230801095800"", ""headline"": ""Dow's 90-point rally led by gains for shares of Caterpillar, Cisco"", ""summary"": ""The Dow Jones Industrial Average is climbing Tuesday morning with shares of Caterpillar and Cisco leading the way for the blue-chip average. The Dow is...""}, {""date"": ""20230801101600"", ""headline"": ""Merck swings to loss as it books charge on $10.8 billion acquisition of Prometheus Biosciences"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801103000"", ""headline"": ""Merck Announces Second-Quarter 2023 Financial Results"", ""summary"": ""RAHWAY, N.J., August 01, 2023--Merck Announces Second-Quarter 2023 Financial Results""}, {""date"": ""20230801103000"", ""headline"": ""Merck posts narrower-than-expected loss as sales of top drugs beat Street estimates"", ""summary"": ""Merck & Co posted narrower-than-expected second-quarter loss and raised its full-year profit forecast on Tuesday on the strength of its two top-selling products, cancer immunotherapy Keytruda and human papillomavirus (HPV) vaccine Gardasil.  Merck reported about $6.3 billion in Keytruda sales for the quarter, up 19%, compared with analysts' forecasts of $5.9 billion.  Sales of Gardasil, which prevents cancers caused by HPV, jumped 47% to $2.5 billion, also well above Wall Street estimates of $2.1 billion.""}, {""date"": ""20230801103723"", ""headline"": ""Merck beats quarterly sales estimate on top drugs' strength"", ""summary"": ""(Reuters) -Merck & Co posted better-than-expected second-quarter sales on Tuesday on strong demand for its two top-selling products, cancer immunotherapy Keytruda and human papillomavirus (HPV) vaccine Gardasil.  Shares of Merck rose about 2% at $108.45 in premarket trading after the company also raised its full-year revenue forecast.  Merck said Keytruda sales for the quarter jumped 19% to $6.3 billion, surpassing analysts' average estimate of $5.9 billion.""}, {""date"": ""20230801104937"", ""headline"": ""UPDATE 2-Merck beats quarterly sales estimate on top drugs' strength"", ""summary"": ""Merck & Co posted better-than-expected second-quarter sales on Tuesday on strong demand for its two top-selling products, cancer immunotherapy Keytruda and human papillomavirus (HPV) vaccine Gardasil.  Shares of Merck rose about 2% at $108.45 in premarket trading after the company also raised its full-year revenue forecast.  Merck said Keytruda sales for the quarter jumped 19% to $6.3 billion, surpassing analysts' average estimate of $5.9 billion.""}, {""date"": ""20230801112300"", ""headline"": ""Merck Posts Narrower-Than Expected Loss, Lifts Sales Outlook on Keytruda Boost"", ""summary"": ""Keytruda cancer-drug sales powered better-than-expected Q2 revenue and a better full-year sales forecast for drugmaker Merck.""}, {""date"": ""20230801114800"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801115400"", ""headline"": ""Stocks Dip, Bond Yields Rise And Dollar Gains As Investors Turn Cautious: What's Driving Markets Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801120026"", ""headline"": ""Merck & Co., Inc. (MRK) Q2 2023 Earnings Call Transcript"", ""summary"": ""Merck & Co., Inc. (NYSE:NYSE:MRK) Q2 2023 Earnings Conference Call August 1, 2023 9:00 AM ETCompany ParticipantsPeter Dannenbaum - VP, IRRobert Davis - Chairman & CEOCaroline...""}, {""date"": ""20230801120201"", ""headline"": ""Merck & Co., Inc. 2023 Q2 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Merck & Co., Inc.""}, {""date"": ""20230801123900"", ""headline"": ""Mixed Brew: Pfizer, Merck Earnings Head Opposite Ways, But Uber And Caterpillar Slug Line Drives"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801133000"", ""headline"": ""VIG: Sell Your VTI And Buy This Instead"", ""summary"": ""The Vanguard Dividend Appreciation ETF offers a higher yield and a different portfolio composition. Read more to see my take on VIG as an alternative.""}, {""date"": ""20230801140113"", ""headline"": ""Merck revenue rises, Pfizer hit by falling COVID product demand"", ""summary"": ""Pharmaceutical company Merck reported a rise in revenue its second quarter. The results got a lift from surging profits from name-brand drugs. Pfizer, on the other hand, reported a decline in revenues due to falling demand for COVID-19 vaccines. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the earnings data from the two pharma giants.""}, {""date"": ""20230801151901"", ""headline"": ""S&P 500 stumbles pressured by cruise stocks as earnings season heats up"", ""summary"": ""Investing.com -- The S&P 500 stumbled Tuesday, pressured by weakness in consumer stocks as investors digested the latest round of quarterly results.""}, {""date"": ""20230801160309"", ""headline"": ""Stock market today: Dow edged higher but S&P stumbled after deluge of earnings"", ""summary"": ""Investing.com -- The S&P 500 stumbled Tuesday, pressured by weakness in consumer stocks as investors digested the latest round of quarterly results.""}, {""date"": ""20230801161200"", ""headline"": ""NEW YORK MARKET CLOSE: Manufacturing malaise holds Wall Street back"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801162800"", ""headline"": ""Merck (MRK) Beats on Q2 Earnings and Sales, Ups 2023 View"", ""summary"": ""Merck (MRK) beats Q2 estimates for earnings and sales. It raises its 2023 guidance. Stock rises in pre-market.""}, {""date"": ""20230801180022"", ""headline"": ""Merck (MRK) Q2 2023 Earnings Call Transcript"", ""summary"": ""Speaking on today's call will be Rob Davis, chairman and chief executive officer; Caroline Litchfield, chief financial officer; and Dr. Dean Li, president of Merck Research Labs.  Before we get started, I'd like to point out a few items.""}, {""date"": ""20230801182600"", ""headline"": ""Merck upgrades guidance on stronger 2023 outlook as COVID business declines"", ""summary"": ""Merck reported stronger-than-expected second quarter earnings.""}, {""date"": ""20230801190120"", ""headline"": ""Checkpoint: PDUFA Date Catalyst Makes This A Must Watch"", ""summary"": ""Checkpoint Therapeutics aims to compete in the $1.6 billion cSCC market. Click to read why I rate CKPT stock as a Buy.""}, {""date"": ""20230801191025"", ""headline"": ""Pfizer reports mixed quarterly results on uncertain COVID outlook"", ""summary"": ""Pfizer reports mixed second quarter earnings as uncertainty around COVID remains a headwind.""}, {""date"": ""20230802020100"", ""headline"": ""Dow falls over 300 points,Nasdaq slumps 2%, after Fitch lowers U.S. credit rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802025000"", ""headline"": ""Fear & Greed Index Moves To 'Greed' Zone After S&P 500 Settles Lower"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802033600"", ""headline"": ""S&P 500 slumps nearly 1.4% in worst day since April as Nasdaq falls over 2% after Fitch lowers U.S. credit rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802033700"", ""headline"": ""Merck & Co. Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802042600"", ""headline"": ""Barclays Remains a Buy on Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802061600"", ""headline"": ""BMO Capital Reaffirms Their Hold Rating on Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802065100"", ""headline"": ""Merck price target raised to $122 from $116 at Truist"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802070400"", ""headline"": ""GLOBAL BROKER RATINGS: DZ Bank raises BP to 'buy'; HSBC raises Nestle"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802074500"", ""headline"": ""Stock futures fall after market mood soured by Fitch lowering U.S. credit rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802084400"", ""headline"": ""U.S. stocks open lower after market mood soured by Fitch lowering U.S. credit rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802094100"", ""headline"": ""Analysts\u2019 Top Healthcare Picks: Exact Sciences (EXAS), IQVIA Holdings (IQV)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802095700"", ""headline"": ""Dow falls 200 points after  Fitch lowers U.S. credit rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802104400"", ""headline"": ""Nasdaq leads stock losses after Fitch lowers U.S. credit rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802120200"", ""headline"": ""Can Moderna spring a surprise for Q2 2023 despite falling vaccine demand"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802121300"", ""headline"": ""Nasdaq falls over 2%, leading stock losses after Fitch lowers U.S. credit rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802123629"", ""headline"": ""Drugmakers brace for list of first 10 drugs for US price negotiations"", ""summary"": ""Drugmakers are bracing for the U.S.\ngovernment's announcement of  the 10 prescription medicines that\nwill be subject to the first-ever price negotiations by the\nMedicare health program that covers 66...""}, {""date"": ""20230802160000"", ""headline"": ""Moderna Raises Hope, Concern, With Update on Sales of Covid-19 Vaccine"", ""summary"": ""The company offered a mixed report about sales of the shots, the only product it has on the market.""}, {""date"": ""20230803024700"", ""headline"": ""Peering Into Merck & Co's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803033600"", ""headline"": ""Merck & Co. Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803052000"", ""headline"": ""Merck KGaA lowers guidance as second quarter sales fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803054800"", ""headline"": ""Merck announces FDA approval of ERVEBO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803064701"", ""headline"": ""U.S. FDA Approves Merck's ERVEBO\u00ae (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and Older"", ""summary"": ""Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease\n\n...""}, {""date"": ""20230803070956"", ""headline"": ""Moderna shares rise on better Covid vaccine outlook despite sharp drop in sales"", ""summary"": ""Moderna and its rivals Pfizer and Novavax have all seen a steep drop in sales of Covid vaccines and treatments as the world moves on from the pandemic. \u00a0""}, {""date"": ""20230803095100"", ""headline"": ""Merck Ebola vaccine gets expanded indication for younger population"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803104500"", ""headline"": ""U.S. FDA Approves Merck\u2019s ERVEBO\u00ae (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and Older"", ""summary"": ""RAHWAY, N.J., August 03, 2023--U.S. FDA Approves Merck\u2019s ERVEBO\u00ae (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and Older""}, {""date"": ""20230804013300"", ""headline"": ""This Is What Whales Are Betting On Merck & Co"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804022130"", ""headline"": ""Q2 2023 Moderna Inc Earnings Call"", ""summary"": ""Q2 2023 Moderna Inc Earnings Call""}, {""date"": ""20230804033600"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804082500"", ""headline"": ""IN BRIEF: US FDA approves Merck's Ervebo vaccine for use in children"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804095622"", ""headline"": ""U.S. FDA Approves Merck's ERVEBO for Use in Children 12 Months of Age and Older"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration  has approved an expanded indication for ERVEBO, which is now...""}, {""date"": ""20230806024100"", ""headline"": ""2023 shaping up to be biggest year for biopharma M&A since pandemic"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
5,2023-08-06,103.53931427001953,2023-08-13,105.94537353515625,0.02323812246681456,U3,"[{""date"": ""20230806024100"", ""headline"": ""2023 shaping up to be biggest year for biopharma M&A since pandemic"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807033600"", ""headline"": ""Merck & Co. Inc. stock underperforms Monday when compared to competitors despite daily gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807060700"", ""headline"": ""Ginkgo Bioworks announces manufacturing collaboration with Merck"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807072300"", ""headline"": ""Ginkgo Bioworks stock pops as company plans Merck collaboration"", ""summary"": ""Ginkgo Bioworks Holdings Inc. shares were rising more than 5% in Monday\u2019s premarket trading after the company said it was collaborating with Merck & Co. Inc....""}, {""date"": ""20230807073400"", ""headline"": ""Anixa Biosciences announces enrollment for Keytruda treatment arm"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807123000"", ""headline"": ""Anixa Biosciences Announces Opening of Enrollment for Keytruda\u00ae Arm in Ongoing Breast Cancer Vaccine Clinical Trial"", ""summary"": ""Anixa Biosciences, Inc. (\""Anixa\"" or the \""Company\"") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its partner, Cleveland Clinic, has begun enrolling subjects in a treatment arm evaluating the combination of the Company's breast cancer vaccine with Keytruda\u00ae (pembrolizumab). An expansion of the ongoing Phase 1 dose escalation trial of Anixa's breast cancer vaccine, this treatment arm aims to determine if the vaccine/Keytruda combina""}, {""date"": ""20230808033800"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808055400"", ""headline"": ""IN THE KNOW: Recovery coming for Merck after \""challenging\"" quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808070000"", ""headline"": ""Eli Lilly's stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook"", ""summary"": ""Eli Lilly's stock soared Tuesday toward its biggest gain in more than 20 years, following a strong earnings report and upbeat outlook for its Mounjaro drug.""}, {""date"": ""20230808110700"", ""headline"": ""Eli Lilly\u2019s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808121500"", ""headline"": ""Merck Is Harnessing Innovation To Reach Indigenous Communities"", ""summary"": ""Merck & Co., Inc. - Alaska is a vast state with extremes in weather and terrain. For people living in its 240 remote villages and communities, obtaining lifesaving medicines can be a challenge.""}, {""date"": ""20230808121700"", ""headline"": ""Merck & Co Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808160100"", ""headline"": ""Ligand Reports Second Quarter 2023 Financial Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808192318"", ""headline"": ""Buy 2 August Dogs Of The Dow, Watch 5"", ""summary"": ""Discover the criteria for stocks to be added to the Dow, the highest-yield stocks in August, and analyst predictions for stocks' performance. Read more here.""}, {""date"": ""20230808233102"", ""headline"": ""4 Factor Dividend Growth Portfolio - Performance Since Launch"", ""summary"": ""Explore the performance of the 4-factor dividend growth portfolio, which has gained 2.44% in July and generated 2.75% alpha over the S&P 500. Read more here.""}, {""date"": ""20230809021100"", ""headline"": ""Analysts\u2019 Top Healthcare Picks: Organon (OGN), Agenus (AGEN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809033600"", ""headline"": ""Merck & Co. Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809070200"", ""headline"": ""Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809104900"", ""headline"": ""UK shareholder meetings calendar - next 7 days"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809112800"", ""headline"": ""Medicare Part D drug price increases far exceed inflation - AARP"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809230037"", ""headline"": ""The 3 Best Healthcare Stocks to Buy in August"", ""summary"": ""Health is undoubtedly the most important thing for all of us. It\u2019s vital to be able to continue with our day-to-day and to be able to carry out everything we want to throughout our lives. There are many important sectors within the financial markets, but the health sector will always be one of the most in demand because, as I mentioned before, taking care of your health is priority number one. There are many companies within this sector making improvements in products and services, applying tech""}, {""date"": ""20230810033600"", ""headline"": ""Merck & Co. Inc. stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810060100"", ""headline"": ""AIM WINNERS & LOSERS: Marks Electrical sales surge in \""fast start\"""", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810063800"", ""headline"": ""IN BRIEF: Marks Electrical starts year off strong as revenue soars"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810092500"", ""headline"": ""Atea downgraded at JPMorgan on shrinking COVID opportunity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810092903"", ""headline"": ""Merck : Reports Strong Progress on its Commitments to Advancing Access to Health and Operating Responsibly"", ""summary"": ""August 10, 2023 9:18 am ET Reached more than 500 million people with its innovations across commercial channels, clinical trials, access strategies, voluntary licensing...""}, {""date"": ""20230810095000"", ""headline"": ""Video: Dow Movers: MRK, NKE"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810100835"", ""headline"": ""The Petri Dish: Agios licenses Alnylam drug, Ikena acquires startup with Gilead stake"", ""summary"": ""Ikena Oncology is set to acquire a South San Francisco startup after Gilead Sciences waived its exclusive option to buy the company in March. Plus other life sciences news you may have missed.""}, {""date"": ""20230810132152"", ""headline"": ""These 10 medications are likely targets for Medicare price negotiations this fall"", ""summary"": ""It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.""}, {""date"": ""20230810180232"", ""headline"": ""S&P 500 inches lower, heads for second losing week in a row: Live updates"", ""summary"": ""The latest inflation report due this week came in hotter than anticipated.""}, {""date"": ""20230811011300"", ""headline"": ""Pharma ETFs in Focus Post Q2 Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230811012035"", ""headline"": ""The 3 Best ESG Stocks to Buy in August"", ""summary"": ""It\u2019s a common assumption that the best ESG (environmental, social, governance) stocks to buy may be profitable for your inner wellbeing but not necessarily for your portfolio. After all, doing the right thing in our personal lives usually comes at a cost; either a direct one or a cost associated with a lack of recognition of upright behavior or action. However, investing in ESG stocks does not need to be a binary affair, where winning in the moral field leads to losses in the portfolio. Accordin""}, {""date"": ""20230811033600"", ""headline"": ""Merck & Co. Inc. stock rises Friday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230811055900"", ""headline"": ""Merck ruling contesting IRA could drive sector rally, says Citi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230811151402"", ""headline"": ""Pfizer's Unexpected Strength: Bullish Case Emerges Amid New Covid-19 Wave"", ""summary"": ""On August 1, Pfizer released its financial report for the second quarter of 2023, which showed mixed results. Click here to read more.""}, {""date"": ""20230811194456"", ""headline"": ""Buy Merck (MRK) Stock Now to Ride a Wave Higher in Healthcare"", ""summary"": ""Merck (NYSE:MRK) has consistently delivered impressive financial results, built a robust product portfolio, and demonstrated an unwavering commitment to research and development. Given this, I think Merck could be a good stock to consider here. When we look at the Health Care Select Sector SPDR Fund (NYSEARCA:XLV) relative to the SPDR S&P 500 ETF (NYSEARCA:SPY), it looks like the sector broadly has bottomed as defensive posturing takes place. This is great for healthcare stocks, but what is the""}, {""date"": ""20230812090000"", ""headline"": ""How To Invest $100,000 Today: 5 Strategies Including The Near-Perfect Portfolio Strategy"", ""summary"": ""Discover five investment strategies, including the Near-Perfect Portfolio, aimed at capital preservation, sustainable income, and long-term growth. Click for more.""}, {""date"": ""20230813010300"", ""headline"": ""Pharma under threat from bill to expand drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230813053032"", ""headline"": ""The Prognosis For PDS Biotechnology"", ""summary"": ""PDS Biotechnology Corporation has had a volatile stock performance in recent years. Read more about PDSB stock here.""}, {""date"": ""20230813112600"", ""headline"": ""PDS Biotechnology: Interim Data Reinforces Push Towards Phase 3 Study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
6,2023-08-13,105.94537353515625,2023-08-20,107.68087768554688,0.01638112257742641,U2,"[{""date"": ""20230813010300"", ""headline"": ""Pharma under threat from bill to expand drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230813053032"", ""headline"": ""The Prognosis For PDS Biotechnology"", ""summary"": ""PDS Biotechnology Corporation has had a volatile stock performance in recent years. Read more about PDSB stock here.""}, {""date"": ""20230814002202"", ""headline"": ""PDS Biotechnology: Interim Data Reinforces Push Towards Phase 3 Study"", ""summary"": ""PDS Biotechnology reports positive results in the phase 2 study of PDS0101 with Keytruda for head and neck cancer and plans for the phase 3 study. Find out why PDSB stock is a Buy.""}, {""date"": ""20230814010600"", ""headline"": ""Check Out What Whales Are Doing With MRK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814025600"", ""headline"": ""The 3 Most Undervalued Penny Stocks to Buy Now: August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814061400"", ""headline"": ""PDS announces submission of Phase 3 protocol to FDA to initiate VERSATILE-003"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814070000"", ""headline"": ""Second Half Outlook For Biotech Stocks"", ""summary"": ""Biotech stocks faced challenges in the first half of the year, with the Nasdaq Biotechnology Index losing 3%. Click here to read my thoughts.""}, {""date"": ""20230814082900"", ""headline"": ""PDS Biotech gains after updates on pivotal trial for lead asset"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814101900"", ""headline"": ""Bullish Two Hundred Day Moving Average Cross - MRK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815020900"", ""headline"": ""Kahn Brothers' Q2 2023 Portfolio Update: Top Holdings and Key Trades"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815032200"", ""headline"": ""Sanofi was mystery bidder in Reata Pharma bidding war - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815033400"", ""headline"": ""Sanofi was mystery suitor in Reata Pharma bidding war - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815033600"", ""headline"": ""Merck & Co. Inc. stock falls Tuesday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815061206"", ""headline"": ""Patent claims to metabolites in Australia : when will use of a prodrug be infringing?"", ""summary"": ""The development of prodrug formulations may present challenges to patent owners seeking to enforce patent claims to the active metabolite.What are the key issues that arise in relation to enforcement...""}, {""date"": ""20230815081100"", ""headline"": ""Wall Street Analysts Are Bullish on Top Healthcare Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815081700"", ""headline"": ""See Which Of The Latest 13F Filers Holds Merck"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815110000"", ""headline"": ""Get In on This Skin Disease Drug Before Big Pharma Does"", ""summary"": ""Biotech MoonLake Immunotherapeutics is developing a drug that has shown great promise for inflammatory skin conditions.""}, {""date"": ""20230815113530"", ""headline"": ""15 Worst Performing Blue Chip Stocks in 2023"", ""summary"": ""In this piece, we will take a look at the 15 worst performing blue chip stocks in 2023. If you want to skip a background of what\u2019s been going on in this lucrative sector this year, then head on over to 5 Worst Performing Blue Chip Stocks in 2023. In traditional poker, a blue chip [\u2026]""}, {""date"": ""20230815115815"", ""headline"": ""Conservative Stock Portfolio: 10 Best Stocks To Buy"", ""summary"": ""In this article, we will be taking a look at a conservative stock portfolio with the 10 best stocks to buy. To skip our detailed analysis of conservative investing in the current market, you can go directly to see the Conservative Stock Portfolio: 5 Best Stocks To Buy. Markets are jittery again amid analyst firms [\u2026]""}, {""date"": ""20230815183328"", ""headline"": ""SCD: Not A Bad Income CEF If It Can Sustain The 10.58% Distribution Yield"", ""summary"": ""Investors can consider closed-end funds, like the LMP Capital and Income Fund (SCD), to earn a high level of income from their assets. Click here to read more.""}, {""date"": ""20230816022400"", ""headline"": ""Federal Court Rules To Prohibit Access To Abortion Pill: Supreme Court To Weigh In"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816100000"", ""headline"": ""Interesting MRK Put And Call Options For November 17th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816120000"", ""headline"": ""Merck Employee Talks Pride, Pediatrics and Parenting"", ""summary"": ""Merck & Co., Inc.""}, {""date"": ""20230816124100"", ""headline"": ""S&P 500 2023 Q2 Earnings Review: Revenues Miss Analyst Expectations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817050300"", ""headline"": ""Morgan Dempsey Capital Management LLC Reduces Stake in Polished.com Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817084500"", ""headline"": ""Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818025100"", ""headline"": ""This Is What Whales Are Betting On Merck & Co"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818033600"", ""headline"": ""Merck & Co. Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818034400"", ""headline"": ""Noteworthy Friday Option Activity: MRK, SFL, BURL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818055000"", ""headline"": ""Merck's Welireg meets Phase 3 primary endpoint in renal cell carcinoma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818062500"", ""headline"": ""Merck succeeds in Phase 3 trial for kidney cancer drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818071100"", ""headline"": ""Merck Phase 3 Welireg Study Hits Key Endpoint in Renal Cell Carcinoma >MRK"", ""summary"": ""By Colin Kellaher A late-stage study of Merck % Co.'s cancer drug Welireg has met a key goal in certain patients with the most common type of kidney cancer....""}, {""date"": ""20230818072703"", ""headline"": ""Merck Phase 3 Welireg Study Hits Key Endpoint in Renal Cell Carcinoma"", ""summary"": ""By Colin Kellaher A late-stage study of Merck % Co.'s cancer drug Welireg has met a key goal in certain patients with the most common type of kidney cancer. Merck on Friday said a Phase 3...""}, {""date"": ""20230818090500"", ""headline"": ""Merck Reveals Mixed Results From Pivotal Kidney Cancer Study Of Welireg In Pretreated Patients"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818091300"", ""headline"": ""IN BRIEF: Merck & Co celebrates positive Phase 3 results for Welrig"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818104500"", ""headline"": ""Merck Announces WELIREG\u00ae (belzutifan) Phase 3 LITESPARK-005 Trial Met Primary Endpoint of Progression-Free Survival in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma"", ""summary"": ""RAHWAY, N.J., August 18, 2023--Merck Announces WELIREG Phase 3 LITESPARK-005 Trial Met Primary Endpoint of PFS in Certain Previously Treated Patients With Advanced RCC""}, {""date"": ""20230818121700"", ""headline"": ""AARP, Public Citizen file briefs in Medicare drug price negotiations case"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818130945"", ""headline"": ""Viatris Emerges As Challenger In Lucrative Anti-Obesity Drugs Market"", ""summary"": ""Viatris surpassed expectations in Q2 2023 with increased revenue and R&D spending. Click here to find out why VTRS stock is rated as a buy.""}, {""date"": ""20230818152126"", ""headline"": ""CVS Health: Blue Shield Runs To Amazon, But Valuation Still Makes Sense"", ""summary"": ""Despite the challenges, CVS's valuation remains attractive, and options strategies can provide a good margin of safety and yield opportunities. Read more here.""}, {""date"": ""20230818170200"", ""headline"": ""Buy Moderna and BioNTech Stock. Both Pharmas Have Strong Drug Pipelines and Plenty of Cash."", ""summary"": ""Moderna and BioNTech are no longer minting money from Covid vaccines. But both have strong drug pipelines and plenty of cash.""}, {""date"": ""20230818185021"", ""headline"": ""Goldman Sachs Dividend Stocks: Top 12 Stock Picks"", ""summary"": ""In this article, we discuss top 12 dividend stock picks of Goldman Sachs. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read Goldman Sachs Dividend Stocks: Top 5 Stock Picks. Investors love dividend stocks because they are reliable and often a refuge during tough times when the [\u2026]""}, {""date"": ""20230818201114"", ""headline"": ""AARP urges courts to keep drug pricing talks on track"", ""summary"": ""AARP is one of the few groups so far to have filed an amicus brief on supporting of the U.S. Department of Health and Human Services. The suit from the U.S. Chamber of Commerce and several pharmaceutical companies, including Merck (MRK) and Johnson & Johnson (JNJ), is asking the courts to delay the implementation of a new law that would let Medicare negotiate the prices of certain drugs. Yahoo Finance Health Care Reporter Anjalee Khemlani reports the details.""}, {""date"": ""20230819013900"", ""headline"": ""Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230819072349"", ""headline"": ""Merck: Expect More Consolidations Ahead (Technical Analysis)"", ""summary"": ""Merck's focus on oncology, particularly the cancer medication Keytruda, has significantly boosted the company's profitability. Read why MRK stock is a hold.""}, {""date"": ""20230820052654"", ""headline"": ""Despite The One-Time Charge, Merck Is Still A Buy"", ""summary"": ""Merck's revenues increased by 31% over the last decade. Current valuation is attractive with a P/E ratio of less than 13. Find out why MRK stock is a Buy.""}]",{}
7,2023-08-20,107.68087768554688,2023-08-27,108.67683410644531,0.009249148431041299,U1,"[{""date"": ""20230820052654"", ""headline"": ""Despite The One-Time Charge, Merck Is Still A Buy"", ""summary"": ""Merck's revenues increased by 31% over the last decade. Current valuation is attractive with a P/E ratio of less than 13. Find out why MRK stock is a Buy.""}, {""date"": ""20230821022700"", ""headline"": ""Lawsuits unlikely to hinder Medicare drug price negotiations \u2013 UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821030200"", ""headline"": ""Lilly's market cap soared 36% in Q2, eclipsing J&J, Merck, Novo Nordisk"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821062800"", ""headline"": ""Dividend Lovers Bet Big on 6 \u2018Strong Buy\u2019 Goldman Sachs Conviction List Picks for Rest of 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821070100"", ""headline"": ""\u2018The sharks are still there.\u2019 Stock market\u2019s decline is just beginning, this top fund manager says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821093010"", ""headline"": ""The 3 Most Undervalued Pharma Stocks to Buy Now: August 2023"", ""summary"": ""There are sectors in the economy that go through an extended period of trending sideways to lower. A good example is the pharmaceutical sector. In the last 10 years, the S&P Pharmaceuticals Select Industry Index has delivered annualized total returns of 2.65%. Furthermore, the index has annualized total returns in the last five years of -2.63%, clearly indicating an extended bear market among pharma stocks. Covid-19 did translate into buying action in selected pharma stocks. However, the interes""}, {""date"": ""20230821100023"", ""headline"": ""Merck Announces WELIREG Phase 3 LITESPARK-005 Trial Met Primary Endpoint of Progression-Free Survival in Certain Previously Treated Patients with Advanced Renal Cell Carcinoma"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced topline results from LITESPARK-005, the first positive Phase 3 trial investigating WELIREG, Merck's oral...""}, {""date"": ""20230821125800"", ""headline"": ""Vaccine makers light up as COVID hospitalizations rise"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821135706"", ""headline"": ""Is Merck's Long-Term Investment Brilliance Unshaken By COVID-19 Drug Sales Slump?"", ""summary"": ""On August 1, Merck released its financial report for the second quarter of 2023, which showed excellent results. Read more about MRK stock here.""}, {""date"": ""20230821163500"", ""headline"": ""Merck & Co. Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.40% higher to $109.64 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""20230821165832"", ""headline"": ""Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS"", ""summary"": ""UBS believes there is little chance the lawsuits brought on by pharma companies will delay Medicare pricing negotiations.""}, {""date"": ""20230821174100"", ""headline"": ""Merck's (MRK) Welireg Meets Renal Cell Carcinoma Study Goals"", ""summary"": ""Based on interim data from a late-stage study, Merck's (MRK) Welireg achieves statistically significant improvements in one of the study's dual endpoints of progression-free survival.""}, {""date"": ""20230821201801"", ""headline"": ""Moderna, Pfizer stocks rise amid new Covid variants"", ""summary"": ""Covid vaccine maker stocks including Moderna (MRNA), Pfizer (PFE), and BioNTech (BNTX), rose as concerns grow about new Covid variants.""}, {""date"": ""20230822031940"", ""headline"": ""Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV)"", ""summary"": ""We recommend a long healthcare and short tech pairs trade strategy for investors during 2H 23 and 24. Click here for a detailed analysis.""}, {""date"": ""20230822043629"", ""headline"": ""Tracking Jeremy Grantham's GMO Capital Portfolio - Q2 2023 Update"", ""summary"": ""Jeremy Grantham's 13F portfolio value increased by 10% this quarter, reaching $21.60B. Check out GMO Capital's holdings and trades for Q2 2023.""}, {""date"": ""20230822091500"", ""headline"": ""Video: Dow Movers: MRK, BA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230822121400"", ""headline"": ""Dow falls 150 points on losses in JPMorgan Chase, Nike shares"", ""summary"": ""Dragged down by negative returns for shares of JPMorgan Chase and Nike, the Dow Jones Industrial Average is falling Tuesday afternoon. The Dow was most...""}, {""date"": ""20230822123830"", ""headline"": ""11 Best Weight Loss Stocks To Invest In"", ""summary"": ""In this article, we will be taking a look at the 11 best weight loss stocks to invest in. To skip our detailed analysis of new developments in the weight loss industry, you can go directly to see the 5 Best Weight Loss Stocks To Invest In. US Versus Peer Nations In Weight Loss Drug [\u2026]""}, {""date"": ""20230822150221"", ""headline"": ""Cantor Fitzgerald Reiterates Merck (MRK) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20230822163500"", ""headline"": ""Merck & Co. Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. slid 2.20% to $107.23 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20230822172458"", ""headline"": ""Health care stocks: What the market technicals show"", ""summary"": ""Why are UnitedHealth (UNH), Merck & Company (MRK), Johnson & Johnson (JNJ), and Amgen (AMGN), this strategist's top health care stock picks? Freedom Capital Markets Chief Global Strategist Jay Woods joins Yahoo Finance Live to discuss and break down the market technicals of health care stocks.\u00a0 Woods says he focuses on those four health care stocks, \""because they're in Dow Jones Industrial Average. If you're looking for reasons why the Dow can rally, I give you health care.\""\u00a0 The Health Care Select Sector (XLV) \""continues to make higher lows, as it goes along,\"" Woods notes. \""If you're a little skittish on the overall market, health care is a safety sector,\"" Woods says.""}, {""date"": ""20230822213220"", ""headline"": ""Billionaire Ken Fisher and Corporate Insiders Are Betting On These Stocks"", ""summary"": ""In this piece, we will take a look at the stocks that Ken Fisher and corporate insiders are betting on. If you want to skip our introduction to insider trading and Mr. Fisher then skip to Ken Fisher\u2019s and Insiders\u2019 5 Stock Picks. Insider trading is often thought to be illegal. The most commonly understood [\u2026]""}, {""date"": ""20230822214656"", ""headline"": ""12 Most Undervalued Blue Chip Stocks to Buy According to Hedge Funds"", ""summary"": ""In this piece, we will take a look at the 12 most undervalued blue-chip stocks to buy according to hedge funds. If you want to skip our introduction to blue chip investing, then jump ahead to 5 Most Undervalued Blue Chip Stocks To Buy According To Hedge Funds. Blue chip stocks are some of the [\u2026]""}, {""date"": ""20230823032600"", ""headline"": ""Cantor Fitzgerald Keeps Their Buy Rating on Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823085500"", ""headline"": ""Early notable gainers among liquid option names on August 23rd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823093300"", ""headline"": ""Roche sends anti-TIGIT developers higher after cancer drug data (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823100700"", ""headline"": ""Dow rallies 113 points on gains for Merck, Intel shares"", ""summary"": ""Behind strong returns for shares of Merck and Intel, the Dow Jones Industrial Average is trading up Wednesday morning. Shares of Merck and Intel are...""}, {""date"": ""20230823103400"", ""headline"": ""Looking At Merck & Co's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823131800"", ""headline"": ""Dow up 200 points on gains for Merck, Intel stocks"", ""summary"": ""The Dow Jones Industrial Average is up Wednesday afternoon with shares of Merck and Intel leading the way for the index. Shares of Merck and Intel have...""}, {""date"": ""20230823132448"", ""headline"": ""25 Most Innovative Companies Of All Time"", ""summary"": ""In this article, we will take a look at the most innovative companies of all time. If you want to explore similar companies, you can go to 5 Most Innovative Companies of All Time. Humans have been innovating since they first stepped foot on Earth. For any civilization, innovation was a milestone that changed the [\u2026]""}, {""date"": ""20230823153302"", ""headline"": ""Merck (MRK): A Fairly Valued Player in the Pharmaceutical Industry"", ""summary"": ""An In-depth Analysis of Merck's Valuation and Financial Strength""}, {""date"": ""20230823163500"", ""headline"": ""Merck & Co. Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. rose 3.80% to $111.30 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230823165600"", ""headline"": ""Top Stock Reports for Merck, Philip Morris & QUALCOMM"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Philip Morris International Inc. (PM) and QUALCOMM Incorporated (QCOM).""}, {""date"": ""20230824022026"", ""headline"": ""Bristol-Myers Squibb: Top Defensive Pick During Recessions With A Value Proposition"", ""summary"": ""Discover why Bristol-Myers is a strong investment, undervalued with a promising dividend yield. After a slow start, expect a bullish turnaround.""}, {""date"": ""20230824022800"", ""headline"": ""AstraZeneca Prostate Cancer, Generalized Myasthenia Gravis Treatments Get Approval in Japan"", ""summary"": ""By Michael Susin AstraZeneca's prostate-cancer treatment Lynparza has been approved in Japan, while Soliris has been approved for expanded use to treat...""}, {""date"": ""20230824054800"", ""headline"": ""Merck, AstraZeneca: LYNPARZA/(abi/pred) combination approved in Japan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824071100"", ""headline"": ""Agilent receives European IVDR certification for companion diagnostic assay"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824084600"", ""headline"": ""Drugs picked for Medicare price negotiations to be announced on Tuesday \u2013 Politico"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824090000"", ""headline"": ""The Zacks Analyst Blog Highlights Merck, Philip Morris, Qualcomm, CVS Health and Chubb"", ""summary"": ""Merck, Philip Morris, Qualcomm, CVS Health and Chubb are included in this Analyst Blog.""}, {""date"": ""20230824104500"", ""headline"": ""LYNPARZA\u00ae (olaparib) Plus Abiraterone and Prednisone or Prednisolone Approved in Japan for the Treatment of BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer"", ""summary"": ""RAHWAY, N.J., August 24, 2023--LYNPARZA Plus Abiraterone and Prednisone or Prednisolone Approved in Japan for the Treatment of BRCA-Mutated mCRPC""}, {""date"": ""20230824111100"", ""headline"": ""Werewolf gains as Wedbush cites bullish views ahead of key readout"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824112400"", ""headline"": ""UPDATE: AstraZeneca, Merck & Co say Lynparza approved in Japan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824115200"", ""headline"": ""MRK October 6th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824130500"", ""headline"": ""Dow down nearly 225 points on losses in Boeing, Walgreens Boots shares"", ""summary"": ""The Dow Jones Industrial Average is falling Thursday afternoon with shares of Boeing and Walgreens Boots facing the biggest losses for the index. Shares of...""}, {""date"": ""20230824163500"", ""headline"": ""Merck & Co. Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. shed 1.66% to $109.45 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20230824205350"", ""headline"": ""AARP to join US government in two more lawsuits over Medicare drug pricing negotiations"", ""summary"": ""AARP is gearing up for legal battles brought by pharma companies against Medicare drug pricing negotiations that impact its members.""}, {""date"": ""20230825051800"", ""headline"": ""Merck, Eisai provide update on Phase 3 LEAP-010 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825053200"", ""headline"": ""Merck begins Phase 3 clinical program for MK-0616"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825063900"", ""headline"": ""Merck, Eisai: Keytruda/Lenvima Combo Fails in Head, Neck Cancer Study"", ""summary"": ""By Colin Kellaher Merck &amp; Co. and Eisai are ending a late-stage study of the cancer drugs Keytruda plus Lenvima in patients with certain types of...""}, {""date"": ""20230825064151"", ""headline"": ""Merck, Eisai discontinue late-stage study for cancer therapy"", ""summary"": ""Merck & Co and partner Eisaisaid on Friday they will shut down a late-stage studytesting an experimental combination therapy for a type of headand neck cancer after an interim analysis showed it...""}, {""date"": ""20230825065200"", ""headline"": ""Merck and Eisai say late-stage trial of treatment for head and neck cancer did not meet goals"", ""summary"": ""Merck & Co. Inc. and Eisai Co. Ltd. said Friday a late-stage trial of a treatment for head and neck cancer failed to meet its main goals and the companies...""}, {""date"": ""20230825065500"", ""headline"": ""Merck Launches Phase 3 for MK-0616 Oral Cholesterol Drug >MRK"", ""summary"": ""By Colin Kellaher Merck &amp; Co. is moving its MK-0616 oral cholesterol drug candidate into late-stage studies. The Rahway, N.J., drugmaker on Friday said...""}, {""date"": ""20230825065505"", ""headline"": ""Merck, Eisai : Keytruda/Lenvima Combo Fails in Head, Neck Cancer Study"", ""summary"": ""By Colin Kellaher Merck & Co. and Eisai are ending a late-stage study of the cancer drugs Keytruda plus Lenvima in patients with certain types of recurrent or metastatic head and neck squamous...""}, {""date"": ""20230825071102"", ""headline"": ""Merck Launches Phase 3 for MK-0616 Oral Cholesterol Drug"", ""summary"": ""By Colin Kellaher Merck & Co. is moving its MK-0616 oral cholesterol drug candidate into late-stage studies. The Rahway, N.J., drugmaker on Friday said it is launching a Phase 3 clinical...""}, {""date"": ""20230825073800"", ""headline"": ""Merck, Eisai end phase 3 combo treatment trial for head and neck cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825080700"", ""headline"": ""Merck Keytruda trial misses primary endpoint; begins MK-0616 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825085013"", ""headline"": ""AstraZeneca - LYNPARZA Plus Abiraterone and Prednisone or Prednisolone Approved in Japan for the Treatment of BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer"", ""summary"": ""RAHWAY - AstraZeneca and Merck , known as MSD outside of the United States and Canada, today announced that LYNPARZA in combination with abiraterone and prednisone or prednisolone has been approved...""}, {""date"": ""20230825085705"", ""headline"": ""Correction to Merck, Eisai : Keytruda/Lenvima Combo Article"", ""summary"": ""Merck & Co. is based in Rahway, N.J. Merck, Eisai: Keytruda/Lenvima Combo Fails in Head, Neck Cancer Study, at 6:39 a.m. ET, incorrectly said the company is based in Kenilworth, N.J. ...""}, {""date"": ""20230825094700"", ""headline"": ""Merck starts phase 3 program for oral PCSK9 inhibitor to lower cholesterol"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825100200"", ""headline"": ""As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit \u2014 even if their drugs aren\u2019t on the list"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825101500"", ""headline"": ""Merck and Eisai Provide Update on Phase 3 LEAP-010 Trial Evaluating KEYTRUDA\u00ae (pembrolizumab) Plus LENVIMA\u00ae (lenvatinib) in Patients With Certain Types of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma"", ""summary"": ""RAHWAY, N.J. & NUTLEY, N.J., August 25, 2023--Merck and Eisai Provide Update on Phase 3 LEAP-010 Trial Evaluating KEYTRUDA + LENVIMA in Patients With Certain Types of Recurrent or Metastatic HNSCC""}, {""date"": ""20230825103000"", ""headline"": ""Merck Initiates Phase 3 Clinical Program for Oral PCSK9 Inhibitor Candidate MK-0616"", ""summary"": ""RAHWAY, N.J., August 25, 2023--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the company\u2019s Phase 3 clinical program, CORALreef, for MK-0616, an investigational, oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, being evaluated for the treatment of adults with hypercholesterolemia. This is the first Phase 3 clinical program for an oral PCSK9 inhibitor. The first participants are now enrolling in two registrational Ph""}, {""date"": ""20230825104151"", ""headline"": ""UPDATE 2-Merck, Eisai discontinue late-stage study for combo cancer therapy"", ""summary"": ""Merck & Co and partner Eisai said on Friday they will shut down a late-stage study testing an experimental combination therapy for a type of head and neck cancer after an interim analysis showed it failed to prolong lives of patients.  The therapy, Merck's blockbuster drug Keytruda in combination with Eisai's Lenvima, failed to show statistical significance in extending overall survival, one of the three main goals of the study, the companies said.  The companies were testing the combination for head and neck squamous cell carcinoma \u2014 a cancer that develops in the mucous membranes of the mouth, nose and throat \u2014 in patients with recurrent or metastatic form of the disease and whose tumors contain a protein called PD-L1.""}, {""date"": ""20230825105600"", ""headline"": ""AstraZeneca latest drugmaker to challenge Medicare drug price negotiation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825125300"", ""headline"": ""Pharma Giants Unite Against Drug Price Negotiation: AstraZeneca Latest To Challenge The Government"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825150733"", ""headline"": ""AstraZeneca files lawsuit against U.S. over drug pricing"", ""summary"": ""AstraZeneca (AZN) joins Johnson & Johnson (JNJ), Merck (MRK), and Bristol-Myers (BMY) in a lawsuit against the U.S. Department of Health and Human Services (HHS) over certain provisions on prices found in President Biden's Inflation Reduction Act (IRA). Yahoo Finance Health Care Reporter Anjalee Khemlani joins the Live show to break down the lawsuit and what to expect moving forward.""}, {""date"": ""20230825163500"", ""headline"": ""Merck & Co. Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.69% higher to $110.21 Friday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20230826115846"", ""headline"": ""Abcam: Further Upside Limited With Potential Acquisition In The Making, Reiterate Hold"", ""summary"": ""Abcam plc has attracted acquisition interest, leading to a surge in stock prices. So, why do I rate it a hold? Click here to find out.""}, {""date"": ""20230827110100"", ""headline"": ""Wall Street lists potential targets for Medicare drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827134744"", ""headline"": ""13 Best Defensive Stocks To Buy Now"", ""summary"": ""In this article, we will take a look at the 13 best defensive stocks to buy now. To see more such companies, go directly to 5 Best Defensive Stocks To Buy Now. The US stock markets are jumpy amid analyst firms downgrading banks and some analysts suggesting the economy is still not out the recession [\u2026]""}]",{}
8,2023-08-27,108.67683410644531,2023-09-03,108.31197357177734,-0.0033572981552867365,D1,"[{""date"": ""20230827110100"", ""headline"": ""Wall Street lists potential targets for Medicare drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827134744"", ""headline"": ""13 Best Defensive Stocks To Buy Now"", ""summary"": ""In this article, we will take a look at the 13 best defensive stocks to buy now. To see more such companies, go directly to 5 Best Defensive Stocks To Buy Now. The US stock markets are jumpy amid analyst firms downgrading banks and some analysts suggesting the economy is still not out the recession [\u2026]""}, {""date"": ""20230828030000"", ""headline"": ""Biden Administration to Reveal Which Pharma Blockbusters Medicare Will Pay Less For"", ""summary"": ""Drugmakers like Eli Lilly and Pfizer could see profits fall if their blockbuster medicines are on the list.""}, {""date"": ""20230828091000"", ""headline"": ""A Step Closer To Cheaper Drugs For Americans: Price Negotiation And Its Implications"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828110044"", ""headline"": ""Has Merck & Co., Inc. (NYSE:MRK) Stock's Recent Performance Got Anything to Do With Its Financial Health?"", ""summary"": ""Merck's (NYSE:MRK) stock is up by 3.6% over the past month. Given that stock prices are usually aligned with a...""}, {""date"": ""20230828114412"", ""headline"": ""Merck and Eisai Provide Update on Phase 3 LEAP-010 Trial Evaluating KEYTRUDA plus LENVIMA in Patients with Certain Types of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, and Eisai today provided an update on the Phase 3 LEAP-010 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, plus LENVIMA,...""}, {""date"": ""20230828114414"", ""headline"": ""Merck Initiates Phase 3 Clinical program for Oral PCSK9 Inhibitor Candidate MK-0616"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced the initiation of the company's Phase 3 clinical program, CORALreef, for MK-0616, an investigational, oral...""}, {""date"": ""20230828121400"", ""headline"": ""Viridian Chart Of The Week: How Capital Intensive Is Cannabis?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828123700"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828123800"", ""headline"": ""Oncology Market's Huge Potential Puts These Stocks in Focus"", ""summary"": ""The oncology treatment market has been experiencing significant growth lately. Companies like Regeneron Pharmaceuticals (REGN), Merck & Co. (MRK), Novartis (NVS) and AstraZeneca (AZN) have made meaningful contributions in cancer treatment.""}, {""date"": ""20230828144500"", ""headline"": ""Merck (MRK), Eisai to End Keytruda-Lenvima Combo Cancer Study"", ""summary"": ""With the phase III LEAP-010 study failing to show an overall survival benefit for patients with recurrent or metastatic HNSCC, Merck (MRK) and Eisai have decided to close the study.""}, {""date"": ""20230828154046"", ""headline"": ""Unveiling Merck (MRK)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""A deep dive into the financials and intrinsic value of Merck & Co Inc (MRK)""}, {""date"": ""20230828163500"", ""headline"": ""Merck & Co. Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. shed 1.16% to $108.93 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230829000400"", ""headline"": ""10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829000400"", ""headline"": ""See which drugs Biden is targeting first for Medicare price-lowering talks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829013500"", ""headline"": ""Drug Companies Mixed as Medicare Plans to Negotiate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829023300"", ""headline"": ""Republicans say Medicare drug negotiations will mean fewer new meds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829024800"", ""headline"": ""Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries, Will Fed Legalization Change This?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829033000"", ""headline"": ""Bristol-Myers Squibb gets US FDA approval for \""superior\"" anaemia drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829033500"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829055200"", ""headline"": ""Merck: EC approves Keytruda in combination with trastuzumab"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829055800"", ""headline"": ""Bristol Myers, Merck win U.S. label expansion for Reblozyl"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829060000"", ""headline"": ""US to name first 10 drugs for Medicare price negotiation"", ""summary"": ""The Biden administration on Tuesday isexpected to release its list of 10 prescription medicines thatwill be subject to the first-ever price negotiations by the U.S.Medicare health program that...""}, {""date"": ""20230829065000"", ""headline"": ""Medicare lists first ten drugs selected for pricing negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829065100"", ""headline"": ""Biden unveils first 10 drugs subject to Medicare price negotiation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829074200"", ""headline"": ""Merck wins EU approval for Keytruda combo in gastric cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829075000"", ""headline"": ""Merck, Amgen, AbbVie products among first 10 drugs selected for Medicare price negotiations"", ""summary"": ""Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implications...""}, {""date"": ""20230829075900"", ""headline"": ""SPLG: The Market\u2019s Lowest-Cost S&P 500 ETF"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829083500"", ""headline"": ""Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829093200"", ""headline"": ""Merck says Keytruda approved as first-line cancer treatment in the EU"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829094700"", ""headline"": ""Verizon, 3M share gains contribute to Dow's nearly 100-point climb"", ""summary"": ""The Dow Jones Industrial Average is climbing Tuesday morning with shares of Verizon and 3M delivering the strongest returns for the index. The Dow is trading...""}, {""date"": ""20230829095600"", ""headline"": ""Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829104500"", ""headline"": ""Merck to Participate in the Citi 18th Annual BioPharma Conference"", ""summary"": ""RAHWAY, N.J., August 29, 2023--Merck to Participate in the Citi 18th Annual BioPharma Conference""}, {""date"": ""20230829105000"", ""headline"": ""European Commission Approves KEYTRUDA\u00ae (pembrolizumab) Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Expressing PD-L1 (CPS \u22651)"", ""summary"": ""RAHWAY, N.J., August 29, 2023--EC Approves KEYTRUDA Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive Advanced Gastric or Gastroesophageal Junction""}, {""date"": ""20230829110200"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829114618"", ""headline"": ""Biden Administration targets drugs from J&J, Merck for controversial Medicare price negotiations"", ""summary"": ""The Biden administration revealed the first 10 drugs that will face the Medicare negotiation process under the Inflation Reduction Act.""}, {""date"": ""20230829132412"", ""headline"": ""Best Buy results, Medicare negotiations list, Hurricane Idalia: Top stories"", ""summary"": ""Best Buy (BBY) lowers its full-year sales outlook despite topping earnings estimates. The Biden administration has shared its list of ten prescription drugs that will be subject to pricing negotiations between manufacturers and Medicare. Tropical Storm Idalia has officially been upgraded to a hurricane. It's expected to make landfall on Florida's west coast on Wednesday.Yahoo Finance Live's Brad Smith highlights three of this morning's biggest stories.""}, {""date"": ""20230829134500"", ""headline"": ""The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Merck, Novartis and AstraZeneca"", ""summary"": ""Regeneron Pharmaceuticals, Merck, Novartis and AstraZeneca are part of the Zacks top Analyst Blog.""}, {""date"": ""20230829150000"", ""headline"": ""Eli Lilly and Other Pharma Stocks Are Ignoring Medicare\u2019s 10 Drug List"", ""summary"": ""The Inflation Reduction Act gives Medicare the ability to directly negotiate the prices of certain drugs for the first time.""}, {""date"": ""20230829153700"", ""headline"": ""Expensive Drugs Targeted for First U.S. Price Negotiations"", ""summary"": ""Lower prices would take effect in 2026 depending on the talks between the U.S. and drugmakers and the outcome of industry lawsuits.""}, {""date"": ""20230829162931"", ""headline"": ""Steady Eddies: 7 Unshakeable Stocks for Any Type of Market"", ""summary"": ""If there\u2019s any one theme that supports the concept of safe stocks to buy, it\u2019s ambiguity. At first glance, Federal Reserve Chair Jerome Powell recently clarified that while inflation is finally moving in the right direction, policymakers still have much work to do. Further, relief in rising borrowing costs in the form of rate cuts probably won\u2019t happen anytime soon. On the other hand, following Powell\u2019s comments last week, the market responded positively. Per CNBC, investors focused on the Fed C""}, {""date"": ""20230829163500"", ""headline"": ""Merck & Co. Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.97% higher to $109.99 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20230830070724"", ""headline"": ""5 things to know before the stock market opens Wednesday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""20230830080942"", ""headline"": ""Merck - European Commission Approves KEYTRUDA Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced that the European Commission has approved KEYTRUDA, Merck's anti-PD-1 therapy, in combination with trastuzumab,...""}, {""date"": ""20230830134818"", ""headline"": ""Medicare drug price negotiations may have a muted impact on drugmakers in the near term"", ""summary"": ""Many of the drugs are already facing strong competition from other branded medications or patent expirations that will open the market to generic alternatives.\u00a0""}, {""date"": ""20230830153330"", ""headline"": ""Medicare price negotiation list: What it means for pharma companies"", ""summary"": ""On Tuesday, the Biden administration listed ten drugs subject to Medicare price negotiations. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the list and how this may impact the pharmaceutical companies who profit from these drugs.\u00a0\u00a0 The ten drugs and pharma companies impacted are:\u00a0 Eliquis - Bristol-Myers Squibb (BMY), Pfizer (PFE) Jardiance - Boehringer Ingelheim, Eli Lilly (LLY) Xarelto- Bayer (BAYRY), Johnson & Johnson (JNJ) Januvia - Merck (MRK) Farxiga - AstraZeneca (AZN) Entresto - Novartis (NVS) Enbrel - Amgen (AMGN) Imbruvica - Johnson & Johnson (JNJ), AbbVie (ABBV) Stelara - Johnson & Johnson (JNJ) Fiasp, NovoLog - Novo Nordisk (NVO)""}, {""date"": ""20230830155100"", ""headline"": ""Merck's (MRK) Keytruda Receives EU Nod in Gastric Cancer"", ""summary"": ""Following the approval, Merck's (MRK) Keytruda is the first immunotherapy approved in the EU for first-line treatment for HER2-positive advanced gastric cancer in adults whose tumors express PD-L1.""}, {""date"": ""20230830155600"", ""headline"": ""Medicare\u2019s Plan to Negotiate Drug Discounts Won\u2019t Hit Pharma Hard, Analysts say"", ""summary"": ""Medicare is seeking discounts on 10 heavily used drugs, but many are mature products and will lose marketing exclusivity soon.""}, {""date"": ""20230830163500"", ""headline"": ""Merck & Co. Inc. stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.20% higher to $110.21 Wednesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20230830172549"", ""headline"": ""Medicare's drug pricing list didn't impact company stocks \u2014 here's why"", ""summary"": ""Company stocks were unaffected by the Biden Administration's historic announcement Tuesday of Medicare's first list of drugs for negotiating prices.""}, {""date"": ""20230830212213"", ""headline"": ""Merus: Petosemtamab And Zeno The Driving Forces Behind Investment Returns"", ""summary"": ""Merus stock rally cools, but long-term investors gained 47% since January. Mixed sentiment and broken price structure pose challenges. Read more on MRUS here.""}, {""date"": ""20230831054100"", ""headline"": ""IN BRIEF: Physiomics to extend anti-cancer regimen work with Merck"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831085100"", ""headline"": ""UPDATE: Physiomics wins new deal following Merck contract extension"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831101700"", ""headline"": ""October 13th Options Now Available For Merck (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831111722"", ""headline"": ""Novo Nordisk: Super Focused Pharma Company For The Long Run"", ""summary"": ""Novo Nordisk is one of the most qualitative big pharma companies globally. Read why I am bullish on NVO stock with the long-term investment horizon here.""}, {""date"": ""20230831115000"", ""headline"": ""LONDON MARKET CLOSE: FTSE 100 down amid stubborn US inflation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831152212"", ""headline"": ""Big Pharma's biggest ally gets trolled on X for attacking Medicare drug pricing list"", ""summary"": ""Drug lobbying firm PhRMA faced backlash on social media for its attempt to call Medicare pricing negotiations unfair.""}, {""date"": ""20230831163500"", ""headline"": ""Merck & Co. Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. slipped 1.12% to $108.98 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20230901030336"", ""headline"": ""Goldman Sachs Growth Stocks: Top 12 Stocks"", ""summary"": ""In this piece, we will take a look at Goldman Sachs\u2019 top 12 growth stock picks. If you want to skip the latest about one of America\u2019s most well known banks, then head on over to Goldman Sachs Growth Stocks: Top 5 Stocks. Investment bank The Goldman Sachs Group, Inc. (NYSE:GS) is making a lot [\u2026]""}, {""date"": ""20230901064700"", ""headline"": ""Merck generates strong cash flows from its portfolios, says Argus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901163500"", ""headline"": ""Merck & Co. Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.79% higher to $109.84 Friday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""20230901172306"", ""headline"": ""Judge withdraws from Medicare drug price case after stock ownership is revealed"", ""summary"": ""Judge Thomas Rose of the U.S. District Court for the Southern District of Ohio withdrew from a case that could block Medicare's drug price negotiation program.""}, {""date"": ""20230902010500"", ""headline"": ""Lilly, Novo Nordisk top pharma performers in August; AstraZeneca, Roche lag"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230903034500"", ""headline"": ""Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal"", ""summary"": ""Explore groundbreaking insights on GenFleet and Verastem's innovations in the China biotech landscape. Click here for more with China Bio Today's latest article.""}, {""date"": ""20230903110000"", ""headline"": ""Why is big pharma unmoved despite Medicare pricing threat?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230903130023"", ""headline"": ""Possible Bearish Signals With Merck Insiders Disposing Stock"", ""summary"": ""Many Merck & Co., Inc. ( NYSE:MRK ) insiders ditched their stock over the past year, which may be of interest to the...""}]",{}
9,2023-09-03,108.31197357177734,2023-09-10,107.53297424316406,-0.007192181094337169,D1,"[{""date"": ""20230903034500"", ""headline"": ""Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal"", ""summary"": ""Explore groundbreaking insights on GenFleet and Verastem's innovations in the China biotech landscape. Click here for more with China Bio Today's latest article.""}, {""date"": ""20230903110000"", ""headline"": ""Why is big pharma unmoved despite Medicare pricing threat?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230903130023"", ""headline"": ""Possible Bearish Signals With Merck Insiders Disposing Stock"", ""summary"": ""Many Merck & Co., Inc. ( NYSE:MRK ) insiders ditched their stock over the past year, which may be of interest to the...""}, {""date"": ""20230905001200"", ""headline"": ""Stock market today: Asian markets are mostly lower as oil prices push higher"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905033600"", ""headline"": ""Merck & Co. Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905051300"", ""headline"": ""Healthcare Portfolio: A Mixed Market Looking for Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905070900"", ""headline"": ""Portage Biotech collaborating with Merck to evaluate antitumor combination"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905071300"", ""headline"": ""Merck announces new 10-year LTFU Gardasil data published in Pediatrics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905072700"", ""headline"": ""Cantor Fitzgerald Sticks to Its Buy Rating for Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905074300"", ""headline"": ""Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905083703"", ""headline"": ""Portage Biotech in Keytruda Collaboration With Merck"", ""summary"": ""By Chris Wack Portage Biotech has entered into a clinical trial collaboration agreement with Merck to evaluate Portage's next-generation adenosine antagonists in combination with Keytruda,...""}, {""date"": ""20230905083900"", ""headline"": ""Novartis sues U.S. government over price regulation, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905085402"", ""headline"": ""Merck : Gardasil 9 Long-Term Followup Study Finds No Serious Adverse Effects or Deaths"", ""summary"": ""By Mary de Wet Merck said a 10-year followup study of girls and boys who received a three-dose regimen of Gardasil 9 found no serous adverse effects or deaths. Gardasil 9 is a human...""}, {""date"": ""20230905104500"", ""headline"": ""Merck to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference"", ""summary"": ""RAHWAY, N.J., September 05, 2023--Merck to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference""}, {""date"": ""20230905110900"", ""headline"": ""Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905120000"", ""headline"": ""Long-Term Follow-up Data on Sustained Immunogenicity and Safety for GARDASIL\u00ae9 Published in Pediatrics"", ""summary"": ""RAHWAY, N.J., September 05, 2023--Long-Term Follow-up Data on Sustained Immunogenicity and Safety for GARDASIL\u00ae9 Published in Pediatrics""}, {""date"": ""20230905165519"", ""headline"": ""Cantor Fitzgerald Reiterates Merck (MRK) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20230905180145"", ""headline"": ""Dow tumbles nearly 200 points, Nasdaq falls a third straight day as Fed rate hike fears return: Live updates"", ""summary"": ""Stocks sold off Wednesday, continuing the sluggish start to September, as concerns mounted that the Federal Reserve may not be done hiking interest rates.""}, {""date"": ""20230906021800"", ""headline"": ""The 25 Best Stocks By Shareholder Wealth Creation (1926-2022)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906025200"", ""headline"": ""How one big stock-market investor is positioning for a decade of inflation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906033600"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906070700"", ""headline"": ""These four Dow stocks take top prizes for dividend growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906084218"", ""headline"": ""Merck - Long-Term Follow-up Data on Sustained Immunogenicity and Safety for GARDASIL9 Published in Pediatrics"", ""summary"": ""certain cancers , or external genital warts observed; One case of CIN1 tested positive for HPV 16, 39 and 59 was observed at Month 84. Cervical cytology results were negative at subsequent visits; In...""}, {""date"": ""20230906084900"", ""headline"": ""Dow drops 88 points on losses for shares of Merck, Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906091700"", ""headline"": ""Video: Dow Movers: MRK, CRM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906095100"", ""headline"": ""Apple, Merck share losses lead Dow's 175-point drop"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906110309"", ""headline"": ""15 Stocks to Buy with Steady Dividends"", ""summary"": ""In this article, we discuss 15 stocks to buy with steady dividends. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Stocks to Buy with Steady Dividends. Investment trends have evolved significantly over time in response to shifts in the market and the [\u2026]""}, {""date"": ""20230906144051"", ""headline"": ""Is Amgen A Worthy Investment Despite President Biden's Inflation Reduction Act?"", ""summary"": ""Amgen discovers, develops, manufactures, and delivers human therapeutics worldwide. Find out why we initiate our coverage of AMGN stock with a hold rating.""}, {""date"": ""20230906184025"", ""headline"": ""Merck & Co., Inc. (MRK) Citi 18th Annual BioPharma Conference (Transcript)"", ""summary"": ""Merck & Co., Inc. (NYSE:NYSE:MRK) Citi 18th Annual BioPharma Conference September 6, 2023 1:50 PM ETCompany ParticipantsMarjorie Green - SVP and Head of Late Stage Oncology, Global...""}, {""date"": ""20230907024300"", ""headline"": ""Astellas withdraws federal lawsuit over Medicare drug pricing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907054700"", ""headline"": ""European Commission approves expanded indication for Merck's ERVEBO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907062808"", ""headline"": ""Bionomics Shares Soar 65% Since August Ahead Of Commencing Planned Phase III Trial To Treat PTSD And SAD ($BNOX)"", ""summary"": ""Bionomics Limited shares have kicked into rally mode, surging by over 65% since August 22nd to score an intra-week high thus far of $1.98. The rally is deserved, with the fuse lit after BNOX...""}, {""date"": ""20230907064602"", ""headline"": ""European Commission Expands Merck's ERVEBO\u00ae [Ebola Zaire Vaccine, (rVSV\u0394G-ZEBOV-GP) live] Indication to Include Children 1 Year of Age and Older"", ""summary"": ""Milestone signifies ongoing effort to help prepare for outbreaks of Zaire ebolavirus...""}, {""date"": ""20230907104500"", ""headline"": ""European Commission Expands Merck\u2019s ERVEBO\u00ae [Ebola Zaire Vaccine, (rVSV\u0394G-ZEBOV-GP) live] Indication to Include Children 1 Year of Age and Older"", ""summary"": ""RAHWAY, N.J., September 07, 2023--European Commission Expands Merck\u2019s ERVEBO\u00ae [Ebola Zaire Vaccine, (rVSV\u0394G-ZEBOV-GP) live] Indication to Include Children 1 Year of Age and Older""}, {""date"": ""20230907110032"", ""headline"": ""Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 78%"", ""summary"": ""Key Insights Institutions' substantial holdings in Merck implies that they have significant influence over the...""}, {""date"": ""20230907110802"", ""headline"": ""7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth"", ""summary"": ""Pharma stocks can be a great way to add profits to your investment account. Companies that make lifesaving medications or develop treatments to ease symptoms can be true moneymakers. Finding the best pharma stocks to buy is well worth your time and effort. But finding the right pharma stocks to buy can be tricky. You have to be comfortable with some fundamental truths about pharma stocks before you can decide if this is a good investment for you. Pharma stocks are heavily affected by regulation.""}, {""date"": ""20230907131142"", ""headline"": ""Vanguard High Dividend Yield ETF: A 3.1% Yielding Dividend ETF For Your Retirement Portfolio"", ""summary"": ""Vanguard High Dividend Yield ETF is a diversified investment portfolio focused on high-quality dividend stocks. Find out if VYM is a buy.""}, {""date"": ""20230907152030"", ""headline"": ""4 Factor Dividend Growth Portfolio - Closing In On A Historic First Year"", ""summary"": ""The 4-factor dividend growth portfolio strategy has outperformed the S&P 500 in August by 1.02% and generating 3.95% alpha since inception. Click here to read the update.""}, {""date"": ""20230907160800"", ""headline"": ""IN BRIEF: Merck's Ervebo vaccine approved by European Commission"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908000309"", ""headline"": ""Biopharma Bounce-Back: From Policy Pains To Profitable Plains"", ""summary"": ""The legal challenges by big pharma companies against the IRA may derail the implementation of the drug pricing reforms. Click here for a detailed analysis.""}, {""date"": ""20230908020600"", ""headline"": ""Catalyst Watch: Arm IPO, Apple event, and Senate AI Forum with Musk, Zuckerberg, and Gates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908021100"", ""headline"": ""BriaCell falls after Phase 2 data for lead asset in breast cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908033600"", ""headline"": ""Merck & Co. Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908055704"", ""headline"": ""Imminent Phase 3 Trials To Treat PTSD And SAD Send Bionomics Ltd. Stock Higher By Over 60% Since August ($BNOX)"", ""summary"": ""Bionomics Limited shares are attracting investor attention. And rightly so, noting that the company is nearing the commencement of potentially two near-term Phase 3 trials to treat critical unmet...""}, {""date"": ""20230909022000"", ""headline"": ""Pfizer Vs. Gilead Sciences: COVID-19 Battle Of Pharma Titans"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230909121645"", ""headline"": ""Why It Might Not Make Sense To Buy Merck & Co., Inc. (NYSE:MRK) For Its Upcoming Dividend"", ""summary"": ""Readers hoping to buy Merck & Co., Inc. ( NYSE:MRK ) for its dividend will need to make their move shortly, as the...""}, {""date"": ""20230910043600"", ""headline"": ""Gilead says Trodelvy with Merck\u2019s Keytruda controls lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910090500"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of September 10"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the September 10 weekly update.""}, {""date"": ""20230910111900"", ""headline"": ""DTD: Almost Identical To DLN, And No Specific Edge"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
10,2023-09-10,107.53297424316406,2023-09-17,106.7470474243164,-0.0073087053006684055,D1,"[{""date"": ""20230910043600"", ""headline"": ""Gilead says Trodelvy with Merck\u2019s Keytruda controls lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910090500"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of September 10"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the September 10 weekly update.""}, {""date"": ""20230911001410"", ""headline"": ""DTD: Almost Identical To DLN, And No Specific Edge"", ""summary"": ""WisdomTree Total U.S. Dividend ETF is almost identical to DLN in strategy and behavior. Learn why DTD ETF has lagged S&P 500 and SCHD.""}, {""date"": ""20230911032000"", ""headline"": ""IN BRIEF: Gilead says Troldevy & Keytruda lung cancer trial promising"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911033600"", ""headline"": ""Merck & Co. Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911084300"", ""headline"": ""IN THE KNOW: \""Sell AO and to switch into Marks Electrical\"" - Shore"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911100200"", ""headline"": ""Interesting MRK Put And Call Options For January 2026"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911114500"", ""headline"": ""Merck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Adults with Pulmonary Arterial Hypertension (PAH)"", ""summary"": ""RAHWAY, N.J., September 11, 2023--Merck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Pulmonary Arterial Hypertension (PAH)""}, {""date"": ""20230911115100"", ""headline"": ""Gilead's Breast Cancer Drug Shows Promise When Combined With Merck's Treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911120655"", ""headline"": ""Reasons for the Rise of Merck & Co. (MRK) in Q2"", ""summary"": ""Carillon Tower Advisers, an investment management company, released its \u201cCarillon Eagle Growth & Income Fund\u201d Q2 2023 investor letter. A copy of the same can be downloaded here. The S&P Index closed the quarter with a gain of 8.7%, which made the first half of the year\u2019s return rose 16%. These gains suggest steady growth, but [\u2026]""}, {""date"": ""20230911154103"", ""headline"": ""Moderna enters cancer collaboration with Immatics worth $1.8B"", ""summary"": ""Moderna Inc. has entered its third cancer-related collaboration, following on the apparent success of the cancer vaccine it developed with Merck & Co.""}, {""date"": ""20230911164022"", ""headline"": ""Merck & Co., Inc. (MRK) Morgan Stanley 21st Annual Global Healthcare Conference (Transcript)"", ""summary"": ""Merck & Co., Inc. (NYSE:NYSE:MRK) Morgan Stanley 21st Annual Global Healthcare Conference September 11, 2023 2:15 PM ETCompany ParticipantsDean Li - PresidentCaroline Litchfield - Chief...""}, {""date"": ""20230912033600"", ""headline"": ""Merck & Co. Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912071300"", ""headline"": ""IO Biotech announces data related to IO102-IO103 in combination with KEYTRUDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912084000"", ""headline"": ""Geron rises as Goldman Sachs upgrades citing FDA nod for imetelstat"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912091000"", ""headline"": ""Dow's nearly 100-point drop led by losses for shares of Amgen, Procter & Gamble"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912094529"", ""headline"": ""Merck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Adults with Pulmonary Arterial Hypertension"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced new analyses from studies of sotatercept, Merck s novel investigational activin signaling inhibitor biologic,...""}, {""date"": ""20230912211618"", ""headline"": ""12 Best Pharma ETFs"", ""summary"": ""In this article, we discuss the 12 best pharma ETFs. If you want to skip our discussion on the pharma industry, you can go directly to the 5 Best Pharma ETFs. As of 2023, Deloitte has valued the pharmaceutical, biotechnology, and medical technology industries at $2.83 trillion. A report on the Global Pharmaceuticals Outlook by [\u2026]""}, {""date"": ""20230913033600"", ""headline"": ""Merck & Co. Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230913081700"", ""headline"": ""Why Is Moderna Stock Trading Higher Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230913110108"", ""headline"": ""Is Merck (NYSE:MRK) A Risky Investment?"", ""summary"": ""Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...""}, {""date"": ""20230913113700"", ""headline"": ""Mainz Biomed Paves The Way For Early Colorectal Cancer Diagnosis And Even Prevention"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230913122300"", ""headline"": ""Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230913215018"", ""headline"": ""Merck (MRK) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Merck (MRK) closed the most recent trading day at $107.81, moving -1.11% from the previous trading session.""}, {""date"": ""20230914012200"", ""headline"": ""FDA approves new and updated indications for Merck's temozolomide"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914022100"", ""headline"": ""FTC warns pharma industry on improperly listed patents"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914033600"", ""headline"": ""Merck & Co. Inc. stock rises Thursday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914050800"", ""headline"": ""Bionomics provides update on Merck collaboration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914100400"", ""headline"": ""December 15th Options Now Available For Merck (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914110355"", ""headline"": ""Merck & Co Inc (MRK): A Comprehensive Analysis of its Dividend Performance and Sustainability"", ""summary"": ""Merck & Co Inc(NYSE:MRK) recently announced a dividend of $0.73 per share, payable on 2023-10-06, with the ex-dividend date set for 2023-09-14.  As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.  Using the data from GuruFocus, let's deep dive into Merck & Co Incs dividend performance and assess its sustainability.""}, {""date"": ""20230914123700"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230915033600"", ""headline"": ""Merck & Co. Inc. stock falls Friday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230915042700"", ""headline"": ""VTI ETF: This Diversified Powerhouse Owns Over 3,800 Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230915081800"", ""headline"": ""Merck announces CHMP opinion recommending approval of Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230915093300"", ""headline"": ""Merck gets positive EU opinion for Keytruda to treat lung cancer form"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230915130218"", ""headline"": ""AbbVie Vs. AstraZeneca: Battle Of The Pharmaceutical Behemoths"", ""summary"": ""AstraZeneca's (AZN) strong revenue growth outperforms AbbVie's (ABBV) declining sales. Click here to read more on the battle of the pharmaceutical behemoths.""}, {""date"": ""20230915131000"", ""headline"": ""Merck Receives Positive EU CHMP Opinion for KEYTRUDA\u00ae (pembrolizumab) as Adjuvant Treatment for Adults with Non-Small Cell Lung Cancer at High Risk of Recurrence Following Complete Resection and Platinum-Based Chemotherapy"", ""summary"": ""RAHWAY, N.J., September 15, 2023--Merck Receives Positive EU CHMP Opinion for KEYTRUDA as Adjuvant Treatment for NSCLC at High Risk of Recurrence Following Resection and Chemotherapy""}, {""date"": ""20230916082636"", ""headline"": ""IXJ: Healthcare Dashboard For September"", ""summary"": ""Healthcare providers and pharmaceuticals/biotechnology look fairly valued, whereas healthcare equipment is the less attractive subsector. Read more here.""}, {""date"": ""20230917013000"", ""headline"": ""New Cancer Drugs Are Changing the Odds. The Latest on Treatments."", ""summary"": ""Over the past decade, a series of drugs and vaccines that use our immune systems to fight cancer have arrived. Survival times for some deadly cancers are...""}, {""date"": ""20230917213615"", ""headline"": ""17 Best Low Risk Investments in 2023"", ""summary"": ""In this article, we will take a look at the 16 best low risk investments in 2023. To see more such companies, go directly to 5 Best Low Risk Investments in 2023. Investors are still in a wait and see mode after the latest inflation and retail sales report which give mixed signals. Some analysts [\u2026]""}]",{}
11,2023-09-17,106.7470474243164,2023-09-24,105.57553100585938,-0.010974696225557246,D2,"[{""date"": ""20230917013000"", ""headline"": ""New Cancer Drugs Are Changing the Odds. The Latest on Treatments."", ""summary"": ""Over the past decade, a series of drugs and vaccines that use our immune systems to fight cancer have arrived. Survival times for some deadly cancers are...""}, {""date"": ""20230917213615"", ""headline"": ""17 Best Low Risk Investments in 2023"", ""summary"": ""In this article, we will take a look at the 16 best low risk investments in 2023. To see more such companies, go directly to 5 Best Low Risk Investments in 2023. Investors are still in a wait and see mode after the latest inflation and retail sales report which give mixed signals. Some analysts [\u2026]""}, {""date"": ""20230918020700"", ""headline"": ""Promising Preclinical Results From Blood Cancer Propel Oncternal To Buy Rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230918020800"", ""headline"": ""AARP weighs in on Merck case challenging Medicare drug negotiation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230918033700"", ""headline"": ""Merck & Co. Inc. stock rises Monday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230918103600"", ""headline"": ""Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230918122900"", ""headline"": ""Merck (MRK) Gets CHMP Nod for Keytruda in Adjuvant Lung Cancer"", ""summary"": ""Merck's (MRK) Keytruda gets a positive CHMP opinion, recommending the approval of the drug for the adjuvant treatment of adults with non-small cell lung cancer, who are at high risk of recurrence, in the EU.""}, {""date"": ""20230918124659"", ""headline"": ""SCHD: Stop The Madness"", ""summary"": ""Schwab U.S. Dividend Equity ETF offers a combination of slow growth blue chip names with consistent dividend hikes. Click here for a detailed analysis on SCHD.""}, {""date"": ""20230919025400"", ""headline"": ""Check Out What Whales Are Doing With MRK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230919033600"", ""headline"": ""Merck & Co. Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230919054900"", ""headline"": ""Merck's supplemental New Drug Application for Welireg accepted by FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230919062100"", ""headline"": ""Merck wins FDA priority review for kidney cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230919080000"", ""headline"": ""FDRR: Attractive Value And Quality, Yet Lagging In Rising Rates"", ""summary"": ""FDRR ETF holds dividend stocks showing a positive correlation to 10-year U.S. Treasury yields. Find out why I'm neutral on the fund.""}, {""date"": ""20230919102206"", ""headline"": ""UPDATE 2-BeiGene regains rights for cancer drug after Novartis deal termination"", ""summary"": ""Beigene said on Tuesday it would regain rights to develop and sell its cancer drug globally from Swiss drugmaker Novartis after the companies mutually decided to end their licensing deal.  Beigene will get back full global rights to the drug, tislelizumab, or Tevimbra, with no royalty payments due to Novartis.  The drug, an anti-PD-1 monoclonal antibody, helps the body's immune system to detect and attack tumors, much like Keytruda from Merck Opdivo from Bristol-Myers Squibb.""}, {""date"": ""20230919104500"", ""headline"": ""FDA Accepts for Priority Review Merck\u2019s Supplemental New Drug Application for WELIREG\u00ae (belzutifan) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)"", ""summary"": ""RAHWAY, N.J., September 19, 2023--FDA Accepts for Priority Review Merck\u2019s Supplemental New Drug Application for WELIREG\u00ae in Certain Previously Treated Patients With Advanced RCC""}, {""date"": ""20230919144533"", ""headline"": ""Regeneron Pharmaceuticals: Game-Changing Discoveries In Healthcare"", ""summary"": ""Regeneron Pharmaceuticals Q2 2023 revenue exceeded expectations despite competition and falling Eylea sales. Click here to read an analysis on REGN stock now.""}, {""date"": ""20230920033600"", ""headline"": ""Merck & Co. Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920041359"", ""headline"": ""Merck: Secure A Safe 8% Annualized Return For The Next Decade"", ""summary"": ""Merck's strong performance in the past two years has outperformed the market. Find out why I recommend a Buy rating for MRK stock at its current price.""}, {""date"": ""20230920054800"", ""headline"": ""Merck: FDA grants priority review to sBLA for Keytruda+concurrent chemotherapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920062100"", ""headline"": ""Merck granted FDA priority review for Keytruda in uterine cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920065200"", ""headline"": ""Exscientia\u2019s stock rockets toward a record gain after AI-driven drug discovery collaboration with Germany\u2019s Merck KGaA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920091300"", ""headline"": ""Merck says new Keytruda application granted priority review by US FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920104500"", ""headline"": ""FDA Grants Priority Review to Merck\u2019s Application for KEYTRUDA\u00ae (pembrolizumab) Plus Concurrent Chemoradiotherapy as Treatment for Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer"", ""summary"": ""RAHWAY, N.J., September 20, 2023--FDA Grants Priority Review to Merck\u2019s Application for KEYTRUDA + Concurrent Chemoradiotherapy for Newly Diagnosed Locally Advanced Cervical Cancer""}, {""date"": ""20230920113200"", ""headline"": ""Broker Darlings of the Dow: Merck Ranks As a Top 15 Analyst Pick"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920113800"", ""headline"": ""Video: Dow Analyst Moves: MRK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920121450"", ""headline"": ""Merck: A Blue-Chip Dividend Stock Worth Buying"", ""summary"": ""Merck's dividend appears secure with strong payout ratios, while a diverse product portfolio indicates potential growth. Find out if MRK stock is a buy.""}, {""date"": ""20230920144500"", ""headline"": ""FDA Accepts Merck (MRK) sNDA for Welireg in Renal Cell Carcinoma"", ""summary"": ""The FDA filing is supported by data from a late-stage study that shows that Merck's (MRK) Welireg achieved statistically significant and clinically meaningful improvement in progression-free survival.""}, {""date"": ""20230921033600"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230921081644"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: September 2023 Fair Value Update"", ""summary"": ""I've been building my cash position in preparation for a market crash and taking advantage of high interest rates. Read more here.""}, {""date"": ""20230921100000"", ""headline"": ""Merck: Still Fundamentally Undervalued Considering Keytruda's Prospects"", ""summary"": ""Keytruda is proving effective in treating more and more types of cancer. Read here to know how this impacts MRK stock's revenue and profitability going forward.""}, {""date"": ""20230921122300"", ""headline"": ""Pfizer Paxlovid efficacy lower in real-world study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230921122600"", ""headline"": ""Merck (MRK) Keytruda Cervical Cancer sBLA Gets FDA Priority Tag"", ""summary"": ""The FDA grants priority review to Merck's (MRK) sBLA seeking expanded use of Keytruda for an earlier stage of cervical cancer disease.""}, {""date"": ""20230921124100"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922045300"", ""headline"": ""Seagen, Astellas Pharma report 'positive' results from Phase 3 EV-302 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922050200"", ""headline"": ""Merck confirms Phase 3 KEYNOTE-A39/EV-302 trial met dual primary endpoints"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922054800"", ""headline"": ""Merck, Eisai provide update on Phase 3 trials, LEAP-006 and LEAP-008"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922055500"", ""headline"": ""Merck succeeds in Phase 3 trial for bladder cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922063200"", ""headline"": ""Merck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits Endpoints"", ""summary"": ""By Colin Kellaher A Phase 3 study of a cancer-drug combination from Merck &amp; Co., Seagen and Astellas Pharma has met its key goals in certain patents with...""}, {""date"": ""20230922064500"", ""headline"": ""Merck and Eisai Provide Update on Two Phase 3 Trials Evaluating KEYTRUDA\u00ae (pembrolizumab) Plus LENVIMA\u00ae (lenvatinib) in Patients With Certain Types of Metastatic Non-Small Cell Lung Cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922071600"", ""headline"": ""Merck, Eisai: Keytruda/Lenvima Combo Fails in Two Non-Small Cell Lung Cancer Studies"", ""summary"": ""By Colin Kellaher A pair of late-stage studies of a cancer-drug combination from Merck &amp; Co. and Eisai missed their main goals in patients with certain...""}, {""date"": ""20230922073100"", ""headline"": ""Merck and Eisai say two lung-cancer trials failed to meet their main goals"", ""summary"": ""Two late-stage trials of a treatment for a certain type of non-small lung cancer failed to meet their primary goals, the companies said Friday.""}, {""date"": ""20230922073900"", ""headline"": ""Merck and Eisai announce Phase 3 setbacks for lung cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922080900"", ""headline"": ""4 stocks to watch on Friday: Activision Blizzard, Apple and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922082600"", ""headline"": ""Merck says two trials miss primary endpoints; third trial positive"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922092400"", ""headline"": ""Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922100000"", ""headline"": ""Merck Announces Phase 3 KEYNOTE-A39/EV-302 Trial Met Dual Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer"", ""summary"": ""RAHWAY, N.J., September 22, 2023--Merck Announces Phase 3 KEYNOTE-A39/EV-302 Trial Met Dual Primary Endpoints of OS & PFS in Certain Patients With Previously Untreated la/m UC""}, {""date"": ""20230922121452"", ""headline"": ""Merck Vs. GSK: The Game-Changer Race In Pharma Excellence"", ""summary"": ""Despite the increasing number of emerging challenges for the pharmaceutical industry, the management teams at GSK and Merck are successfully coping with them. Learn which one is best.""}, {""date"": ""20230922163500"", ""headline"": ""Merck & Co. Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. shed 0.37% to $106.34 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230922194755"", ""headline"": ""20 Most Innovative Companies in America"", ""summary"": ""In this article, we will take a look at the most innovative companies in America. If you want to explore similar companies, you can go to 5 Most Innovative Companies in America. Innovation and American Companies Innovation comes with new and creative ideas that bring a healthy change in society. Innovation in business and technology [\u2026]""}]",{}
12,2023-09-24,105.57553100585938,2023-10-01,102.20990753173828,-0.03187882118191099,D4,"[{""date"": ""20230925042708"", ""headline"": ""Verve's New Beat: CMO Onboard, Catalysts Ahead, But We're Dancing Solo For Now"", ""summary"": ""Verve Therapeutics' Q2 2023 results show progress in their VERVE-101 trial, with a new CMO appointed. Read why we maintain a Hold rating for VERV stock.""}, {""date"": ""20230925043000"", ""headline"": ""Merck COVID drug molnupiravir linked to virus mutation transmission"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230925072500"", ""headline"": ""With Cancer Immunotherapy Market Set To Grow At Double-Digit CAGR Till 2032, This Company Plans To Ride The Wave Through Treatments For Complex Cancers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230925094500"", ""headline"": ""3M, Merck share losses lead Dow's nearly 100-point drop"", ""summary"": ""Shares of 3M and Merck are trading lower Monday morning, sending the Dow Jones Industrial Average into negative territory. Shares of 3M and Merck are...""}, {""date"": ""20230925135607"", ""headline"": ""10 Best Ways to Prevent Type 2 Diabetes"", ""summary"": ""In this article, we shall discuss the 10 best ways to prevent type 2 diabetes. To skip our detailed analysis of the global diabetes industry and the larger pharmaceutical industry in 2023, go directly and see 5 Best Ways to Prevent Type 2 Diabetes. Diabetes is directly responsible for more than 280,000 deaths each year. [\u2026]""}, {""date"": ""20230925143900"", ""headline"": ""Merck\u2019s COVID antiviral may be linked to virus mutations, study finds"", ""summary"": ""Molnupiravir, which was granted an emergency use authorization by the FDA in December 2021, may allow mutated viruses to spread, a study has found.""}, {""date"": ""20230925160600"", ""headline"": ""Merck (MRK), Eisai Combo Therapy Fail Two Lung Cancer Studies"", ""summary"": ""Data from both late-stage studies evaluating Merck's (MRK) Keytruda and Eisai's Lenvima combination in certain types of metastatic non-small cell lung cancer, fail to achieve their primary endpoints.""}, {""date"": ""20230925163500"", ""headline"": ""Merck & Co. Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. slipped 0.47% to $105.84 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230926040000"", ""headline"": ""MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230926084000"", ""headline"": ""Unusually active option classes on open September 26th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230926122020"", ""headline"": ""Big Pharma R&D Spending: The Secret Ingredient To Outperformance?"", ""summary"": ""High R&D spending by pharma companies does not necessarily lead to sales growth, let alone shareholder returns. See why bold M&A deals may be a different story.""}, {""date"": ""20230926163500"", ""headline"": ""Merck & Co. Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Merck & Co. Inc. shed 0.43% to $105.39 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20230927104800"", ""headline"": ""Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927105300"", ""headline"": ""Dow falls nearly 100 points on losses for Walgreens Boots, Johnson & Johnson stocks"", ""summary"": ""The Dow Jones Industrial Average is falling Wednesday morning with shares of Walgreens Boots and Johnson & Johnson delivering the stiffest headwinds for the...""}, {""date"": ""20230927120600"", ""headline"": ""Johnson & Johnson, Verizon share losses contribute to Dow's 186-point fall"", ""summary"": ""Shares of Johnson & Johnson and Verizon are seeing declines Wednesday afternoon, dragging the Dow Jones Industrial Average into negative territory. Shares of...""}, {""date"": ""20230927130014"", ""headline"": ""Merck & Co., Inc.'s (NYSE:MRK) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?"", ""summary"": ""It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 6.3% over...""}, {""date"": ""20230927132700"", ""headline"": ""Dow's 270-point fall led by losses in shares of Walgreens Boots, Johnson & Johnson"", ""summary"": ""The Dow Jones Industrial Average is falling Wednesday afternoon with shares of Walgreens Boots and Johnson & Johnson facing the biggest declines for the...""}, {""date"": ""20230927142900"", ""headline"": ""Dow down nearly 175 points on losses for shares of McDonald's, Verizon"", ""summary"": ""Behind declines for shares of McDonald's and Verizon, the Dow Jones Industrial Average is falling Wednesday afternoon. The Dow was most recently trading 172...""}, {""date"": ""20230927155300"", ""headline"": ""Dow down 88 points on losses for shares of Verizon, McDonald's"", ""summary"": ""Dragged down by declines for shares of Verizon and McDonald's, the Dow Jones Industrial Average is falling Wednesday afternoon. The Dow was most recently...""}, {""date"": ""20230927163500"", ""headline"": ""Merck & Co. Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. shed 1.38% to $103.94 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20230927204300"", ""headline"": ""Top Stock Reports for Alphabet, Exxon Mobil & Merck"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Exxon Mobil Corp. (XOM) and Merck & Co., Inc. (MRK).""}, {""date"": ""20230928022100"", ""headline"": ""Amazon Web Services Now Offers Generative AI Tools For Businesses, Catches Up With Microsoft Azure, Google Cloud"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928032300"", ""headline"": ""Mirati stock climbs 10% ahead of data presentation, FDA meeting on rival drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928033300"", ""headline"": ""Teva names Novartis exec to lead US commercial business"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928054900"", ""headline"": ""Merck's new application for sotatercept given priority review by FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928061300"", ""headline"": ""Merck wins FDA priority review for lung disease therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928071100"", ""headline"": ""Merck Gets FDA Priority Review of Sotatercept in Pulmonary Arterial Hypertension >MRK"", ""summary"": ""By Colin Kellaher Merck &amp; Co. has won U.S. Food and Drug Administration priority review of its sotatercept drug candidate for the treatment of adults...""}, {""date"": ""20230928092100"", ""headline"": ""Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928095000"", ""headline"": ""Merck, Bristol Myers, AstraZeneca agree to Medicare drug pricing talks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928101400"", ""headline"": ""Dow's 84-point rally led by gains for UnitedHealth, JPMorgan Chase shares"", ""summary"": ""Shares of UnitedHealth and JPMorgan Chase are posting positive momentum Thursday morning, sending the Dow Jones Industrial Average into positive territory....""}, {""date"": ""20230928104500"", ""headline"": ""Merck Receives Priority Review from FDA for New Biologics License Application for Sotatercept, an Activin Signaling Inhibitor to Treat Adults with Pulmonary Arterial Hypertension (PAH)"", ""summary"": ""RAHWAY, N.J., September 28, 2023--Merck Receives Priority Review from FDA for Biologics License Application for Sotatercept, an Activin Signaling Inhibitor to Treat Adults with PAH""}, {""date"": ""20230928113700"", ""headline"": ""The Zacks Analyst Blog Highlights Alphabet, Exxon Mobil, Merck, Abbott Laboratories and NextEra Energy"", ""summary"": ""Alphabet, Exxon Mobil, Merck, Abbott Laboratories and NextEra Energy are part of the Zacks top Analyst Blog.""}, {""date"": ""20230928163500"", ""headline"": ""Merck & Co. Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.35% higher to $104.30 Thursday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20230929033600"", ""headline"": ""Merck & Co. Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929092100"", ""headline"": ""As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929102000"", ""headline"": ""As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment\u00a0"", ""summary"": ""A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.""}, {""date"": ""20230929123900"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231001062143"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of October 1"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the update for the week of October 1.""}, {""date"": ""20231001093100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: POINT Biopharma Global (PNT), Keros Therapeutics (KROS) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.5541, ""bookValue"": 41246, ""cashRatio"": 0.37260760370659046, ""currentRatio"": 1.3836, ""ebitPerShare"": 2.2569, ""eps"": 1.8637, ""ev"": 286476.8, ""fcfMargin"": 0.427, ""fcfPerShareTTM"": 5.1941, ""grossMargin"": 0.7349, ""inventoryTurnoverTTM"": 2.7183, ""longtermDebtTotalAsset"": 0.3183, ""longtermDebtTotalCapital"": 0.4464, ""longtermDebtTotalEquity"": 0.8236, ""netDebtToTotalCapital"": 0.345, ""netDebtToTotalEquity"": 0.6365, ""netMargin"": 0.2973, ""operatingMargin"": 0.36, ""payoutRatioTTM"": 0.5157, ""pb"": 6.309, ""peTTM"": 56.472, ""pfcfTTM"": 19.7633, ""pretaxMargin"": 0.3521, ""psTTM"": 4.3872, ""ptbv"": 11.8031, ""quickRatio"": 1.1182, ""receivablesTurnoverTTM"": 5.9684, ""roaTTM"": 0.0431, ""roeTTM"": 0.1067, ""roicTTM"": 0.0602, ""rotcTTM"": 0.094, ""salesPerShare"": 6.2694, ""sgaToSale"": 0.2651, ""tangibleBookValue"": 22047, ""totalDebtToEquity"": 0.8451, ""totalDebtToTotalAsset"": 0.3266, ""totalDebtToTotalCapital"": 0.458, ""totalRatio"": 1.6299, ""period"": ""2023-09-30""}"
13,2023-10-01,102.20990753173828,2023-10-08,103.13321685791016,0.00903346210234246,U1,"[{""date"": ""20231001062143"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of October 1"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the update for the week of October 1.""}, {""date"": ""20231001093100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: POINT Biopharma Global (PNT), Keros Therapeutics (KROS) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002020100"", ""headline"": ""Drugmakers comply with Medicare pricing talks despite lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002033700"", ""headline"": ""Merck & Co. Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002111600"", ""headline"": ""Cantor Fitzgerald Reaffirms Their Buy Rating on Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002122800"", ""headline"": ""This fund shows that industry expertise can help you make a lot of money in the stock market"", ""summary"": ""The managers of the Janus Henderson Global Life Sciences Fund have direct experience to help them separate promising innovators from flashes in the pan.""}, {""date"": ""20231002123400"", ""headline"": ""How Is The Market Feeling About Merck & Co?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002123900"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002153400"", ""headline"": ""FDA Accepts Merck's (MRK) Filing for Sotatercept in PAH Disease"", ""summary"": ""The FDA grants priority review to Merck's (MRK) FDA filing for sotatercept to treat adults with pulmonary arterial hypertension. A final decision is expected before March 2023-end.""}, {""date"": ""20231002164952"", ""headline"": ""Drugmakers sign on to negotiate Medicare prices under protest"", ""summary"": ""All the drugmakers that make the 10 prescription medicines  subject to the first-ever price negotiations for the U.S. Medicare health program, including Amgen and Novartis, said they signed on to participate in the talks by the Oct. 1 deadline.  The penalties for not doing so would have been steep: drugmakers would have to pay 65% to 95% taxes on their drug's Medicare sales or withdraw all of their products from the Medicare and Medicaid programs, which together provide health benefits to 158 million Americans.  \""Merck will sign the initial agreement with CMS under protest,\"" the U.S. company said in a statement.""}, {""date"": ""20231003013100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Maravai Lifesciences Holdings (MRVI) and Karuna Therapeutics (KRTX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003033600"", ""headline"": ""Merck & Co. Inc. stock falls Tuesday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003070100"", ""headline"": ""Medicare drug price negotiations move forward with all drugmakers participating, White House says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003075800"", ""headline"": ""PDS Biotech updates Phase 2 data for lead asset in head and neck cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003080000"", ""headline"": ""Medicare drug price negotiations move forward with all drugmakers participating, White House says\u00a0"", ""summary"": ""Novo Nordisk is latest drugmaker to challenge negotiation program in court.""}, {""date"": ""20231003081300"", ""headline"": ""Selected drugmakers agree to US government price talks - White House"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003110600"", ""headline"": ""Merck is Oversold"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003120000"", ""headline"": ""Drugmakers agree to US government price talks amid pushback"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003121200"", ""headline"": ""IN BRIEF: NetScientific portfolio company updates on cancer trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003123900"", ""headline"": ""Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003140000"", ""headline"": ""Merck Helps To Improve Diversity in Clinical Trials Through Beacon of Hope"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / October 3, 2023 / Merck & Co., Inc.Unique collaboration expands our clinical trials efforts to four Historically Black Medical School Clinical Trial Centers of ExcellenceIncreasing diversity in clinical trials plays ...""}, {""date"": ""20231003140806"", ""headline"": ""The 10 pharma companies participating in Medicare price negotiations"", ""summary"": ""Ten pharmaceutical manufacturers are signing the Inflation Reduction Act's Medicare drug price negotiation program. These companies are Bristol Myers Squibb (BMY), AstraZeneca (AZN), Boehringer Ingelheim, Immunex, Janssen Pharmaceuticals, Pharmacyclics, Merck & Company (MRK), Janssen Biotech, Novartis (NVS), and Novo Nordisk (NVO), according to the Biden administration. Yahoo Finance Health Care Reporter Anjalee Khemlani discusses the news. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231004030300"", ""headline"": ""9 Analysts Have This to Say About Merck & Co"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004033700"", ""headline"": ""Merck & Co. Inc. stock rises Wednesday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004085100"", ""headline"": ""Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004090011"", ""headline"": ""Gilead Sciences: A Healthy Buy With Solid Dividend"", ""summary"": ""Gilead Sciences has outperformed the S&P 500 with a 19% total return since my last Buy rating in August last year. Learn why GILD stock is a buy.""}, {""date"": ""20231004125900"", ""headline"": ""US government to stop distributing Merck's COVID-19 drug for free: report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004134601"", ""headline"": ""4 Factor Dividend Growth Portfolio: First Year Is Coming Down To The Wire"", ""summary"": ""Learn about the 4-factor dividend growth portfolio, utilizing the same index as the Schwab U.S. Dividend Equity ETF, with a few minor twists. Click here to read.""}, {""date"": ""20231004140604"", ""headline"": ""Cantor Fitzgerald Reiterates Merck (MRK) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20231004163244"", ""headline"": ""US plans shift of Merck COVID treatment to commercial market"", ""summary"": ""The U.S. government will stop distributing free doses of Merck & Co's COVID-19 antiviral treatment molnupiravir by the middle of next month and expects it to be sold on the commercial market instead.  The Administration for Strategic Preparedness and Response (ASPR), a division of the U.S. Department of Health and Human Services, said in a statement posted on its website late last week they anticipate transition of the drug, sold under the brand name Lagevrio, from government-managed to traditional commercial distribution in November.  Merck, which developed the drug with Ridgeback Biotherapeutics, said in an emailed statement on Wednesday that it needs an updated letter of authorization from the U.S. Food and Drug Administration to allow it to start selling the drug commercially.""}, {""date"": ""20231005060700"", ""headline"": ""Merck announces AMBASSADOR trial meets one of two primary endpoints of DFS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005063300"", ""headline"": ""Merck posts Phase 3 win for Keytruda in muscle-invasive bladder cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005071700"", ""headline"": ""Merck Keytruda Study Hits Key Goal in Advanced Bladder Cancer"", ""summary"": ""By Colin Kellaher A late-stage study of Merck &amp; Co.'s blockbuster cancer drug Keytruda has met one of its key goals in certain patients with an advanced...""}, {""date"": ""20231005072600"", ""headline"": ""Merck reports positive results in late-stage trial of Keytruda as treatment for bladder cancer"", ""summary"": ""Merck & Co. Inc. said Thursday a late-stage trial of its cancer treatment Keytruda met its main goal of disease-free survival for patients with advanced...""}, {""date"": ""20231005080200"", ""headline"": ""EMD Serono Launches New Collaboration with United Nations\u2019 Global Initiative on Ageing to Support Caregivers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005080400"", ""headline"": ""No Merck's COVID-19 Pill - US Government Ceases Free Distribution"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005082700"", ""headline"": ""Merck's Keytruda improves urothelial carcinoma survival, data shows"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005083900"", ""headline"": ""Merck's Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005090300"", ""headline"": ""Disney Slashes Ticket Prices For Children, US Government Ceases Free Distribution Of Merck COVID Pill, UK Deep Dives Into Amazon And Microsoft's Cloud Power: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005104500"", ""headline"": ""Merck to Hold Third-Quarter 2023 Sales and Earnings Conference Call Oct. 26"", ""summary"": ""RAHWAY, N.J., October 05, 2023--Merck to Hold Third-Quarter 2023 Sales and Earnings Conference Call Oct. 26""}, {""date"": ""20231005110000"", ""headline"": ""Merck\u2019s KEYTRUDA\u00ae (pembrolizumab) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Muscle-Invasive Urothelial Carcinoma (MIUC) After Surgery"", ""summary"": ""RAHWAY, N.J., October 05, 2023--Merck\u2019s KEYTRUDA Met Primary Endpoint of Disease-Free Survival in Certain Patients With Muscle-Invasive Urothelial Carcinoma After Surgery""}, {""date"": ""20231005121500"", ""headline"": ""Merck is Collaborating to Address Antimicrobial Resistance"", ""summary"": ""Shared commitments like the AMR Action Fund are vital to make progress against this public health threatNORTHAMPTON, MA / ACCESSWIRE / October 5, 2023 / Antibiotics have transformed health care and saved countless lives. But rising levels of antimicrobial ...""}, {""date"": ""20231005140020"", ""headline"": ""Merck Insiders Sell US$8.3m Of Stock, Possibly Signalling Caution"", ""summary"": ""The fact that multiple Merck & Co., Inc. ( NYSE:MRK ) insiders offloaded a considerable amount of shares over the past...""}, {""date"": ""20231005143000"", ""headline"": ""EMD Serono Launches New Collaboration with United Nations-Guided Global Initiative on Ageing to Support Caregivers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005163500"", ""headline"": ""Merck & Co. Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. rallied 1.40% to $103.60 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20231006160300"", ""headline"": ""Merck's (MRK) Meets Goal in Muscle-Invasive Bladder Cancer Study"", ""summary"": ""Data from a late-stage study shows that Merck's (MRK) Keytruda lowered the risk of disease recurrence or death when used after surgery in certain patients with urothelial carcinoma.""}, {""date"": ""20231006163500"", ""headline"": ""Merck & Co. Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.27% higher to $103.88 Friday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""20231006180948"", ""headline"": ""Biotech-Pharma Trade: Buying Opportunities On The Horizon"", ""summary"": ""Concerns over interest rates, pricing erosion, and Medicare's drug price negotiation plan weigh on biotech and pharma sectors. Learn what investors need to know.""}, {""date"": ""20231006220854"", ""headline"": ""Truist Securities Reiterates Merck (MRK) Buy Recommendation"", ""summary"": """"}, {""date"": ""20231008022300"", ""headline"": ""As FDA mulls fate of Amgen drug, Sanofi could snap up rival Mirati"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.5541, ""bookValue"": 41246, ""cashRatio"": 0.37260760370659046, ""currentRatio"": 1.3836, ""ebitPerShare"": 2.2569, ""eps"": 1.8637, ""ev"": 286476.8, ""fcfMargin"": 0.427, ""fcfPerShareTTM"": 5.1941, ""grossMargin"": 0.7349, ""inventoryTurnoverTTM"": 2.7183, ""longtermDebtTotalAsset"": 0.3183, ""longtermDebtTotalCapital"": 0.4464, ""longtermDebtTotalEquity"": 0.8236, ""netDebtToTotalCapital"": 0.345, ""netDebtToTotalEquity"": 0.6365, ""netMargin"": 0.2973, ""operatingMargin"": 0.36, ""payoutRatioTTM"": 0.5157, ""pb"": 6.309, ""peTTM"": 56.472, ""pfcfTTM"": 19.7633, ""pretaxMargin"": 0.3521, ""psTTM"": 4.3872, ""ptbv"": 11.8031, ""quickRatio"": 1.1182, ""receivablesTurnoverTTM"": 5.9684, ""roaTTM"": 0.0431, ""roeTTM"": 0.1067, ""roicTTM"": 0.0602, ""rotcTTM"": 0.094, ""salesPerShare"": 6.2694, ""sgaToSale"": 0.2651, ""tangibleBookValue"": 22047, ""totalDebtToEquity"": 0.8451, ""totalDebtToTotalAsset"": 0.3266, ""totalDebtToTotalCapital"": 0.458, ""totalRatio"": 1.6299, ""period"": ""2023-09-30""}"
14,2023-10-08,103.13321685791016,2023-10-15,103.26229095458984,0.0012515278841491728,U1,"[{""date"": ""20231008022300"", ""headline"": ""As FDA mulls fate of Amgen drug, Sanofi could snap up rival Mirati"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009014700"", ""headline"": ""3 Artificial Intelligence Stocks That Could Outperform the \u2018Godfather of AI\u2019"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009121300"", ""headline"": ""Will more bidders emerge or CVR ever be paid in Mirati takeover deal?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009163500"", ""headline"": ""Merck & Co. Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.60% higher to $104.50 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20231009193005"", ""headline"": ""Merck: Right On Time"", ""summary"": ""Merck is slowly executing a pivot into adjacent areas of oncology, immunology, and beyond. Read more to see why MRK stock is a Hold.""}, {""date"": ""20231010053200"", ""headline"": ""Merck: KEYNOTE-671 trial meets dual primary endpoint of OS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010061200"", ""headline"": ""Merck succeeds in Phase 3 trial for Keytruda in lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010064700"", ""headline"": ""Merck: Phase 3 Keytruda Study Hits Second Goal in Non-Small Cell Lung Cancer"", ""summary"": ""By Colin Kellaher Merck &amp; Co. on Tuesday said a Phase 3 study of its Keytruda cancer drug met the second of its dual primary endpoints as a perioperative...""}, {""date"": ""20231010065600"", ""headline"": ""Merck reports positive results for blockbuster cancer drug in treating non-small cell lung cancer"", ""summary"": ""Keytruda showed a 'statistically significant and clinically meaningful improvement' in overall survival in a late-stage trial.""}, {""date"": ""20231010071500"", ""headline"": ""Oncotelic Therapeutics' (OTCQB: OTLC) Lead Immunotherapy Candidate For Treating Deadly Cancers, OT-101, Could Hold Potential Applications In Multiple Multi-Billion Dollar Markets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010081300"", ""headline"": ""Merck phase 3 Keytruda trial meets primary overall survival endpoint"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010103000"", ""headline"": ""Merck Announces Pivotal KEYNOTE-671 Trial Meets Dual Primary Endpoint of Overall Survival (OS) in Resectable Stage II, IIIA or IIIB Non-Small Cell Lung Cancer (NSCLC)"", ""summary"": ""RAHWAY, N.J., October 10, 2023--Merck Announces Pivotal KEYNOTE-671 Trial Meets Dual Primary Endpoint of Overall Survival (OS) in Resectable Stage II, IIIA or IIIB NSCLC""}, {""date"": ""20231010113200"", ""headline"": ""Merck's Lead Cancer Drug Meets Primary Goal In Certain Type Of Lung Cancer Patients"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010124500"", ""headline"": ""BioXcel Therapeutics Shares Rise 14% After Positive Trial Data for Cancer Treatment"", ""summary"": ""By Chris Wack BioXcel Therapeutics shares were up 14% to $3.13 after the company reported positive overall survival data from its Phase 2 trial of BXCL701,...""}, {""date"": ""20231010163500"", ""headline"": ""Merck & Co. Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. sank 0.85% to $103.61 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231011021500"", ""headline"": ""Evobrutinib, CNS-Penetrant BTKi, Has Shown Sustained Clinical Benefit Up to Five Years in People with RMS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011031400"", ""headline"": ""EMD Electronics Celebrates Opening of New Arizona Factory, Contributing to the State's Growing Semiconductor Industry"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011103521"", ""headline"": ""AQR Capital Management: AUM, Performance, Stock Picks"", ""summary"": ""In this article, we looked at Cliff Asness\u2019 investment philosophy and outlook on the US stock market. We also reviewed Asness\u2019 AQR Capital Management\u2019s assets under management, performance and stock picks. You can skip our detailed discussion of AQR Capital Management and go straight to AQR Capital Management\u2019s Top 5 Stock Picks. Following record-breaking returns [\u2026]""}, {""date"": ""20231011110031"", ""headline"": ""With 78% institutional ownership, Merck & Co., Inc. (NYSE:MRK) is a favorite amongst the big guns"", ""summary"": ""Key Insights Institutions' substantial holdings in Merck implies that they have significant influence over the...""}, {""date"": ""20231011141500"", ""headline"": ""Merck's (MRK) Keytruda Early-Stage NSCLC Study Shows OS Benefit"", ""summary"": ""Merck's (MRK) phase III study on Keytruda shows a statistically significant overall survival benefit for patients with stage II, IIIA or IIIB NSCLC.""}, {""date"": ""20231011163500"", ""headline"": ""Merck & Co. Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. sank 0.14% to $103.46 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20231011165831"", ""headline"": ""Morgan Stanley Maintains Merck (MRK) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20231012010000"", ""headline"": ""Buy McKesson Stock. Ozempic Can Lift Drug Distributors Too."", ""summary"": ""McKesson\u2019s business is relatively simple. It buys drugs from manufacturers and then distributes them to pharmacies. It's more difficult than it sounds.""}, {""date"": ""20231012055400"", ""headline"": ""Marks Electrical half-year revenue climbs but suffers margin pressure"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012080000"", ""headline"": ""Better Passive Income Snowball: SCHD Or DIVO?"", ""summary"": ""We compare two potential core ETFs for building a passive income snowball. Click here to learn which one is a better fit for the investing strategy.""}, {""date"": ""20231012103200"", ""headline"": ""Stocks to watch out in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012104900"", ""headline"": ""Stocks to watch in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012140746"", ""headline"": ""25 US Cities with Cleanest Air and Water"", ""summary"": ""In this article, we will discuss the 25 US cities with cleanest air and water. If you want to skip our discussion on the overall environmental conditions in the US, you can go directly to the 5 US Cities with Cleanest Air and Water. According to IQAir US, the air quality in the United States [\u2026]""}, {""date"": ""20231012163500"", ""headline"": ""Merck & Co. Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.13% higher to $103.59 Thursday, on what proved to be an all-around poor trading session for the stock market, with the...""}, {""date"": ""20231012205251"", ""headline"": ""15 Worst Performing Dow Stocks YTD"", ""summary"": ""In this article, we discuss 15 worst performing Dow stocks year-to-date. If you want to skip our detailed discussion on stock market performance overall, head directly to 5 Worst Performing Dow Stocks YTD. In a July report by J.P. Morgan, it was stated that global economic growth is expected to slow down in the latter [\u2026]""}, {""date"": ""20231012215018"", ""headline"": ""(MRK) Rises As Market Takes a Dip: Key Facts"", ""summary"": ""In the latest trading session, Merck (MRK) closed at $103.59, marking a +0.13% move from the previous day.""}, {""date"": ""20231013013800"", ""headline"": ""See Which Of The Latest 13F Filers Holds Merck & Co"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013020500"", ""headline"": ""Catalyst watch: Tesla earnings, Jerome Powell speech, UAW drama and Baidu event"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013034100"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Terns Pharmaceuticals (TERN), BridgeBio Pharma (BBIO)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013065100"", ""headline"": ""Merck adopts opinion recommending approval of Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013074500"", ""headline"": ""Merck Receives Positive EU CHMP Opinion for KEYTRUDA\u00ae (pembrolizumab) Plus Chemotherapy as First-Line Treatment for HER2-Negative Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Expressing PD-L1 (CPS \u22651)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013075600"", ""headline"": ""Merck's Keytruda combo gets EMA panel backing for expanded use in gastric cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013091400"", ""headline"": ""Merck receives positive EU opinion for Keytruda to treat cancer forms"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013114500"", ""headline"": ""Merck Receives Positive EU CHMP Opinion for KEYTRUDA\u00ae (pembrolizumab) Plus Chemotherapy as First-Line Treatment for HER2-Negative Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma\nExpressing PD-L1 (CPS \u22651)"", ""summary"": ""RAHWAY, N.J., October 13, 2023--Merck Receives Positive CHMP Opinion for KEYTRUDA Plus Chemotherapy as First-Line Treatment for HER2-Negative Advanced Gastric Cancer""}, {""date"": ""20231013163500"", ""headline"": ""Merck & Co. Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.41% higher to $104.01 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""20231015040007"", ""headline"": ""Merck to open \u00a31bn London research centre with plea for government support of industry"", ""summary"": ""Drugmaker praises country\u2019s scientific expertise but says it must address conflicts in areas such as drug pricing""}, {""date"": ""20231015055000"", ""headline"": ""ClearBridge Appreciation Strategy Q3 2023 Portfolio Manager Commentary"", ""summary"": ""We believe 2023\u00e2\u0080\u0099s market increase is a rally in a multiyear bear market and that we need to retain a conservative tilt to our portfolio.""}, {""date"": ""20231015173000"", ""headline"": ""7 Safe Stocks to Steady Your Portfolio in 2024"", ""summary"": ""With the high-flying equities sector suddenly going soft in the second half, investors may want to consider safe stocks. These ideas might not be the first choice among market participants. Maybe they\u2019re too boring or seemingly not relevant to present circumstances. Still, some surprises may be in order. To better qualify which ideas are the steady stocks to trust, I turned to TipRanks\u2019 Top Smart Score Stocks indicator. Measuring the viability of publicly traded securities based on eight factors""}]","{""assetTurnoverTTM"": 0.5541, ""bookValue"": 41246, ""cashRatio"": 0.37260760370659046, ""currentRatio"": 1.3836, ""ebitPerShare"": 2.2569, ""eps"": 1.8637, ""ev"": 286476.8, ""fcfMargin"": 0.427, ""fcfPerShareTTM"": 5.1941, ""grossMargin"": 0.7349, ""inventoryTurnoverTTM"": 2.7183, ""longtermDebtTotalAsset"": 0.3183, ""longtermDebtTotalCapital"": 0.4464, ""longtermDebtTotalEquity"": 0.8236, ""netDebtToTotalCapital"": 0.345, ""netDebtToTotalEquity"": 0.6365, ""netMargin"": 0.2973, ""operatingMargin"": 0.36, ""payoutRatioTTM"": 0.5157, ""pb"": 6.309, ""peTTM"": 56.472, ""pfcfTTM"": 19.7633, ""pretaxMargin"": 0.3521, ""psTTM"": 4.3872, ""ptbv"": 11.8031, ""quickRatio"": 1.1182, ""receivablesTurnoverTTM"": 5.9684, ""roaTTM"": 0.0431, ""roeTTM"": 0.1067, ""roicTTM"": 0.0602, ""rotcTTM"": 0.094, ""salesPerShare"": 6.2694, ""sgaToSale"": 0.2651, ""tangibleBookValue"": 22047, ""totalDebtToEquity"": 0.8451, ""totalDebtToTotalAsset"": 0.3266, ""totalDebtToTotalCapital"": 0.458, ""totalRatio"": 1.6299, ""period"": ""2023-09-30""}"
15,2023-10-15,103.26229095458984,2023-10-22,101.93191528320312,-0.012883460739523622,D2,"[{""date"": ""20230322182251"", ""headline"": ""Stock Market Today: Stock Market News And Analysis"", ""summary"": ""Check the Stock Market Today column to spot changes in market trend and track the best stocks to buy and watch.""}, {""date"": ""20231015040007"", ""headline"": ""Merck to open \u00a31bn London research centre with plea for government support of industry"", ""summary"": ""Drugmaker praises country\u2019s scientific expertise but says it must address conflicts in areas such as drug pricing""}, {""date"": ""20231015055000"", ""headline"": ""ClearBridge Appreciation Strategy Q3 2023 Portfolio Manager Commentary"", ""summary"": ""We believe 2023\u00e2\u0080\u0099s market increase is a rally in a multiyear bear market and that we need to retain a conservative tilt to our portfolio.""}, {""date"": ""20231015173000"", ""headline"": ""7 Safe Stocks to Steady Your Portfolio in 2024"", ""summary"": ""With the high-flying equities sector suddenly going soft in the second half, investors may want to consider safe stocks. These ideas might not be the first choice among market participants. Maybe they\u2019re too boring or seemingly not relevant to present circumstances. Still, some surprises may be in order. To better qualify which ideas are the steady stocks to trust, I turned to TipRanks\u2019 Top Smart Score Stocks indicator. Measuring the viability of publicly traded securities based on eight factors""}, {""date"": ""20231016020000"", ""headline"": ""EMD Serono to Present Latest Research from Oncology Portfolio at ESMO 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016035200"", ""headline"": ""Healthcare Portfolio Focus Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016044500"", ""headline"": ""ClearBridge Appreciation ESG Strategy Q3 2023 Portfolio Manager Commentary"", ""summary"": ""The ClearBridge Appreciation ESG Strategy outperformed its benchmark in the third quarter, driven by positive stock selection. Click here to read the full fund letter.""}, {""date"": ""20231016054700"", ""headline"": ""Merck: EC approves KEYTRUDA as adjuvant treatment for NSCLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016060300"", ""headline"": ""FDA approves Merck's Keytruda for treatment of resectable NSCLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016062500"", ""headline"": ""FDA grants expanded approval for Merck's lung cancer drug Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016062900"", ""headline"": ""Merck (NYSE:MRK) Requests UK Government to Support Pharma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016063700"", ""headline"": ""Merck (NYSE:MRK) Urges UK Government to Support Pharma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016070300"", ""headline"": ""Merck's Keytruda gets approval in EU for expanded use in lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016070621"", ""headline"": ""Worried About a Recession? This Pharma Stock Could Be the Safe Haven You Need."", ""summary"": ""When you\u2019re concerned about an economic downturn, a relatively safe solution is to stick with famous names like Merck (NYSE:MRK). I recommend holding MRK stock, reinvesting the dividend payments and sleeping soundly at night. Believe me, I fully understand the importance of low-volatility investments in 2023\u2019s fourth quarter. Interest rates could stay higher for longer, and the stock market\u2019s high flyers may be vulnerable to a sharp pullback. That\u2019s why prudent investors should look at tried-and""}, {""date"": ""20231016082000"", ""headline"": ""IN BRIEF: EU approves Merck's Keytruda as lung cancer treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016104428"", ""headline"": ""AbbVie: Successfully Navigating Humira's Patent Cliff With 4% Yield And 270% DGR Since 2014"", ""summary"": ""Despite declining Humira sales, AbbVie remains resilient, focusing on new therapies, M&A, and R&D for sustained growth. Find out why ABBV stock is a Hold.""}, {""date"": ""20231016104500"", ""headline"": ""European Commission Approves KEYTRUDA\u00ae (pembrolizumab) as Adjuvant Treatment for Adults With Non-Small Cell Lung Cancer at High Risk of Recurrence Following Complete Resection and Platinum-Based Chemotherapy"", ""summary"": ""RAHWAY, N.J., October 16, 2023--EC Approves KEYTRUDA as Adjuvant Treatment for Adults With NSCLC at High Risk of Recurrence Following Complete Resection & Platinum-Based Chemotherapy""}, {""date"": ""20231016114700"", ""headline"": ""Promising Oncology and Vaccine Catalysts Drive Buy Rating for Merck & Company: An Analysis of Daina Graybosch\u2019s Recommendation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016115600"", ""headline"": ""Maintaining Buy Rating for Merck & Co.: Unaffected by Pfizer\u2019s Revenue Cut and Anticipated Growth in Non-COVID Business"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016122600"", ""headline"": ""My Dividend Growth Portfolio - Q3 2023 Summary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016140021"", ""headline"": ""Is Merck & Co., Inc. (NYSE:MRK) Trading At A 48% Discount?"", ""summary"": ""Key Insights Using the 2 Stage Free Cash Flow to Equity, Merck fair value estimate is US$199 Current share price of...""}, {""date"": ""20231016144700"", ""headline"": ""CHMP Endorses Merck's (MRK) Keytruda Expansion in Gastric Cancer"", ""summary"": ""If approved, Merck's (MRK) Keytruda will be approved for a second indication in advanced gastric or GEJ cancer.""}, {""date"": ""20231016145657"", ""headline"": ""Health Care Select Sector Fund ETF: Riding The Healthcare Boom"", ""summary"": ""Health Care Select Sector SPDR Fund ETF tracks performance of US healthcare sector. It has a diverse portfolio of holdings. Find out why XLV ETF is a Buy.""}, {""date"": ""20231016163500"", ""headline"": ""Merck & Co. Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.12% higher to $104.14 Monday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""20231016192500"", ""headline"": ""Merck Gets FDA Approval for Resectable Lung Cancer Treatment With Keytruda and Chemotherapy"", ""summary"": ""By Ben Glickman Merck received approval from the Food and Drug Administration for the use of blockbuster cancer drug Keytruda to treat certain types of...""}, {""date"": ""20231016230000"", ""headline"": ""FDA Approves KEYTRUDA\u00ae (pembrolizumab) for Treatment of Patients With Resectable (T\u22654 cm or N+) NSCLC in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as a Single Agent as Adjuvant Treatment After Surgery"", ""summary"": ""RAHWAY, N.J., October 16, 2023--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck\u2019s anti-PD-1 therapy, for the treatment of patients with resectable (tumors \u22654 centimeters [cm] or node positive) non-small cell lung cancer (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then continued as a single agent as adjuvant treatment after surgery.""}, {""date"": ""20231016230211"", ""headline"": ""UPDATE 3-Merck's Keytruda gets FDA nod for expanded use in lung cancer"", ""summary"": ""The U.S. Food and Drug Administration on Monday approved the expanded use of Merck & Co's blockbuster immunotherapy Keytruda in early-stage patients with non-small cell lung cancer who can get their tumors removed surgically.  The U.S. health regulator's approval extends Keytruda's use in combination with chemotherapy as a treatment given before surgery to shrink the size of the tumor in patients.  The U.S. drugmaker is aiming to widen use of Keytruda, used as a second line of treatment in some cancer patients, into earlier lines of treatment.""}, {""date"": ""20231017031700"", ""headline"": ""Merck & Co's Keytruda gets FDA approval for lung cancer treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017054700"", ""headline"": ""Merck receives positive EU CHMP opinion for PREVYMIS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017063300"", ""headline"": ""FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017073200"", ""headline"": ""Kineta announces first patient dosed in Phase 1/2 VISTA-101 trial of KVA12123"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017073900"", ""headline"": ""IN BRIEF: Merck gains positive EU opinion to Prevymis in CMV disease"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017080300"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Black Diamond Therapeutics (BDTX) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017081100"", ""headline"": ""Analysts\u2019 Top Healthcare Picks: Black Diamond Therapeutics (BDTX), Ultragenyx Pharmaceutical (RARE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017083000"", ""headline"": ""Merck price target lowered to $127 from $128 at Guggenheim"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017095100"", ""headline"": ""Merck cytomegalovirus therapy endorsed for approval in EU"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017104500"", ""headline"": ""Merck Receives Positive EU CHMP Opinion for PREVYMIS\u00ae for Prevention of CMV Disease in High-Risk Adult Kidney Transplant Recipients and Extended 200-Day Dosing in Adult HSCT Recipients at Risk for Late CMV Infection and Disease"", ""summary"": ""RAHWAY, N.J., October 17, 2023--Merck Receives Positive EU CHMP Opinion for PREVYMIS\u00ae for Prevention of CMV Disease in High-Risk Adult Kidney Transplant Recipients""}, {""date"": ""20231017112336"", ""headline"": ""UPDATE 1-EU regulator backs use of Merck's viral infection drug"", ""summary"": ""Merck & Co said on Tuesday the European Union medicines regulator recommended a marketing authorisation for the company's drug Prevymis to treat a type of infection in adult kidney transplant recipients at high risk.  The drugmaker says Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) also recommended the approval for extending dosing of the drug to 200 days from 100 days, following a type of transplant in adult patients.""}, {""date"": ""20231017163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.03% higher to $104.17 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231018150100"", ""headline"": ""Merck (MRK) Gets CHMP Nod for Expanded Use of Antiviral Drug"", ""summary"": ""CHMP gives a positive opinion to Merck (MRK) for the expanded use of Prevymis to help prevent CMV disease in high-risk kidney transplant patients.""}, {""date"": ""20231018163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Merck & Co. Inc. slipped 2.09% to $101.99 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20231019035300"", ""headline"": ""Looking At Merck & Co's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019100300"", ""headline"": ""Peering Into Merck & Co's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019101800"", ""headline"": ""Dow drops nearly 100 points on losses in shares of Merck, Amgen"", ""summary"": ""Shares of Merck and Amgen are posting losses Thursday morning, dragging the Dow Jones Industrial Average into negative territory. The Dow was most recently...""}, {""date"": ""20231019104200"", ""headline"": ""Eli Lilly, Novo among notable decliners in pharma weakness"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019105700"", ""headline"": ""Merck to pay up to $22B in cancer drug deal with Daiichi Sankyo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019111500"", ""headline"": ""BioNTech starts another Phase 2 trial for mRNA-based cancer shot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019143100"", ""headline"": ""Dow's 100-point fall led by losses in Travelers, Caterpillar shares"", ""summary"": ""The Dow Jones Industrial Average is declining Thursday afternoon with shares of Travelers and Caterpillar delivering the stiffest headwinds for the...""}, {""date"": ""20231019163500"", ""headline"": ""Merck & Co. Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. shed 1.53% to $100.43 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20231019220800"", ""headline"": ""Daiichi Sankyo shares jump on multibillion-dollar drug development deal with Merck"", ""summary"": ""Daiichi Sankyo shares rose sharply after the Japanese drugmaker announced a multibillion dollar deal with Merck to jointly develop and commercialize three...""}, {""date"": ""20231019233000"", ""headline"": ""Daiichi Sankyo and Merck Announce Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd ADCs"", ""summary"": ""BASKING RIDGE, N.J. & RAHWAY, N.J., October 19, 2023--Daiichi Sankyo (TSE: 4568) and Merck (known as MSD outside of the United States and Canada) (NYSE: MRK) have entered into a global development and commercialization agreement for three of Daiichi Sankyo\u2019s DXd antibody drug conjugate (ADC) candidates: patritumab deruxtecan (HER3-DXd), ifinatamab deruxtecan (I-DXd) and raludotatug deruxtecan (R-DXd). The companies will jointly develop and potentially commercialize these ADC candidates worldwide""}, {""date"": ""20231020010600"", ""headline"": ""TOP NEWS: Daiichi Sankyo soars on USD22 billion Merck cancer drug deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020020200"", ""headline"": ""Catalyst Watch: Tech earnings blitz, Qualcomm event and Stellantis reveals"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020020400"", ""headline"": ""Friday Sector Leaders: Healthcare, Consumer Products"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020020600"", ""headline"": ""Merck, Daiichi Sankyo Ink Commercialization Deal for Up to $22 Billion"", ""summary"": ""Merck and  Daiichi Sankyo  agreed to jointly develop and commercialize three potential cancer treatments in a deal worth up to $22 billion.  Merck and Daiichi Sankyo will develop and commercialize three antibody drug conjugate candidates\u2014patritumab deruxtecan, ifinatamab deruxtecan and raludotatug deruxtecan\u2014worldwide.  Daiichi Sankyo will retain exclusive rights in Japan.""}, {""date"": ""20231020030000"", ""headline"": ""Bond Prices Are Slumping Again. Consider These Dividend ETFs Instead."", ""summary"": ""Morningstar has identified four dividend funds that hold quality companies and have a proven record.""}, {""date"": ""20231020031100"", ""headline"": ""Investor Risk Sentiment Wavers Amid War, Interest Rate Concerns; Tesla Earnings Disappoint: The Week In The Markets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020041700"", ""headline"": ""Merck assumed with Buy from Neutral at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020053600"", ""headline"": ""Merck & Company\u2019s Stock: A Buy Recommendation due to Favorable Collaborations and Promising ADC Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020055700"", ""headline"": ""Merck (NYSE:MRK) Joins Hands with Daichi Sankyo to Develop Cancer Drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020061217"", ""headline"": ""Morgan Stanley raised to Peerperform, Merck a Buy at UBS: 4 big analyst picks"", ""summary"": ""Wolfe Research upgraded Morgan Stanley (NYSE:MS) to Peerperform from Underperform.""}, {""date"": ""20231020071000"", ""headline"": ""Merck announces results from KEYNOTE-671 trial at ESMO Congress"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020072600"", ""headline"": ""Merck announces results from KEYNOTE-811 trial at ESMO Congress"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020072900"", ""headline"": ""Merck announces results from KEYNOTE-756 trial at ESMO Congress"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020074700"", ""headline"": ""7 Healthcare Stocks to invest in for a Healthy Future"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020081300"", ""headline"": ""Merck\u2019s Keytruda shows positive results in confirmatory trial as treatment for rare form of esophageal cancer"", ""summary"": ""Merck & Co. said Friday a late-stage trial of its blockbuster cancer drug Keytruda plus trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy...""}, {""date"": ""20231020090200"", ""headline"": ""Merck announces results from Phase 3 KEYNOTE-A18 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020091400"", ""headline"": ""CVS Health pulls some cough-and-cold treatments with ingredient deemed ineffective by doctors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020092100"", ""headline"": ""Merck, Daiichi Sankyo announce development and commercialization collaboration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020101600"", ""headline"": ""Merck study shows Keytruda can help lower death risk from cervical cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020101600"", ""headline"": ""Merck upgraded to Buy at UBS citing upside to consensus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020120000"", ""headline"": ""KEYTRUDA\u00ae (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as Single Agent After Surgery Reduced Risk of Death by 28% Versus Pre-Operative Chemotherapy in Resectable Stage II, IIIA or IIIB Non-Small Cell Lung Cancer (NSCLC)"", ""summary"": ""RAHWAY, N.J., October 20, 2023--KEYTRUDA Plus Chemo Before Surgery & Continued as Single Agent After Surgery Reduced Risk of Death by 28% Vs Pre-Operative Chemo in Resectable NSCLC""}, {""date"": ""20231020120100"", ""headline"": ""KEYTRUDA\u00ae (pembrolizumab) Plus Trastuzumab and Chemotherapy Significantly Improved Progression-Free Survival (PFS) Versus Trastuzumab and Chemotherapy in First-Line HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma"", ""summary"": ""RAHWAY, N.J., October 20, 2023--KEYTRUDA Plus Trastuzumab and Chemo Significantly Improved PFS Versus Trastuzumab and Chemo in First-Line HER2+ Advanced Gastric or GEJ Cancer""}, {""date"": ""20231020120200"", ""headline"": ""Merck\u2019s KEYTRUDA\u00ae (pembrolizumab) Plus Chemotherapy Showed Statistically Significant Improvement in Pathological Complete Response (pCR) Rate as Neoadjuvant Therapy Versus Chemotherapy in High-Risk, Early-Stage ER+/HER2- Breast Cancer"", ""summary"": ""RAHWAY, N.J., October 20, 2023--Neoadjuvant KEYTRUDA Plus Chemo Showed Statistically Significant Improvement in pCR Rate Vs Chemo in High-Risk, Early-Stage ER+/HER2- Breast Cancer""}, {""date"": ""20231020122600"", ""headline"": ""Buy Rating Assigned to Merck & Co.: Strategic Collaboration for Anti-Cancer ADCs Promises Revenue Diversification and Long-Term Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020133037"", ""headline"": ""Merck Q3 2023 Earnings Preview: Keytruda LOE Continues To Dominate Narrative"", ""summary"": ""Keytruda, Merck's immuno-oncology drug, continues to drive significant revenue growth. Read more to see a detailed analysis on MRK stock.""}, {""date"": ""20231020140000"", ""headline"": ""Merck\u2019s KEYTRUDA\u00ae (pembrolizumab) Plus Concurrent Chemoradiotherapy Significantly Improved Progression-Free Survival (PFS) Versus Concurrent Chemoradiotherapy Alone in Newly Diagnosed, High-Risk Locally Advanced Cervical Cancer"", ""summary"": ""RAHWAY, N.J., October 20, 2023--Merck\u2019s KEYTRUDA Plus Concurrent Chemoradiotherapy Significantly Improved PFS in Newly Diagnosed, High-Risk Locally Advanced Cervical Cancer""}, {""date"": ""20231020161900"", ""headline"": ""NEW YORK MARKET CLOSE: Tech suffers as rate nerves, Middle East weighs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020163500"", ""headline"": ""Merck & Co. Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. rose 2.23% to $102.67 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231020170200"", ""headline"": ""Merck (MRK) Inks Deal With Daiichi to Develop Cancer Drugs"", ""summary"": ""Per the terms, Merck (MRK) and Daiichi Sankyo will develop and market three ADC drugs to treat multiple types of cancer. Following the execution, Merck will make an upfront payment of $4 billion.""}, {""date"": ""20231020203022"", ""headline"": ""AT&T, Merck-Daiichi Sankyo, Klaviyo: Top Stocks"", ""summary"": ""Scotiabank analysts upgrade AT&T (T) stock from \""Sector Perform\"" to \""Sector Outperform.\"" Merck (MRK) strikes a deal worth up to $22 billion with Japanese pharmaceutical company Daiichi Sankyo (4568.T) to jointly develop an antibody drug for cancer treatment. Lastly, Klaviyo (KVYO) closes Friday lower below its IPO debut price of $30 per share. Yahoo Finance's Julie Hyman and Josh Lipton highlight several of Friday's trending sticks after the closing bell. For more expert insight and the latest market action,\u00a0click here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231021083300"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), American Well (AMWL) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231021124500"", ""headline"": ""Merck\u2019s WELIREG\u00ae (belzutifan) Significantly Improved Progression-Free Survival and Objective Response Rates Versus Everolimus in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)"", ""summary"": ""RAHWAY, N.J., October 21, 2023--Merck\u2019s WELIREG\u00ae Significantly Improved PFS and Objective Response Rates Versus Everolimus in Certain Previously Treated Patients With Advanced RCC""}, {""date"": ""20231022034200"", ""headline"": ""Merck announces results from Phase 3 KEYNOTE-A39 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022071200"", ""headline"": ""Merck announces results from Phase 3 LITESPARK-005 trial investigating WELIREG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022071900"", ""headline"": ""Earnings week ahead: Amazon, Microsoft, Alphabet, Meta, Ford, GM and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022143000"", ""headline"": ""KEYTRUDA\u00ae (pembrolizumab) Plus Padcev\u00ae (enfortumab vedotin-ejfv) Reduced Risk of Death by More Than Half Versus Chemotherapy in Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer"", ""summary"": ""RAHWAY, N.J., October 22, 2023--KEYTRUDA Plus Padcev (enfortumab vedotin-ejfv) Reduced Risk of Death by More Than Half Vs. Chemotherapy in Patients With Previously Untreated la/mUC""}, {""date"": ""20231022211100"", ""headline"": ""Immutep Shares Jump 13% on Lung-Cancer Combination Trial Data"", ""summary"": ""By Stuart Condie SYDNEY--Immutep shares are on course for their best day since June after the Australia-listed developer of cancer treatments presented...""}]",{}
16,2023-10-22,101.93191528320312,2023-10-29,102.08084106445312,0.001461031913667421,U1,"[{""date"": ""20231022034200"", ""headline"": ""Merck announces results from Phase 3 KEYNOTE-A39 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022071200"", ""headline"": ""Merck announces results from Phase 3 LITESPARK-005 trial investigating WELIREG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022071900"", ""headline"": ""Earnings week ahead: Amazon, Microsoft, Alphabet, Meta, Ford, GM and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022143000"", ""headline"": ""KEYTRUDA\u00ae (pembrolizumab) Plus Padcev\u00ae (enfortumab vedotin-ejfv) Reduced Risk of Death by More Than Half Versus Chemotherapy in Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer"", ""summary"": ""RAHWAY, N.J., October 22, 2023--KEYTRUDA Plus Padcev (enfortumab vedotin-ejfv) Reduced Risk of Death by More Than Half Vs. Chemotherapy in Patients With Previously Untreated la/mUC""}, {""date"": ""20231022211100"", ""headline"": ""Immutep Shares Jump 13% on Lung-Cancer Combination Trial Data"", ""summary"": ""By Stuart Condie SYDNEY--Immutep shares are on course for their best day since June after the Australia-listed developer of cancer treatments presented...""}, {""date"": ""20231023012800"", ""headline"": ""Seagen/ Astellas succeed in Phase 3 trial for bladder cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023015100"", ""headline"": ""Check Out What Whales Are Doing With MRK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023021700"", ""headline"": ""Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023035300"", ""headline"": ""Merck, Seagen, Astellas hail \""groundbreaking\"" data for bladder cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023042700"", ""headline"": ""Hold Rating on Merck & Company: Assessing Growth Potential Through Collaborative Oncology Ventures"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023050400"", ""headline"": ""Merck says Welireg data shows reduction is disease progression"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023060911"", ""headline"": ""Daiichi Sankyo: Positive Long-Term Outlook With High Market Expectations"", ""summary"": ""Daiichi Sankyo is a Japanese pharmaceutical company known for its flagship products Lixiana and Enhertu. Click here to read my analysis of DSKYF stock.""}, {""date"": ""20231023064100"", ""headline"": ""Astellas Pharma upgraded to Buy from Hold at Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023070700"", ""headline"": ""Promising Collaborations and Emerging Treatments Reinforce Buy Rating for Merck & Company: An Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023071600"", ""headline"": ""Cantor Fitzgerald Sticks to Their Buy Rating for Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023073600"", ""headline"": ""Merck & Company\u2019s Stock Receives a Buy Rating: Analysis of Growth Opportunities and Strategic Partnerships"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023073937"", ""headline"": ""Merck discontinues some cancer drug development with China's Sichuan Kelun"", ""summary"": ""Chinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning the joint development of two candidate cancer drugs which have yet to start clinical trials.  Representatives for Merck did not immediately respond to a Reuters request for comment.  The move comes days after Merck said it would pay Daiichi Sankyo $5.5 billion to jointly develop three of its candidate cancer drugs in a deal that could be worth up to $22 billion for the Japanese firm.""}, {""date"": ""20231023090258"", ""headline"": ""Daiichi Sankyo: Merck Partnership Poises Both Companies For ADC Expansion"", ""summary"": ""Daiichi Sankyo (DSNKY) collaboration with Merck on 3 antibody-drug conjugates offers financial security and potential success. Read more on this partnership.""}, {""date"": ""20231023103500"", ""headline"": ""Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield..."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023110022"", ""headline"": ""Those who invested in Merck (NYSE:MRK) five years ago are up 76%"", ""summary"": ""When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...""}, {""date"": ""20231023113210"", ""headline"": ""Merck & Co. Inc. (MRK) Merck & Co. Announced Collaboration with Daiichi Sankyo and ESMO Investor Event (Transcript)"", ""summary"": ""Merck & Co. Inc.""}, {""date"": ""20231023141000"", ""headline"": ""Charles River (CRL) Offers Access to Preclinical Cancer Research"", ""summary"": ""Charles River (CRL) contributes to 84 percent of the FDA-approved cancer medicines and provides partners with 16 oncology prospects.""}, {""date"": ""20231023155648"", ""headline"": ""Cantor Fitzgerald Reiterates Merck (MRK) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20231023161000"", ""headline"": ""NetScientific investee claims promising results in biomarker study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024054500"", ""headline"": ""Merck expected to report higher Q3 revenue, despite drop in COVID-19 drug sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024084400"", ""headline"": ""VTV: A Great ETF for Value Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024084500"", ""headline"": ""VTV: A Must-Watch ETF for Value Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024120000"", ""headline"": ""Merck Senior Vice President Sarah Aiosa Named to Most Powerful Latinas List"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / October 24, 2023 / We're proud to celebrate Sarah M. Aiosa, SVP and president, Latin America, for being recognized as one of The Association of Latino Professionals for Americas' 2023 Most Powerful Latinas! Sarah was ...""}, {""date"": ""20231024150259"", ""headline"": ""12 Defensive Healthcare Dividend Stocks To Invest In"", ""summary"": ""In this article, we discuss 12 defensive healthcare dividend stocks to invest in. You can skip our detailed analysis of the healthcare sector and dividend stocks, and go directly to read 5 Defensive Healthcare Dividend Stocks To Invest In. The healthcare sector has undergone significant evolution over the years, especially after the pandemic. Advances in [\u2026]""}, {""date"": ""20231024163500"", ""headline"": ""Merck & Co. Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. dropped 0.31% to $103.03 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20231025010800"", ""headline"": ""Merck\u2019s Oncology Strategy: Pembrolizumab Success and Promising ADC Pipeline \u2013 A Buy Recommendation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025012100"", ""headline"": ""Merck & Company: A Buy Rating Driven by Oncology Portfolio Diversification and Strategic Collaborations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025072500"", ""headline"": ""Notable companies reporting before tomorrow's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025081552"", ""headline"": ""10 Best Dialysis and Kidney Disease Stocks to Buy"", ""summary"": ""In this article, we will take a look at the 10 best dialysis and kidney disease stocks to buy. To see more such companies, go directly to 5 Best Dialysis and Kidney Disease Stocks to Buy. According to the National Kidney Foundation, millions of people die every year due to kidney failures because they do not [\u2026]""}, {""date"": ""20231025082809"", ""headline"": ""20 Countries with Lowest Rates of Cancer"", ""summary"": ""In this article, we will be taking a look at the 20 countries with lowest rates of cancer. If you want to skip our analysis of the oncology industry, then head straight to 5 Countries with Lowest Rates of Cancer. Cancer\u2014 a disease in which some of the body\u2019s cells grow uncontrollably and spread to [\u2026]""}, {""date"": ""20231025085158"", ""headline"": ""10 Most Effective Methods of Birth Control and Biggest Brands In This Space"", ""summary"": ""In this article, we shall discuss the 10 most effective methods of birth control and biggest brands in this space. To skip our detailed analysis of the contraceptives industry and the FemTech revolution in 2023, go directly and see 5 Most Effective Methods of Birth Control. According to a market report by Precedence Research, the [\u2026]""}, {""date"": ""20231025112000"", ""headline"": ""Travelers, Microsoft share gains contribute to Dow's 85-point climb"", ""summary"": ""Shares of Travelers and Microsoft are trading higher Wednesday morning, lifting the Dow Jones Industrial Average into positive territory. The Dow was most...""}, {""date"": ""20231025113000"", ""headline"": ""KEYTRUDA\u00ae (pembrolizumab) Plus LENVIMA\u00ae (lenvatinib) is Available for the First-Line Treatment of Adult Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC)"", ""summary"": ""Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai announced today that KEYTRUDA\u00ae, an anti-PD-1 therapy, in combination with LENVIMA\u00ae, the multiple receptor tyrosine kinase inhibitor discovered by Eisai, is reimbursed under the Alberta, British Columbia, Nova Scotia, Ontario, Quebec, and Saskatchewan drug plans with respective clinical criteria and conditions for adult patients with advanced (not amenable to curative surgery or radiation) or metastatic renal cell car""}, {""date"": ""20231025114000"", ""headline"": ""Merck ends trial for oral Alzheimer\u2019s candidate amid liver toxicity cases"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025145900"", ""headline"": ""Is a Surprise Coming for Merck & Co. (MRK) This Earnings Season?"", ""summary"": ""Merck & Co. (MRK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.""}, {""date"": ""20231025154737"", ""headline"": ""Amazon earnings, Merck reports, Southwest Airlines: 3 things to watch"", ""summary"": ""Investing.com -- Stocks weakened, led by a sinking Nasdaq after Alphabet (NASDAQ:GOOGL)'s miss on revenue expectations from its cloud operations.""}, {""date"": ""20231025163500"", ""headline"": ""Merck & Co. Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.58% higher to $103.63 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the...""}, {""date"": ""20231025172700"", ""headline"": ""Merck Raises Sales Outlook After Earnings Beat"", ""summary"": ""Pharmaceutical stocks have generally fallen, partly because of regulatory concerns, but also because high interest rates have made the companies dividends...""}, {""date"": ""20231025212448"", ""headline"": ""Amazon and Ford earnings, U.S. GDP: What to Watch"", ""summary"": ""Yahoo Finance Live anchor Josh Lipton previews the top industry headlines for Thursday, October 26, including Amazon (AMZN) and Ford (F) earnings among many others, as well as the latest reading of the U.S. Gross Domestic Product. For more expert insight and the latest market action,\u00a0click here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231026003900"", ""headline"": ""GLOBAL BRIEFING: Dollar crosses JPY150; StanChart profit down 54%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026033500"", ""headline"": ""What You Missed On Wall Street On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026044700"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Merck & Company (MRK) and Integra Lifesciences (IART)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026053100"", ""headline"": ""Merck reports Q3 adjusted EPS $2.13, consensus $1.84"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026053200"", ""headline"": ""Merck cuts FY23 adjusted EPS view to $1.33-$1.38 from $2.95-$3.05"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026053500"", ""headline"": ""Merck Non-GAAP EPS of $2.13 beats by $0.18, revenue of $16B beats by $730M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026061000"", ""headline"": ""Merck lifts 2023 outlook amid strong sales for COVID-19 pill"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026062100"", ""headline"": ""Merck in charts: Pharmaceutical sales up 10% Y/Y, led by KEYTRUDA and GARDASIL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026063200"", ""headline"": ""Merck third-quarter results beat estimates, boosted by cancer drug and vaccine growth"", ""summary"": ""Drugmaker raises full-year sales outlook but cuts earnings guidance as it digests recent deals""}, {""date"": ""20231026064300"", ""headline"": ""Nasdaq Futures Plunge As Meta Warns Of Q4 Softness: GDP Data, Amazon Earnings On Investors' Radar Amid Market Mayhem"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026064800"", ""headline"": ""Merck: Q3 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026070500"", ""headline"": ""The Passive Income Snowball Path To Wealth: VYM Vs. DGRW"", ""summary"": ""WisdomTree US Quality Dividend Growth ETF and Vanguard High Dividend Yield ETF are 2 popular dividend growth ETFs. Read our take on which is the better buy right now.""}, {""date"": ""20231026071700"", ""headline"": ""TOP NEWS: Merck hails Daiichi Sankyo partnership but will take charge"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026073500"", ""headline"": ""Merck 3Q Profit Rose as Sales of Breast Cancer Treatment Jumped"", ""summary"": ""By Jeffrey T. Lewis Merck's profit increased in the third quarter after sales of cancer treatments and vaccines boosted sales in the period. The Rahway,...""}, {""date"": ""20231026080600"", ""headline"": ""5 stocks to watch on Thursday: Ford, Meta, Comcast and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026103000"", ""headline"": ""Merck 3rd-quarter profit tops expectations on COVID pill surprise"", ""summary"": ""Merck & Co on Thursday reported higher-than-expected third-quarter sales and profit on surprisingly strong demand for  its COVID-19 treatment, primarily in Japan.  Sales of Merck's top-selling cancer immunotherapy Keytruda rose 17% to $6.34 billion for the quarter, while Gardasil, its vaccine to prevent cancers caused by the human papillomavirus (HPV) rose 13% to $2.59 billion.  Molnupiravir was initially hailed as a potential breakthrough when few treatment options were available, but was soon eclipsed by Pfizer's rival treatment Paxlovid, which had more impressive data, and it fell out of favor.""}, {""date"": ""20231026103000"", ""headline"": ""Merck Announces Third-Quarter 2023 Financial Results"", ""summary"": ""RAHWAY, N.J., October 26, 2023--Merck Announces Third-Quarter 2023 Financial Results""}, {""date"": ""20231026103316"", ""headline"": ""Merck quarterly profit tops expectations on COVID pill surprise"", ""summary"": ""(Reuters) -Merck & Co on Thursday reported higher-than-expected results in the third quarter on surprisingly strong demand for its COVID-19 treatment, primarily in Japan, and raised its annual sales forecast for the therapy.  Sales of molnupiravir, the COVID-19 antiviral pill sold under brand name Lagevrio, jumped 47% to $640 million in the quarter, crushing Wall Street estimates of $120 million, according to LSEG data.  Molnupiravir was initially hailed as a potential breakthrough when few treatment options were available, but was soon eclipsed by Pfizer's rival treatment Paxlovid, which had more impressive data.""}, {""date"": ""20231026105800"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026110900"", ""headline"": ""MRK May 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026120528"", ""headline"": ""UPDATE 1-Merck quarterly profit tops expectations on COVID pill surprise"", ""summary"": ""Merck & Co on Thursday reported higher-than-expected results in the third quarter on surprisingly strong demand for its COVID-19 treatment, primarily in Japan, and raised its annual sales forecast for the therapy.  Molnupiravir was initially hailed as a potential breakthrough when few treatment options were available, but was soon eclipsed by Pfizer's rival treatment Paxlovid, which had more impressive data.  Paxlovid dominates the out-of-hospital COVID-treatment market in the United States, and in the EU, the regulator recommended against use of Merck's drug.""}, {""date"": ""20231026120837"", ""headline"": ""12 Best Dow Jones Dividend Stocks According to Hedge Funds"", ""summary"": ""In this article, we discuss 12 best Dow Jones dividend stocks according to hedge funds. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Dow Jones Dividend Stocks According to Hedge Funds. The Dow Jones Industrial Average, often simply referred to as the Dow, is [\u2026]""}, {""date"": ""20231026122900"", ""headline"": ""US Stocks Sink, VIX Soars As Overheated Economy, Mixed Earnings Complicate Fed's Action: What's Driving Markets Thursday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026125700"", ""headline"": ""US Stocks Sink, VIX Soars As Overheated Economy, Mixed Earnings Complicate Fed's Path: What's Driving Markets Thursday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026135648"", ""headline"": ""Merck & Co., Inc. 2023 Q3 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Merck & Co., Inc.""}, {""date"": ""20231026144304"", ""headline"": ""Merck & Co., Inc. (MRK) Q3 2023 Earnings Call Transcript"", ""summary"": ""Merck & Co., Inc. (NYSE:NYSE:MRK) Q3 2023 Earnings Conference Call October 26, 2023 9:00 AM ETCompany ParticipantsPeter Dannenbaum - Vice President,...""}, {""date"": ""20231026161400"", ""headline"": ""NEW YORK MARKET CLOSE: Tech slips again despite robust economic growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. rallied 1.85% to $105.55 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""20231026175100"", ""headline"": ""Health Care Down Amid Mixed Earnings -- Health Care Roundup"", ""summary"": ""Health-care companies fell amid mixed earnings. Merck shares rose after the Big Pharma concern reported third-quarter results that topped analysts'...""}, {""date"": ""20231027011900"", ""headline"": ""Merck & Company: A Buy Recommendation Based on Consistent Outperformance and Promising Future Growth Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027020300"", ""headline"": ""Catalyst Watch: Apple earnings, Fed policy meeting, jobs report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027041800"", ""headline"": ""Merck upgraded to Outperform from Market Perform at BMO Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027050100"", ""headline"": ""Pfizer, Merck COVID-19 drugs moving to commercial market on Nov. 1: report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027060200"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Blueprint Medicines (BPMC), Abbott Labs (ABT) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027074100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Aclaris Therapeutics (ACRS) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027075000"", ""headline"": ""GLOBAL BROKER RATINGS: BofA cuts Mercedes-Benz to 'neutral'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027091119"", ""headline"": ""Moderna: Looking Beyond Covid, The Pipeline Is Promising"", ""summary"": ""Investors should consider accumulating Moderna stock due to its promising pipeline and significant upside potential, despite short-term setbacks. Click here to read my analysis.""}, {""date"": ""20231027095300"", ""headline"": ""Chevron, JPMorgan Chase share losses lead Dow's 100-point drop"", ""summary"": ""Behind negative returns for shares of Chevron and JPMorgan Chase, the Dow Jones Industrial Average is falling Friday morning. Shares of Chevron and JPMorgan...""}, {""date"": ""20231027110059"", ""headline"": ""Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly"", ""summary"": ""Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...""}, {""date"": ""20231027112900"", ""headline"": ""3 Deeply Undervalued Growth Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027122700"", ""headline"": ""Dow down nearly 200 points on losses for shares of Chevron, Verizon"", ""summary"": ""Shares of Chevron and Verizon are trading lower Friday afternoon, dragging the Dow Jones Industrial Average into negative territory. The Dow was most...""}, {""date"": ""20231027132800"", ""headline"": ""Chevron, JPMorgan Chase share losses contribute to Dow's 286-point drop"", ""summary"": ""Shares of Chevron and JPMorgan Chase are trading lower Friday afternoon, sending the Dow Jones Industrial Average into negative territory. Shares of Chevron...""}, {""date"": ""20231027133300"", ""headline"": ""Company News for Oct 27, 2023"", ""summary"": ""Companies in The News Are: MRK, UPS, IBM, CBRE""}, {""date"": ""20231027140122"", ""headline"": ""Roblox upgraded, Bristol Myers downgraded: Wall Street's top analyst calls"", ""summary"": ""Roblox upgraded, Bristol Myers downgraded: Wall Street's top analyst calls""}, {""date"": ""20231027163500"", ""headline"": ""Merck & Co. Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. slipped 2.59% to $102.82 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""20231027202238"", ""headline"": ""Morgan Stanley Maintains Merck (MRK) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20231027202238"", ""headline"": ""BMO Capital Upgrades Merck (MRK)"", ""summary"": """"}, {""date"": ""20231028014000"", ""headline"": ""Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231028093000"", ""headline"": ""5 Buy Rated Stocks For November 2023"", ""summary"": ""S&P 500 has fallen 10% since August 1st, providing opportunities to buy high-quality stocks at discounted prices. Explore more details here.""}, {""date"": ""20231028192627"", ""headline"": ""Merck & Co., Inc. (NYSE:MRK) Q3 2023 Earnings Call Transcript"", ""summary"": ""Merck & Co., Inc. (NYSE:MRK) Q3 2023 Earnings Call Transcript October 26, 2023 Merck & Co., Inc. beats earnings expectations. Reported EPS is $2.13, expectations were $1.95. Operator: [Started Abruptly] \u2026 Merck & Co. Q3 Sales and Earnings Conference Call. At this time, all participants are in a listen-only mode until the question-and-answer session of [\u2026]""}, {""date"": ""20231029093600"", ""headline"": ""Merck & Company (MRK) Receives a Buy from Truist Financial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231029110500"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
17,2023-10-29,102.08084106445312,2023-11-05,102.63681030273438,0.005446362240787428,U1,"[{""date"": ""20231029093600"", ""headline"": ""Merck & Company (MRK) Receives a Buy from Truist Financial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231029110500"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030024600"", ""headline"": ""Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030092541"", ""headline"": ""11 Best Immunotherapy Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 of the best immunotherapy stocks to buy now. If you want to skip our detailed discussion on the cancer and oncology industry, head directly to the 5 Best Immunotherapy Stocks To Buy Now. The global oncology landscape is continually transforming, driven by persistent efforts to explore, create, and deliver [\u2026]""}, {""date"": ""20231030163500"", ""headline"": ""Merck & Co. Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. dropped 0.14% to $102.68 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231030203554"", ""headline"": ""13 Most Undervalued Pharma Stocks To Buy According To Analysts"", ""summary"": ""In this piece, we will take a look at the 13 most undervalued pharmaceutical stocks to buy according to analysts. If you want to skip our overview of the pharma industry, then check out 5 Most Undervalued Pharma Stocks To Buy. The pharmaceutical industry is one of the biggest in the world and one that [\u2026]""}, {""date"": ""20231031012100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), AbbVie (ABBV) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031021100"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Abcam (ABCM), Viridian Therapeutics (VRDN) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031033600"", ""headline"": ""Merck & Co. Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031052000"", ""headline"": ""Daiichi Sankyo ups revenue and profit, boosts quarterly dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031060100"", ""headline"": ""2 No-Brainer AI Stocks to Buy and One to Run Away From"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031081800"", ""headline"": ""Jim Cramer Says Hold Onto This Tech Stock, But 'You're Not Going To Make A Lot Of Money In It Right Now, Because That Was A Really Terrible Last Quarter'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031130018"", ""headline"": ""Merck & Co., Inc.'s (NYSE:MRK) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?"", ""summary"": ""Merck (NYSE:MRK) has had a rough three months with its share price down 2.5%. But if you pay close attention, you might...""}, {""date"": ""20231031152510"", ""headline"": ""Analyzing The Acquisition Potential Of ImmunoGen"", ""summary"": ""ImmunoGen has an approved drug, a modest pipeline with a catalyst upcoming, and a market cap of around $3.6 billion. Find out why IMGN stock is a Buy.""}, {""date"": ""20231101011100"", ""headline"": ""Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101053600"", ""headline"": ""Merck reports KEYNOTE-564 trial met its key overall survival secondary endpoint"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101055700"", ""headline"": ""Merck therapy shows improved survival in certain kidney cancer patients"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101060500"", ""headline"": ""Merck: FDA approves Keytruda in combination with gemcitabine and cisplatin"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101085300"", ""headline"": ""Merck wins FDA approval for Keytruda in biliary tract cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101100000"", ""headline"": ""Dow's 100-point rally highlighted by gains for Microsoft, Boeing shares"", ""summary"": ""Led by positive growth for shares of Microsoft and Boeing, the Dow Jones Industrial Average is trading up Wednesday morning. Shares of Microsoft and Boeing...""}, {""date"": ""20231101103000"", ""headline"": ""KEYTRUDA\u00ae (pembrolizumab) Significantly Improved Overall Survival (OS) Versus Placebo as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Nephrectomy"", ""summary"": ""RAHWAY, N.J., November 01, 2023--KEYTRUDA Significantly Improved OS Versus Placebo as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Nephrectomy""}, {""date"": ""20231101104500"", ""headline"": ""FDA Approves Merck\u2019s KEYTRUDA\u00ae (pembrolizumab) Plus Gemcitabine and Cisplatin as Treatment for Patients With Locally Advanced Unresectable or Metastatic Biliary Tract Cancer"", ""summary"": ""RAHWAY, N.J., November 01, 2023--FDA Approves Merck\u2019s KEYTRUDA\u00ae Plus Gemcitabine and Cisplatin as Treatment for Patients With Locally Advanced Unresectable or Metastatic BTC""}, {""date"": ""20231101105000"", ""headline"": ""Merck to Participate in the UBS BioPharma Conference"", ""summary"": ""RAHWAY, N.J., November 01, 2023--Merck to Participate in the UBS BioPharma Conference""}, {""date"": ""20231101120300"", ""headline"": ""Dow's 100-point rally led by gains in Microsoft, Intel stocks"", ""summary"": ""Powered by strong returns for shares of Microsoft and Intel, the Dow Jones Industrial Average is climbing Wednesday afternoon. The Dow was most recently...""}, {""date"": ""20231101121800"", ""headline"": ""A Look Into Merck & Co Inc's Price Over Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101122300"", ""headline"": ""Merck & Co says Keytruda to treat biliary cancer approved by US FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101125700"", ""headline"": ""Merck's Blockbuster Cancer Drug Keytruda Secures FDA Approval For Biliary Tract Cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101163500"", ""headline"": ""Merck & Co. Inc. stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.15% higher to $102.85 Wednesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20231102090000"", ""headline"": ""Pfizer: Value Investment Opportunity After Recent Price Decline"", ""summary"": ""Pfizer still generates significant gross profit and has a strong revenue growth rate. Read why I feel PFE stock presents a value investment opportunity now.""}, {""date"": ""20231102121800"", ""headline"": ""Merck & Company: A Promising Investment Driven by Diversification and Innovative Pipeline"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102124000"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102163500"", ""headline"": ""Merck & Co. Inc. stock remains steady Thursday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. were unchanged Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231102203700"", ""headline"": ""Q3 Earnings Season Scorecard and Analyst Reports for Merck, Bank of America & AMD"", ""summary"": ""Today's Research Daily features the Q3 earnings season scorecard and new research reports on Merck (MRK), Bank of America (BAC), AMD (AMD) and others.""}, {""date"": ""20231103062800"", ""headline"": ""Merck price target raised to $135 from $130 at Citi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231103064000"", ""headline"": ""Actinium Pharmaceuticals names Lynn Bodarky as Chief Business Officer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231103070500"", ""headline"": ""Werewolf Therapeutics jumps on early-sage data from lead program"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231103072100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Nuvation Bio (NUVB) and Generation Bio (GBIO)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231103083200"", ""headline"": ""Moderna upgraded at HSBC; says bearish thesis has played out"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231103134600"", ""headline"": ""The Zacks Analyst Blog Highlights Merck, Bank of America, AMD, Netflix and Union Pacific"", ""summary"": ""Merck, Bank of America, AMD, Netflix and Union Pacific are part of the Zacks top Analyst Blog.""}, {""date"": ""20231103163500"", ""headline"": ""Merck & Co. Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.52% higher to $103.38 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""20231104130000"", ""headline"": ""3 Trustworthy Blue-Chip Stocks to Buy Now"", ""summary"": ""As economic uncertainty rises, blue-chip stocks to buy can provide stability for the prudent investor. Typically, these are resilient and established businesses with a track record of steady performance. In addition, in prior downturns, they have preserved capital relative to the market. In today\u2019s financial markets, you must bolster your portfolio with blue-chip stocks. Rising interest rates, unsustainable U.S. debt, and conflicts in the Middle East and Ukraine all pose significant risks. There""}, {""date"": ""20231105014000"", ""headline"": ""Mizuho's Top Stock Picks For November Revealed"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
18,2023-11-05,102.63681030273438,2023-11-12,100.66111755371094,-0.019249358424097474,D2,"[{""date"": ""20231105014000"", ""headline"": ""Mizuho's Top Stock Picks For November Revealed"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106073600"", ""headline"": ""Portage Biotech presents updates on its iNKT, adenosine programs at SITC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106074300"", ""headline"": ""Merck highlights list of healthcare stocks among Mizuho's top picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106090000"", ""headline"": ""Acurx Undervalued And Set For Potential M&A With Next-Gen C. Diff Treatment"", ""summary"": ""Acurx is a promising antibiotic company with perfect Phase 2a data in treating C. difficile infection. Find out why ACXP stock is a Buy.""}, {""date"": ""20231106101300"", ""headline"": ""Walt Disney Co. names PepsiCo's Hugh Johnston as chief financial officer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106110500"", ""headline"": ""Eli Lilly chief scientific officer \u2018extremely optimistic\u2019 that major new Alzheimer\u2019s breakthrough is coming\u00a0"", ""summary"": ""Dr. Daniel Skovronsky believes a big leap in Alzheimer\u2019s disease treatment may be just around the corner\u2013and that an overlooked class of medicines could...""}, {""date"": ""20231106121300"", ""headline"": ""Risk On For Biotech - Time To Trade The Small Caps"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106140009"", ""headline"": ""Insiders At Merck Sold US$5.5m In Stock, Alluding To Potential Weakness"", ""summary"": ""In the last year, many Merck & Co., Inc. ( NYSE:MRK ) insiders sold a substantial stake in the company which may have...""}, {""date"": ""20231106154453"", ""headline"": ""IHE: You Better Like Eli Lilly And Johnson & Johnson To Buy This"", ""summary"": ""The iShares U.S. Pharmaceuticals ETF offers targeted exposure to the pharmaceutical industry with a concentrated portfolio. Read more about IHE here.""}, {""date"": ""20231106162812"", ""headline"": ""November Dogs Of The Dow: 3 Buyable, 4 Watchable"", ""summary"": ""Learn about the Dow Jones Industrial Average and the top-performing stocks in November. Click to see our exclusive list of dividend stocks we consider buyable now.""}, {""date"": ""20231106163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.93% higher to $104.34 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20231107163500"", ""headline"": ""Merck & Co. Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. sank 0.33% to $104.00 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231108021900"", ""headline"": ""BioXcel Therapeutics Reveals Survival Data From Prostate Cancer Combo Therapy Trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108032800"", ""headline"": ""Merck initiated with a Buy at Deutsche Bank"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108064100"", ""headline"": ""Grab these 2 funds with rich 11%-12% yields while you can"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108075000"", ""headline"": ""BioXcel spikes after mid-stage data for prostate cancer drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108114500"", ""headline"": ""Merck to Participate in the Jefferies London Healthcare Conference"", ""summary"": ""RAHWAY, N.J., November 08, 2023--Merck to Participate in the Jefferies London Healthcare Conference""}, {""date"": ""20231108160100"", ""headline"": ""Ligand Reports Third Quarter 2023 Financial Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108163500"", ""headline"": ""Merck & Co. Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.38% higher to $104.40 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231109060300"", ""headline"": ""10 Analysts Have This to Say About Merck & Co"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109060809"", ""headline"": ""Deutsche warms to Merck; Ralph Lauren snags a buy rating: 4 big analyst picks"", ""summary"": ""Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: a Buy initiation at Merck, and upgrades at Ralph Lauren, TopBuild, and Valaris.  Deutsche Bank initiated coverage on Merck (NYSE:MRK) with a Buy rating and a price target of $115.00, as reported in real time on InvestingPro.  Analysts noted that Merck's Keytruda drug has become a central element for oncology treatment regimens and is likely to continue being a growth driver until at least fiscal year 2028.""}, {""date"": ""20231109065700"", ""headline"": ""GLOBAL BROKER RATINGS: Wells Fargo raises Adyen; HSBC likes AB InBev"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109075845"", ""headline"": ""Merck: Investing In Excellence"", ""summary"": ""Merck's diverse portfolio, including its flagship drug Keytruda, positions it for future growth. See why I think MRK stock is still a strong buy.""}, {""date"": ""20231109122200"", ""headline"": ""Eli Lilly declines a day after FDA nod for weight loss therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109123937"", ""headline"": ""Deutsche Bank Initiates Coverage of Merck (MRK) with Buy Recommendation"", ""summary"": """"}, {""date"": ""20231109125200"", ""headline"": ""Fortunes Can Be Made With Bristol-Myers Squibb"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109125830"", ""headline"": ""Zoetis: High-Quality Compounder With A Reasonable Price After Earnings"", ""summary"": ""Zoetis operates in 2 main categories: livestock, which is growing slowly, and the faster-growing companion market for pets. Find out why ZTS stock is a Buy.""}, {""date"": ""20231109142617"", ""headline"": ""7 Safe Stocks to Buy if You Think Q3\u2019s Gangbuster Growth Won\u2019t Last"", ""summary"": ""At first glance, the proposal to dive into safe stocks to buy might appear overly conservative. As NPR recently pointed out, the U.S. GDP grew 4.9% in the third quarter, catalyzed by stronger-than-expected consumer spending. While stunning, the good times might not last. For one thing, experts warn that the economy is unlikely to sustain the current blistering pace. In particular, higher interest rates \u2013 which obviously impose elevated borrowing costs \u2013 may crimp upside. Pointing to the slowdown""}, {""date"": ""20231109144200"", ""headline"": ""Dow's nearly 250-point fall led by losses in shares of Amgen, Home Depot"", ""summary"": ""Shares of Amgen and Home Depot are posting losses Thursday afternoon, sending the Dow Jones Industrial Average into negative territory. Shares of Amgen and...""}, {""date"": ""20231109163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Merck & Co. Inc. shed 1.93% to $102.38 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20231109173700"", ""headline"": ""Top Analyst Reports for McDonald's, ConocoPhillips & RTX"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including McDonald's Corporation (MCD), ConocoPhillips (COP) and RTX Corporation (RTX).""}, {""date"": ""20231110023000"", ""headline"": ""Cantor biotech/biopharma analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110064600"", ""headline"": ""Merck announces CHMP opinion recommending approval of Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110070700"", ""headline"": ""Qualcomm, Merck And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110071300"", ""headline"": ""IO Biotech completes enrollment in Phase 3 trial of advanced melanoma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110073300"", ""headline"": ""Merck's Keytruda gets CHMP nod for combo therapy of biliary tract cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110080500"", ""headline"": ""Merck Gets CHMP Backing for Keytruda in Biliary Tract Cancer"", ""summary"": ""By Colin Kellaher Merck &amp; Co. on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval...""}, {""date"": ""20231110082700"", ""headline"": ""WHO\u2019s new COVID guidelines see fewer patients requiring hospitalization"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110091800"", ""headline"": ""Looking Into Merck & Co's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110113700"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110120000"", ""headline"": ""7 Biotech Stocks to Buy for Big-Time Gains"", ""summary"": ""This is an amazing week to consider biotech stocks. Big news by the U.S. Food & Drug Administration (which we\u2019ll get to momentarily) shows the benefits and outsized gains you can enjoy by choosing the right biotech stock. Biotech companies have the potential to be big winners because of their very nature. They\u2019re at the forefront of scientific innovation and push the boundaries of medical research, drug development, and healthcare solutions. By investing in biotech stocks, you support and potent""}, {""date"": ""20231110124000"", ""headline"": ""Merck Receives Positive EU CHMP Opinion for KEYTRUDA\u00ae (pembrolizumab) Plus Gemcitabine and Cisplatin as First-Line Treatment for Locally Advanced Unresectable or Metastatic Biliary Tract Cancer"", ""summary"": ""RAHWAY, N.J., November 10, 2023--Merck Receives EU CHMP Opinion for KEYTRUDA Plus Gemcitabine and Cisplatin as First-Line Treatment for Locally Advanced Unresectable or Metastatic BTC""}, {""date"": ""20231110163500"", ""headline"": ""Merck & Co. Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. slumped 0.97% to $101.39 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20231111110034"", ""headline"": ""Merck & Co., Inc. (NYSE:MRK) is favoured by institutional owners who hold 77% of the company"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Merck's stock price might be vulnerable to their...""}, {""date"": ""20231111121020"", ""headline"": ""Merck & Co., Inc. (MRK) Presents at UBS BioPharma Conference (Transcript)"", ""summary"": ""Merck & Co., Inc. (NYSE:NYSE:MRK) UBS BioPharma Conference November 8, 2023 12:00 PM ETCompany ParticipantsJannie Oosthuizen - President, U.S.""}, {""date"": ""20231112054732"", ""headline"": ""High-Quality Dividend Growth Near 52-Week Lows: Pfizer Is Phenomenal"", ""summary"": ""Pfizer appears to be a good investment opportunity due to its high quality, future growth projections, and sustainable dividend. Explore more details here.""}, {""date"": ""20231112220615"", ""headline"": ""Passive Income Snowball: How Does VYM Stack Up Against 6 Competing ETFs?"", ""summary"": ""Vanguard High Dividend Yield Index Fund ETF is a well-diversified, low-cost dividend growth fund for passive income. Find out why VYM is a Hold.""}]",{}
19,2023-11-12,100.66111755371094,2023-11-19,101.0185317993164,0.003550668364224796,U1,"[{""date"": ""20231112054732"", ""headline"": ""High-Quality Dividend Growth Near 52-Week Lows: Pfizer Is Phenomenal"", ""summary"": ""Pfizer appears to be a good investment opportunity due to its high quality, future growth projections, and sustainable dividend. Explore more details here.""}, {""date"": ""20231112220615"", ""headline"": ""Passive Income Snowball: How Does VYM Stack Up Against 6 Competing ETFs?"", ""summary"": ""Vanguard High Dividend Yield Index Fund ETF is a well-diversified, low-cost dividend growth fund for passive income. Find out why VYM is a Hold.""}, {""date"": ""20231113030600"", ""headline"": ""Barrow, Hanley, Mewhinney & Strauss Adjusts Portfolio, Major Moves in Dollar General Corp"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231113041955"", ""headline"": ""OUSA: Attractive Quality, Average Performance"", ""summary"": ""OUSA ETF holds 100 dividend stocks selected and weighted based on profitability, dividend quality, leverage and volatility. Read why I'm neutral on the fund.""}, {""date"": ""20231113101235"", ""headline"": ""Nike, Merck Among 13 Companies To Announce Annual Dividend Increases In H2 Of November"", ""summary"": ""13 companies are set to announce annual dividend increases in the second half of November. Click here to read what investors need to know.""}, {""date"": ""20231113163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. rallied 1.07% to $102.47 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20231113195611"", ""headline"": ""10 Healthcare Focused Hedge Funds and 10 Top Stock Picks"", ""summary"": ""In this article, we discuss 10 healthcare focused hedge funds and 10 top stock picks. You can skip our detailed analysis of the performance of healthcare focused hedge funds and go directly to read 10 Healthcare Focused Hedge Funds and 5 Top Stock Picks. Hedge funds resort to defensive stocks when faced with economic growth uncertainty [\u2026]""}, {""date"": ""20231113210344"", ""headline"": ""Robert Bruce's Investment Strategy Leads to Notable Changes in Portfolio, Highlighting Merck ..."", ""summary"": ""Insight into the Latest 13F Filing Reveals Key Stock Adjustments by Value Investing Firm Bruce & Co""}, {""date"": ""20231114000505"", ""headline"": ""13 Cheap Blue Chip Stocks To Buy"", ""summary"": ""In this piece, we will take a look at the 13 cheap blue chip stocks to buy. To skip our overview of the blue chip sector and the latest news about the stock market, take a look at the 5 Cheap Blue Chip Stocks To Buy. Within the American stock market, the Dow Jones Industrial [\u2026]""}, {""date"": ""20231114001238"", ""headline"": ""The 3 Best Defensive Stocks for Uncertain Times"", ""summary"": ""Investment is not just the art of finding potential multi-bagger stocks. There is a lot of thinking and strategizing involved in creating a portfolio that beats the index, delivers regular cash flows, and ensures capital preservation in challenging market conditions. To ensure capital preservation, some of the best defensive stocks need to be included in the portfolio. In general, defensive stocks can be defined as names that have a low beta. Further, defensive stocks are invariably blue-chip st""}, {""date"": ""20231114070700"", ""headline"": ""Natera enters oncology research agreement with Merck"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114075700"", ""headline"": ""Agilent gastric cancer assay wins FDA nod"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114080000"", ""headline"": ""MilliporeSigma Launches ChemisTwin\u2122, First Ever Digital Reference Material Platform for Analytical Testing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114080400"", ""headline"": ""Kahn Brothers Adjusts Holdings with Notable Moves in BP PLC and CSX Corp"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114093500"", ""headline"": ""Merck to use Natera's database for oncology drug research"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114103000"", ""headline"": ""Earnings Estimates Are Falling. These Two Companies Are Shouldering the Blame."", ""summary"": ""Investors appear to be taking the shifting picture in stride, partly because much of the responsibility appears to fall on Pfizer and Merck.""}, {""date"": ""20231114111900"", ""headline"": ""Merck: Tracking Well Above The Industry"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114123000"", ""headline"": ""EMD Serono Announces Plans for New U.S. Healthcare Headquarters in Boston\u2019s Seaport District"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114163500"", ""headline"": ""Merck & Co. Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. slid 0.29% to $102.17 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231114173001"", ""headline"": ""The S&P 500 Has Two Companies to Thank for the Slide in Earnings Estimates"", ""summary"": ""Wall Street analysts often trim their estimates for S&P 500 earnings during the first month of a quarter. This time, the cuts have been deeper than usual. Investors don't seem particularly rattled. That may be because just two companies\u2014Pfizer and Merck\u2014accounted for half of the decline in quarterly profit estimates from Oct.""}, {""date"": ""20231115042100"", ""headline"": ""FDA reviewers reportedly question efficacy of Merck cough drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115084100"", ""headline"": ""UBS highlights 14 stocks on its list of high-conviction names"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115121500"", ""headline"": ""Alkermes separates cancer drug business as new company Mural"", ""summary"": ""Now independent Mural Oncology will focus on advancing a pipeline of engineered cytokines for cancer, while Alkermes has recast itself as a \u201cpure-play\u201d neuroscience company.""}, {""date"": ""20231115121800"", ""headline"": ""Pfizer, Merck said to be behind cuts to Q4 earnings views"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115122331"", ""headline"": ""US FDA staff flags concerns on Merck's chronic cough drug"", ""summary"": ""U.S. Food and Drug Administration'sreviewers on Wednesday flagged concerns that data on Merck'schronic cough drug might not be sufficient to provemeaningful benefit, according to documents released...""}, {""date"": ""20231115163500"", ""headline"": ""Merck & Co. Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. shed 0.80% to $101.35 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20231116012400"", ""headline"": ""Pembrolizumab with chemo approved for HER2-negative gastric or GEJ adenocarcinoma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116022600"", ""headline"": ""Cantor Fitzgerald Sticks to Its Buy Rating for Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116044100"", ""headline"": ""FDA approves Merck's Keytruda plus chemotherapy as first-line treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116055000"", ""headline"": ""FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116075505"", ""headline"": ""Merck & Co., Inc. (MRK) Presents at Jefferies London Healthcare Conference (Transcript)"", ""summary"": ""Merck & Co., Inc. (NYSE:NYSE:MRK) Jefferies London Healthcare Conference November 16, 2023 5:00 AM ETCompany ParticipantsCaroline Litchfield - Chief...""}, {""date"": ""20231116085700"", ""headline"": ""Pfizer: Undervalued At Peak Pessimism in the Post-COVID-19 Era"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116092000"", ""headline"": ""Marks Electrical half-year profit declines despite strong sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116112400"", ""headline"": ""MRK July 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116113300"", ""headline"": ""Merck's Gefapixant Under FDA Lens: Advisory Committee To Discuss Chronic Cough Drug's Future"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116163500"", ""headline"": ""Merck & Co. Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.63% higher to $101.99 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231116175200"", ""headline"": ""Merck\u2019s Keytruda gets approval to treat certain types of gastric cancer"", ""summary"": ""Merck said late Thursday that the Food and Drug Administration has approved its star cancer drug Keytruda as treatment for some adult gastrointestinal...""}, {""date"": ""20231116224000"", ""headline"": ""FDA Approves Merck\u2019s KEYTRUDA\u00ae (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Locally Advanced Unresectable or Metastatic HER2-Negative Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma"", ""summary"": ""RAHWAY, N.J., November 16, 2023--FDA Approves Merck\u2019s KEYTRUDA Plus Chemo as First-Line Treatment for Locally Advanced Unresectable or Metastatic HER2-Negative Gastric or GEJ Cancer""}, {""date"": ""20231117010800"", ""headline"": ""Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117044900"", ""headline"": ""FDA panel votes 12-1 against Merck's gefapixant, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117050800"", ""headline"": ""Merck gets FDA nod for Keytruda in stomach cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117051100"", ""headline"": ""Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117062503"", ""headline"": ""Merck : FDA approves Keytruda for gastric cancer"", ""summary"": ""Merck announced on Friday that the U.S. Food and Drug Administration had approved Keytruda for the first-line treatment of cancers of the stomach and esogastric junction.The pharmaceutical group...""}, {""date"": ""20231117074600"", ""headline"": ""FDA Approves Merck's Blockbuster Cancer Drug For Type Of Gastric Cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117082400"", ""headline"": ""4 stocks to watch on Friday: Zoom, ChargePoint, Li Auto and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117091842"", ""headline"": ""FDA Approves Merck's KEYTRUDA Plus Chemotherapy as First-Line Treatment for Locally Advanced Unresectable or Metastatic HER2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration has approved KEYTRUDA, Merck's anti-PD-1 therapy, in combination...""}, {""date"": ""20231117094500"", ""headline"": ""Cantor biotech/biopharma analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117111300"", ""headline"": ""AstraZeneca: Growth Is Still A Better Choice"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117121000"", ""headline"": ""5 Top Growth Stocks to Buy Now, According to Analysts \u2013 November 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117132700"", ""headline"": ""Merck & Co says Keytruda combination receives US FDA approval"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117160738"", ""headline"": ""US FDA panel votes against Merck's chronic cough drug"", ""summary"": ""The U.S. health regulator's adviserson Friday did not recommend Merck's drug for thetreatment of chronic cough. The FDA panel voted 12 to 1 that the data presented does notdemonstrate...""}, {""date"": ""20231117162900"", ""headline"": ""Merck (MRK) Gets FDA Nod for Keytruda Expansion in Gastric Cancer"", ""summary"": ""Following this approval, Merck's (MRK) Keytruda is approved for seven gastrointestinal cancers. Overall, the drug is approved for 38 indications in the country.""}, {""date"": ""20231117163500"", ""headline"": ""Merck & Co. Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. dropped 0.24% to $101.75 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231117174503"", ""headline"": ""Merck : Provides Update on FDA Advisory Committee Meeting Evaluating Gefapixant"", ""summary"": ""November 17, 2023 5:31 pm ET RAHWAY, N.J., Nov. 17, 2023 - Merck , known as MSD outside of the United States and Canada, today announced the outcome of the U.S. Food and Drug...""}, {""date"": ""20231118122700"", ""headline"": ""Merck's Latest Drug For Chronic Cough Faces FDA Pushback"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119110200"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119144337"", ""headline"": ""Ken Griffin Stock Portfolio: Top 10 Stock Picks"", ""summary"": ""In this piece, we will take a look at the top ten stock picks of Ken Griffin and his hedge fund Citadel Investment Group. If you want to skip our introduction to the billionaire hedge fund boss and his firm, then take a look at Ken Griffin Stock Portfolio: Top 5 Stock Picks. Ken Griffin\u2019s [\u2026]""}]",{}
20,2023-11-19,101.0185317993164,2023-11-26,101.1376724243164,0.0011793937496209494,U1,"[{""date"": ""20231119110200"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119144337"", ""headline"": ""Ken Griffin Stock Portfolio: Top 10 Stock Picks"", ""summary"": ""In this piece, we will take a look at the top ten stock picks of Ken Griffin and his hedge fund Citadel Investment Group. If you want to skip our introduction to the billionaire hedge fund boss and his firm, then take a look at Ken Griffin Stock Portfolio: Top 5 Stock Picks. Ken Griffin\u2019s [\u2026]""}, {""date"": ""20231120011100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Fresenius Medical Care (FMS), Solid Biosciences (SLDB) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120033700"", ""headline"": ""Merck & Co. Inc. stock rises Monday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120035100"", ""headline"": ""Merck disappointed as FDA panel refuses to recommend gefapixant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120043500"", ""headline"": ""Three Solid Stocks That Still Have Plenty Of Growth Left"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120071800"", ""headline"": ""Merck fails to win over FDA panel for cough therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120114500"", ""headline"": ""Merck to Participate in the 6th Annual Evercore ISI HealthCONx Conference"", ""summary"": ""RAHWAY, N.J., November 20, 2023--Merck to Participate in the 6th Annual Evercore ISI HealthCONx Conference""}, {""date"": ""20231121010000"", ""headline"": ""A Golden Age of Vaccines Is Here. What It Means for You."", ""summary"": ""Pharmaceutical companies are currently developing vaccines for a range of purposes, from preventing disease to treating cancers.""}, {""date"": ""20231121013400"", ""headline"": ""Noteworthy Tuesday Option Activity: MRK, MDT, MA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121022600"", ""headline"": ""Merck & Company (MRK) Gets a Buy from Cantor Fitzgerald"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121033600"", ""headline"": ""Merck & Co. Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121041600"", ""headline"": ""These ten stocks, not just from tech, are the key to next year\u2019s S&P 500 earnings growth"", ""summary"": ""Here are the companies that are expected to drive the bulk of earnings growth next year for the S&P 500.""}, {""date"": ""20231121043144"", ""headline"": ""Merck: A Dividend Growth Stock Worth Considering"", ""summary"": ""Merck reports positive quarterly earnings and consistent dividend growth over 12 years. Read why MRK stock is well-positioned for potential future success.""}, {""date"": ""20231121054700"", ""headline"": ""Merck to acquire Caraway Therapeutics for up to $610M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121060200"", ""headline"": ""Merck to acquire Caraway Therapeutics for $610M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121065056"", ""headline"": ""Merck & Co To Acquire Caraway Therapeutics"", ""summary"": ""Merck & Co Inc: * MERCK TO ACQUIRE CARAWAY THERAPEUTICS, INC. * MERCK & CO INC: PROPOSED DEAL FOR TOTAL POTENTIAL CONSIDERATION OF UP TO$610MILLION * MERCK...""}, {""date"": ""20231121065129"", ""headline"": ""Merck to acquire Caraway Therapeutics for up to $610 mln"", ""summary"": ""Merck & Co will acquireCaraway Therapeutics for a total potential consideration of upto $610 million, the companies said on Tuesday. ...""}, {""date"": ""20231121071300"", ""headline"": ""Merck paying $610 million for Caraway Therapeutics"", ""summary"": ""Merck & Co. Inc. said Tuesday it agreed to pay up to $610 million to acquire Caraway Therapeutics, a preclinical biopharmaceutical company pursuing new...""}, {""date"": ""20231121081803"", ""headline"": ""Merck : agreement to acquire Caraway Therapeutics"", ""summary"": ""Merck announced on Tuesday that it had reached a definitive agreement to acquire the US biopharmaceutical company Caraway Therapeutics for up to $610 million.Under the terms of the agreement, the US...""}, {""date"": ""20231121092100"", ""headline"": ""IN BRIEF: Merck & Co inks deal to buy investee Caraway Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121113700"", ""headline"": ""J&J, Merck, Bristol Myers CEOs asked to testify before Senate panel on drug prices"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121114500"", ""headline"": ""Merck to Acquire Caraway Therapeutics, Inc."", ""summary"": ""RAHWAY, N.J., & CAMBRIDGE, Mass., November 21, 2023--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. announced today that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Caraway Therapeutics for a total potential consideration of up to $610 million, including an undisclosed upfront payment as well as contingent milestone payments. The upfront payment will be expensed by Merck in t""}, {""date"": ""20231121122000"", ""headline"": ""Merck to buy private biotech Caraway in neuroscience deal"", ""summary"": ""In a deal worth up to $610 million, Merck will gain a pipeline of neuroscience and rare disease programs from a startup it previously backed.""}, {""date"": ""20231121122043"", ""headline"": ""UPDATE 1-Merck to acquire Caraway Therapeutics for up to $610 mln"", ""summary"": ""Merck & Co will acquire Caraway Therapeutics for a total potential consideration of up to $610 million, the companies said on Tuesday, to build on its treatment pipeline of nervous system-related diseases.  Merck, through a subsidiary, will acquire all outstanding shares of Caraway for an undisclosed upfront payment and earnout milestones linked to the development of certain drugs Caraway has in the pipeline.  Drug developer Caraway's drug pipeline includes experimental treatment of genetically defined neurodegenerative and rare diseases, including Parkinson's disease.""}, {""date"": ""20231121211515"", ""headline"": ""Tracking Jeremy Grantham's GMO Capital Portfolio - Q3 2023 Update"", ""summary"": ""Jeremy Grantham's 13F portfolio value declined by 2% to $21.17B in Q3 2023. Microsoft, UnitedHealth, Alphabet, J&J, and Meta Platforms are top holdings.""}, {""date"": ""20231122011800"", ""headline"": ""Top gainers and laggards in S&P, DJI, and NDX on Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122033600"", ""headline"": ""Merck & Co. Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122060300"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Merck & Company (MRK) and Twist Bioscience (TWST)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122061900"", ""headline"": ""Strategic Acquisition of Caraway Therapeutics Bolsters Merck\u2019s Portfolio: An In-depth Analysis and Buy Rating Recommendation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122085900"", ""headline"": ""GSK: Undervalued At Peak Pessimism"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122090000"", ""headline"": ""Merck: Keytruda Patent Expiry Nears With Replacement Yet To Be Found"", ""summary"": ""For now, Merck's prospects have somewhat dimmed, with management engaging on expensive partnerships to boost its pipelines. Learn why we rate MRK stock a hold.""}, {""date"": ""20231122103804"", ""headline"": ""Merck: Not The Time To Be Adding"", ""summary"": ""Merck's stock has seen a sustained pattern of lower highs and lower lows. Read why MRK stock remains a hold for us at present.""}, {""date"": ""20231122105700"", ""headline"": ""Merck's Caraway Deal: Analyst Says \""Timely, Anchored By Novel Programs & Management Team\"""", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122123800"", ""headline"": ""Top gainers and laggards in S&P, DJI, and NDX Today - CNBC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122171502"", ""headline"": ""20 Healthiest States in the US in 2023"", ""summary"": ""In this article, we will look into the 20 healthiest states in the US in 2023. If you want to skip our detailed analysis, you can go directly to the 5 Healthiest States in the US in 2023. Health Status of the US According to the OECD Health at a Glance 2023 report, The United [\u2026]""}, {""date"": ""20231123023824"", ""headline"": ""Merck Will Keep Your Retirement Income Healthy"", ""summary"": ""Merck presents a compelling investment opportunity with its strong growth prospects, low forward P/E ratio, and upcoming dividend hike. Read more on MRK here.""}, {""date"": ""20231123210253"", ""headline"": ""Stability Seekers: 7 Low-Volatility Stocks for Uncertain Times"", ""summary"": ""At first blush, focusing on low-volatility stocks may appear an overly pessimistic strategy. After all, the benchmark S&P 500 gained almost 8% in the trailing month. On a year-to-date basis, the venerable index is up nearly 19%, very close to its record high. Nevertheless, it doesn\u2019t hurt to prepare for negative outcomes. Yes, thinking positively carries a desirable premium in society. However, that\u2019s not how this works on Wall Street. Mister Market gives two you-know-whats about investors\u2019 feel""}, {""date"": ""20231124163500"", ""headline"": ""Merck & Co. Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.19% higher to $101.87 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""20231125032010"", ""headline"": ""MannKind: Continues To Kick The Can Down The Road For Investors"", ""summary"": ""MannKind (MNKD) needs to decide if Afrezza will be a reliable source of revenue or a drag on future revenues. Click here to read more.""}, {""date"": ""20231125120024"", ""headline"": ""Merck (NYSE:MRK) shareholders have earned a 9.4% CAGR over the last five years"", ""summary"": ""When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...""}, {""date"": ""20231125140000"", ""headline"": ""SCHD: Time To Be Really Greedy"", ""summary"": ""Learn why SCHD may have reached peak pessimism in October, making it an opportunity for investors to be greedy and capitalize on its recovery.""}, {""date"": ""20231125212254"", ""headline"": ""11 Best Fortune 500 Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 best Fortune 500 dividend stocks to buy now. You can skip our detailed analysis of large-cap dividend stocks and their performance in the past, and go directly to read 5 Best Fortune 500 Dividend Stocks To Buy Now. The Fortune 500 is an annual list compiled and published by [\u2026]""}]",{}
21,2023-11-26,101.1376724243164,2023-12-03,102.71623992919922,0.015608105931685268,U2,"[{""date"": ""20231127022900"", ""headline"": ""Biden Plans to Boost Drug Production Using Cold-War Era Law"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127104410"", ""headline"": ""Mastercard, Pfizer Among 18 Companies To Announce Dividend Increases In December"", ""summary"": ""2H of November saw announcements of annual dividend increases from 9 companies. 16 other companies will announce annual increases before Christmas. Read more here.""}, {""date"": ""20231127115300"", ""headline"": ""Biotech And Healthcare Portfolio Playbook For December 2023/24"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127121500"", ""headline"": ""President Biden to use 1950 law to boost essential drug production"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127163500"", ""headline"": ""Merck & Co. Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. sank 0.43% to $101.43 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231128015100"", ""headline"": ""PFAS's Forever Problem: Ohio Lawsuit Against Chemical Companies Fizzles Out"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128020900"", ""headline"": ""Merck raises dividend by 5.5% to $0.77"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128055000"", ""headline"": ""Merck's pneumococcal vaccine shows superior immunogenicity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128071300"", ""headline"": ""Merck pneumococcal shot shows superior immunogenicity in late-stage trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128074200"", ""headline"": ""Vaxcyte appoints Lee to board of directors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128091602"", ""headline"": ""Merck : promising results for pneumococcal vaccine"", ""summary"": ""Merck today announced the results of a Phase 3 trial evaluating V116, its investigational 21-valent pneumococcal conjugate vaccine specifically designed to protect adults. In adults aged 50 and over ,...""}, {""date"": ""20231128110800"", ""headline"": ""Merck Highlights Data On New Vaccine, Compares 'Tolerability And Safety' To Pfizer's"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128114500"", ""headline"": ""Merck\u2019s V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed to Protect Adults, Demonstrated Superior Immunogenicity for 10 of 11 Unique Serotypes Compared to PCV20 in Adults 50 Years of Age and Older"", ""summary"": ""RAHWAY, N.J., November 28, 2023--Merck\u2019s V116 an Investigational 21-valent PCV Demonstrated Superior Immunogenicity for 10 of 11 Unique Serotypes Compared to PCV20 in Adults 50+""}, {""date"": ""20231128121900"", ""headline"": ""Merck raises quarterly dividend to 77c from 73c per share"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128124200"", ""headline"": ""Coherus cancer drug undercuts Merck's Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128131700"", ""headline"": ""Merck Declares Dividend for the First Quarter of 2024, Payable on January 8, 2024"", ""summary"": ""Merck announced that the Board of Directors has declared a quarterly dividend of $0.77 per share of the company?s common stock for the first quarter of 2024. Payment will be made on January 8, 2024,...""}, {""date"": ""20231128132300"", ""headline"": ""Merck raises quarterly dividend to 77 cents vs. 73 cents"", ""summary"": ""Merck & Co. Inc. said Tuesday its board has raised its quarterly dividend to 77 cents. The dividend was previously 73 cents. The new dividend is payable Jan....""}, {""date"": ""20231128134000"", ""headline"": ""Merck Raises Quarterly Dividend 5.5% To 77c"", ""summary"": ""By Ben Glickman Merck &amp; Co. raised its quarterly dividend 5.5% on Tuesday. The Rahway, N.J.-based pharmaceutical company lifted its payout to 77 cents a...""}, {""date"": ""20231128135602"", ""headline"": ""Merck Raises Quarterly Dividend 5.5% To 77 Cents"", ""summary"": ""By Ben Glickman Merck & Co. raised its quarterly dividend 5.5% on Tuesday. The Rahway, N.J.-based pharmaceutical company lifted its payout to 77 cents a share from 73 cents a share. ...""}, {""date"": ""20231128163500"", ""headline"": ""Merck & Co. Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. slid 1.23% to $100.18 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231128181700"", ""headline"": ""Merck Announces First-Quarter 2024 Dividend"", ""summary"": ""RAHWAY, N.J., November 28, 2023--Merck Announces First-Quarter 2024 Dividend""}, {""date"": ""20231129081400"", ""headline"": ""Vanguard Health Care Fund's Strategic Moves: Spotlight on Ono Pharmaceutical Co Ltd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129082700"", ""headline"": ""Amazon Web Services, Accenture aid Merck move its IT infrastructure to AWS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129090600"", ""headline"": ""Analyst Ratings for Merck & Co"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129091615"", ""headline"": ""Merck's V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed to Protect Adults, Demonstrated Superior Immunogenicity for 10 of 11 Unique Serotypes Compared to PCV20 in Adults 50 Years of Age and Older"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced results from STRIDE-3, a Phase 3 trial evaluating V116, the company's investigational 21-valent pneumococcal...""}, {""date"": ""20231129110600"", ""headline"": ""Video: Daily Dividend Report: MRK,MSFT,UNP,MKC,ENB"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129112526"", ""headline"": ""Why I Made Big Changes To My Dividend Growth Portfolio"", ""summary"": ""How to make significant changes to your portfolio, for when buying a new house and selling stocks for cash? Click here to read about my strategy.""}, {""date"": ""20231129124400"", ""headline"": ""Spyre gains as TD Cowen starts at Outperform on anti-TL1A potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129130011"", ""headline"": ""We Think Merck (NYSE:MRK) Can Stay On Top Of Its Debt"", ""summary"": ""David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...""}, {""date"": ""20231129132600"", ""headline"": ""Merck's (MRK) Pneumococcal Jab Shows Upbeat Responses in Study"", ""summary"": ""Positive data from Merck's (MRK) phase III study on V116, an investigational, 21-valent pneumococcal conjugate vaccine, supports the immunogenicity of V116 compared to standard of care.""}, {""date"": ""20231129140000"", ""headline"": ""AWS and Accenture Help Merck Use Cloud Technology to Reduce Drug Discovery Time and Accelerate Clinical Trial Development"", ""summary"": ""LAS VEGAS, November 29, 2023--At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced it is working with Accenture (NYSE: ACN) to help Merck (NYSE: MRK), known as MSD outside of the U.S. and Canada, to move a substantial portion of its IT infrastructure to AWS as part of the company\u2019s multiyear cloud migration.""}, {""date"": ""20231129155859"", ""headline"": ""12 Best Quality Stocks To Buy Now"", ""summary"": ""In this piece, we will take a look at the 12 best quality stocks to buy now. If you want to skip our analysis of stock quality and want to jump ahead to the top five stocks in this list, then take a look at the 5 Best Quality Stocks To Buy Now. When it [\u2026]""}, {""date"": ""20231129163500"", ""headline"": ""Merck & Co. Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.95% higher to $101.13 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231130021600"", ""headline"": ""Cantor Fitzgerald Sticks to Their Buy Rating for Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130040700"", ""headline"": ""Seagen, Astellas and Merck announce FDA grants priority review to Padcev BLA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130045000"", ""headline"": ""FDA to decide on approving Keytruda/Padcev combo therapy by May 9"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130071900"", ""headline"": ""AbbVie to acquire cancer drugmaker ImmunoGen for $10B cash (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130112700"", ""headline"": ""AbbVie-ImmunoGen buyout deal lifts ADC-focused biotechs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130121900"", ""headline"": ""Price Over Earnings Overview: Merck & Co"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130162424"", ""headline"": ""For DSI, Ethics Is Not A Drag"", ""summary"": ""Valuation and growth metrics for the iShares MSCI KLD 400 Social ETF are underwhelming, but quality is above-par. Read more to see our analysis on DSI.""}, {""date"": ""20231130163019"", ""headline"": ""Merck & Co., Inc. (MRK) Management Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)"", ""summary"": ""Merck &amp; Co., Inc. (NYSE:NYSE:MRK) 6th Annual Evercore ISI HealthCONx Conference Transcript November 30, 2023 1:20 PM ETExecutivesDr.""}, {""date"": ""20231130163500"", ""headline"": ""Merck & Co. Inc. stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of Merck & Co. Inc. advanced 1.33% to $102.48 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""20231130165530"", ""headline"": ""17 Ideal Pre-Crash Recovery December Divi-Dogs"", ""summary"": ""Discover the top pre-crash-recovery stocks of 2023 in financial services, healthcare, and real estate sectors. Click for our top dividend picks in several sectors.""}, {""date"": ""20231130220000"", ""headline"": ""FDA Grants Priority Review to Merck\u2019s Application for KEYTRUDA\u00ae (pembrolizumab) Plus Padcev\u00ae (enfortumab vedotin-ejfv) for the First-Line Treatment of Patients With Locally Advanced or Metastatic Urothelial Cancer"", ""summary"": ""RAHWAY, N.J., November 30, 2023--FDA Grants Priority Review to Merck\u2019s Application for KEYTRUDA Plus Padcev for the First-Line Treatment of Patients With Advanced Urothelial Cancer""}, {""date"": ""20231201064500"", ""headline"": ""Dividend Roundup: Merck, TD Bank, Kohl\u2019s, Haliburton, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201081603"", ""headline"": ""Merck : priority review in bladder cancer"", ""summary"": ""Merck announced on Friday that the FDA had granted priority review to its marketing application for Keytruda in bladder cancer.The American biopharmaceutical group explains that the FDA's decision...""}, {""date"": ""20231201100300"", ""headline"": ""Salesforce, Boeing share gains contribute to Dow's 100-point climb"", ""summary"": ""Buoyed by strong returns for shares of Salesforce and Boeing, the Dow Jones Industrial Average is climbing Friday morning. Shares of Salesforce and Boeing...""}, {""date"": ""20231201163500"", ""headline"": ""Merck & Co. Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.96% higher to $103.46 Friday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""20231202090000"", ""headline"": ""Which ETF May Disappoint Retirees The Most, SCHD Or VYM?"", ""summary"": ""Schwab's US Dividend Equity ETF (SCHD) and Vanguard's High Dividend Yield Index Fund ETF (VYM) have struggled in the past year. Explore the alternatives here.""}, {""date"": ""20231202090000"", ""headline"": ""5 Relatively Secure And Cheap Dividend Stocks To Invest In - December 2023"", ""summary"": ""Discover five large-cap dividend-paying companies with discounts to their historical norms, selected from over 7,500 U.S. traded companies. Click for our picks!""}, {""date"": ""20231202122000"", ""headline"": ""Week In Review: Tang Capital Offers $465 Million For LianBio Plus 80% Of Any Licenses/Divestments"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231202122743"", ""headline"": ""Merck (NYSE:MRK) Is Increasing Its Dividend To $0.77"", ""summary"": ""Merck & Co., Inc. ( NYSE:MRK ) will increase its dividend on the 8th of January to $0.77, which is 5.5% higher than...""}, {""date"": ""20231203040032"", ""headline"": ""Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio"", ""summary"": ""Abbott Laboratories had a difficult last three years, with its stock price trading sideways as sales driven by COVID-19 plummeted. Read more on ABT stock here.""}, {""date"": ""20231203043000"", ""headline"": ""Week In Review: Tang Capital Offers $465M For LianBio Plus 80% Of Any Licenses/Divestments"", ""summary"": ""Tang Capital offering $465M for LianBio Plus 80% of any Licenses/Divestments is ChinaBio's lead news this week. Click here to read more.""}, {""date"": ""20231203071023"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the update for the week of December 3.""}, {""date"": ""20231203114231"", ""headline"": ""Billionaire Ken Fisher\u2019s 10 Stock Picks with Huge Upside Potential"", ""summary"": ""In this article, we discuss billionaire Ken Fisher\u2019s 10 stock picks with huge upside potential. To skip Fisher\u2019s comments on current economic conditions and details about his Q3 bets, go directly to Billionaire Ken Fisher\u2019s 5 Stock Picks with Huge Upside Potential. Ken Fisher runs one of the largest and most successful hedge funds in [\u2026]""}]",{}
22,2023-12-03,102.71623992919922,2023-12-10,103.00415802001953,0.002803043520856807,U1,"[{""date"": ""20231203040032"", ""headline"": ""Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio"", ""summary"": ""Abbott Laboratories had a difficult last three years, with its stock price trading sideways as sales driven by COVID-19 plummeted. Read more on ABT stock here.""}, {""date"": ""20231203043000"", ""headline"": ""Week In Review: Tang Capital Offers $465M For LianBio Plus 80% Of Any Licenses/Divestments"", ""summary"": ""Tang Capital offering $465M for LianBio Plus 80% of any Licenses/Divestments is ChinaBio's lead news this week. Click here to read more.""}, {""date"": ""20231203071023"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the update for the week of December 3.""}, {""date"": ""20231203114231"", ""headline"": ""Billionaire Ken Fisher\u2019s 10 Stock Picks with Huge Upside Potential"", ""summary"": ""In this article, we discuss billionaire Ken Fisher\u2019s 10 stock picks with huge upside potential. To skip Fisher\u2019s comments on current economic conditions and details about his Q3 bets, go directly to Billionaire Ken Fisher\u2019s 5 Stock Picks with Huge Upside Potential. Ken Fisher runs one of the largest and most successful hedge funds in [\u2026]""}, {""date"": ""20231204061900"", ""headline"": ""Merck a Top Socially Responsible Dividend Stock With 3.0% Yield (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204075109"", ""headline"": ""December Dogs Of The Dow: 3 Buyable, 5 Watchable"", ""summary"": ""Some of these Dow Industrials are too pricey and reveals only skinny dividends. Read here about 3 of the 5 lowest-priced Dogs of the Dow which are ready to buy.""}, {""date"": ""20231204083900"", ""headline"": ""Merck to Pay at Least $70 Mln for Rights to Abbisko Joint-Tumor Drug"", ""summary"": ""By David Sachs Merck has a deal worth at least $70 million with Abbisko Therapeutics to commercialize a drug to treat joint tumors. The German pharmaceutical...""}, {""date"": ""20231204104900"", ""headline"": ""(MRK) - Analyzing Merck & Co's Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204180434"", ""headline"": ""Pfizer: This Year's Disaster Should Set The Stage For A Strong 2024"", ""summary"": ""Read about Pfizer's challenges in 2023, including decreased demand for COVID-19 vaccines and antiviral products, a destructive tornado, and a weight-loss treatment.""}, {""date"": ""20231205011600"", ""headline"": ""Buy Rating for Merck & Co. on Strong Prospects for New Pneumococcal Vaccine V116"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205053700"", ""headline"": ""Vaxcyte's pneumococcal shot shows safety profile comparable to Pfizer's Prevnar 20"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205053956"", ""headline"": ""Macroeconomic Factors Pulled Merck & Co. (MRK) in Q3"", ""summary"": ""Carillon Tower Advisers, an investment management company, released its \u201cCarillon Eagle Mid Cap Growth Fund\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. After a robust first half of the year, the S&P 500 Index declined 3.3% in the third quarter, leaving the market up 13.1% through the first nine [\u2026]""}, {""date"": ""20231205070400"", ""headline"": ""Curis signs agreement for emavusertib/pembrolizumab combination melanoma study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205093300"", ""headline"": ""Incyte's Bullish Outlook: A Surprising Strength You Shouldn't Overlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205094204"", ""headline"": ""5 Stocks That Recently Increased Their Dividend"", ""summary"": ""Dividend growth stocks consistently increase dividend year after year with 5-year growth rate of 10% or more. Find out 5 stocks that recently increased dividend.""}, {""date"": ""20231205104900"", ""headline"": ""Video: Dow Analyst Moves: MRK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205105000"", ""headline"": ""Broker Darlings of the Dow: Merck Ranks As a Top 15 Analyst Pick"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205114933"", ""headline"": ""25 States with the Lowest Life Expectancy in the US"", ""summary"": ""In this article, we will look into the 25 states with the lowest life expectancy in the US. If you want to skip our detailed analysis, you can go directly to the 5 States with the Lowest Life Expectancy in the US. Health Outlook of the United States According to the OECD Health at a [\u2026]""}, {""date"": ""20231205140000"", ""headline"": ""MilliporeSigma Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205163200"", ""headline"": ""Merck trial for evobrutinib does not meet primary endpoint"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205163500"", ""headline"": ""Merck & Co. Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. rallied 1.11% to $106.23 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""20231206010700"", ""headline"": ""Merck MS Drug Fails to Meet Target of Late-Stage Trials"", ""summary"": ""By David Sachs Merck's multiple sclerosis drug evobrutinib didn't meet a key goal in late-stage trials. The German pharmaceutical company's phase 3 clinical...""}, {""date"": ""20231206023500"", ""headline"": ""German stocks rise after ending at a record high"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206051000"", ""headline"": ""Amgen: Relative Valuation Remains Unattractive"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206053400"", ""headline"": ""White House to back controversial patent ploy to fight drug costs, STAT says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206070900"", ""headline"": ""LONDON MARKET MIDDAY: Stocks rise amid dovish Fed, ECB expectations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206071000"", ""headline"": ""Merck a Top 25 Dividend Giant With 2.90% Yield (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206082000"", ""headline"": ""Seagen's breast cancer drug shows positive results in combination therapy trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206110048"", ""headline"": ""Merck & Co., Inc.'s (NYSE:MRK) Stock's On An Uptrend: Are Strong Financials Guiding The Market?"", ""summary"": ""Merck's (NYSE:MRK) stock is up by a considerable 6.0% over the past week. Given that the market rewards strong...""}, {""date"": ""20231206115200"", ""headline"": ""LONDON MARKET CLOSE: Stocks in Europe boosted by dovish rhetoric"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206144200"", ""headline"": ""5 Dividend Stocks That Recently Increased Their Payouts"", ""summary"": ""My favorite stocks to invest in are those that continuously increase their dividend. Merck & Co (NYSE: MRK) is one stock that I like a lot that has been growing its dividend at a solid clip for a number of years.""}, {""date"": ""20231206161347"", ""headline"": ""Hedge Funds are Betting on These 14 Sliding Stocks"", ""summary"": ""In this article, we will take a look at the hedge funds that are betting on these 14 sliding stocks. To see more such companies, go directly to Hedge Funds are Betting on These 5 Sliding Stocks. Stocks jumped on December 6 after the release of yet another welcome data point for the Federal Reserve, [\u2026]""}, {""date"": ""20231206163500"", ""headline"": ""Merck & Co. Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. dropped 0.56% to $105.63 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""20231207050700"", ""headline"": ""Merck reports Phase 2 results of coformulation for lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207054900"", ""headline"": ""Merck discontinues trial evaluating Keytruda combination in NSCLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207055700"", ""headline"": ""Merck coformulation fails to meet key goal in lung cancer trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207060945"", ""headline"": ""Merck's lung cancer drug combo fails to meet trial goal"", ""summary"": ""Merck said on Thursday itsexperimental therapy in combination with Keytruda to treat atype of lung cancer in previously treated patients did not reachstatistical significance in a mid-stage...""}, {""date"": ""20231207063100"", ""headline"": ""Merck halts lung cancer trial for Keytruda combo after failure in main goal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207070000"", ""headline"": ""Merck says trial shows improvement to progression-free survival"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207081000"", ""headline"": ""Merck & Co to stop phase 3 trial probing Keytruda on lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207082402"", ""headline"": ""Merck discontinues lung cancer clinical trial"", ""summary"": ""On Thursday, Merck announced the discontinuation of a Phase 3 clinical trial of its flagship immunotherapy Keytruda in squamous and metastatic non-small cell lung cancer.The biopharmaceutical group...""}, {""date"": ""20231207083900"", ""headline"": ""Double Flops For Merck's Lung Cancer Studies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207092200"", ""headline"": ""Video: Dow Movers: MRK, AAPL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207095600"", ""headline"": ""January 2024 Options Now Available For Merck (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207110000"", ""headline"": ""Merck Announces Findings from Phase 2 KeyVibe-002 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)"", ""summary"": ""RAHWAY, N.J., December 07, 2023--Merck Announces Findings from Ph 2 KeyVibe-002 Trial Evaluating Investigational Coformulation Vibostolimab/Pembrolizumab in Previously Treated mNSCLC""}, {""date"": ""20231207113500"", ""headline"": ""Morning Brew: AI Hype Boosts Tech Stocks; AMD and Google Shine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207114500"", ""headline"": ""Merck Announces KEYLYNK-008 Trial Evaluating KEYTRUDA\u00ae (pembrolizumab) Plus LYNPARZA\u00ae (olaparib) for Patients With Metastatic Squamous Non-Small Cell Lung Cancer to Stop for Futility"", ""summary"": ""RAHWAY, N.J., December 07, 2023--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that it will stop the Phase 3 KEYLYNK-008 trial evaluating KEYTRUDA, Merck\u2019s anti-PD-1 therapy, in combination with maintenance LYNPARZA, a PARP inhibitor, for the treatment of patients with metastatic squamous non-small cell lung cancer (NSCLC). Merck is discontinuing the study based on the recommendation of an independent Data Monitoring Committee (DMC), which reviewed data""}, {""date"": ""20231207123300"", ""headline"": ""Merck Scraps Phase 3 Keytruda-Lynparza Lung Cancer Study"", ""summary"": ""Merck & Co. is ending a late-stage study of the combination of Keytruda and Lynparza in certain lung cancer patients due to an expected failure of the trial.""}, {""date"": ""20231207141601"", ""headline"": ""13 Best S&P 500 Dividend Stocks To Buy"", ""summary"": ""In this article, we discuss 13 best S&P 500 dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best S&P 500 Dividend Stocks To Buy. In the market conditions of 2022, when the S&P 500 Index dropped by over [\u2026]""}, {""date"": ""20231207150000"", ""headline"": ""Rare Stock Picks In November 2023 - From 31 Discerning Analysts"", ""summary"": ""Welcome to another installment of our monthly Rare Stock Picks article, where we highlight investment picks you may have missed. Explore more details here.""}, {""date"": ""20231207161400"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks up despite eyes on US jobs report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207163500"", ""headline"": ""Merck & Co. Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. slipped 1.66% to $103.88 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20231207171400"", ""headline"": ""Health Care Slips on Rotation Into Rate-Sensitive Sectors -- Health Care Roundup"", ""summary"": ""Health-care companies fell as traders rotated into sectors with more to gain from a shift in Federal Reserve policy. Drug giant Merck &amp; Co. pulled the...""}, {""date"": ""20231207183310"", ""headline"": ""15 Upcoming Dividend Increases"", ""summary"": ""Discover the top up-and-coming companies set to raise their dividends in December.""}, {""date"": ""20231208021800"", ""headline"": ""Merck (MRK) Shares Cross 3% Yield Mark"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231208042600"", ""headline"": ""Hold Rating on Merck Amid Uncertainty Over TIGIT Program\u2019s Efficacy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231208054800"", ""headline"": ""Merck, Eisai provide update on Phase 3 LEAP-001 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231208062800"", ""headline"": ""Merck Keytruda combo fails in late-stage trial for uterine cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231208065347"", ""headline"": ""Merck-Eisai's cancer therapy combo fails in late-stage study"", ""summary"": ""Merck said on Friday itsexperimental combination therapy being developed with partnerEisai to treat a type of cancer in the lining of theuterus failed to meet the main goals in a late-stage...""}, {""date"": ""20231208070600"", ""headline"": ""Merck, Eisai: Keytruda/Lenvima Combo Fails in 1st-Line Endometrial Cancer Study"", ""summary"": ""By Colin Kellaher Merck &amp; Co. and Eisai on Friday said a late-stage study of the cancer drugs Keytruda plus Lenvima as a first-line treatment in certain...""}, {""date"": ""20231208071547"", ""headline"": ""Merck-Eisai's uterine cancer therapy combo fails first-line treatment trial"", ""summary"": ""Merck said a combinationtherapy being developed with partner Eisai failed alate-stage trial testing it as a first-line treatment for a typeof cancer in the uterus lining, the two companies said...""}, {""date"": ""20231208072102"", ""headline"": ""Merck, Eisai : Keytruda/Lenvima Combo Fails in 1st-Line Endometrial Cancer Study"", ""summary"": ""By Colin Kellaher Merck & Co. and Eisai on Friday said a late-stage study of the cancer drugs Keytruda plus Lenvima as a first-line treatment in certain patients with endometrial cancer missed...""}, {""date"": ""20231208073300"", ""headline"": ""Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231208075600"", ""headline"": ""Merck and Eisai combination endometrial cancer treatment fails to meet goals in clinical trial"", ""summary"": ""Merck & Co. Inc. and Eisai Co. Ltd. said Friday that a late-stage trial of Merck\u2019s blockbuster cancer treatment Keytruda in combination with Eisai\u2019s drug...""}, {""date"": ""20231208082910"", ""headline"": ""Merck : study in endometrial carcinoma fails"", ""summary"": ""Merck and Eisai report that the phase III LEAP-001 trial evaluating their Keytruda-Lenvima combination failed to meet its primary endpoints as a first-line treatment for patients with advanced or...""}, {""date"": ""20231208083000"", ""headline"": ""ALX Oncology shares jump 9% after Jefferies upgrade"", ""summary"": ""ALX Oncology Holdings Inc. shares climbed 9% premarket on Friday after Jefferies analysts upgraded the stock to buy, from hold. The stock is \u201cvery cheap,\u201d...""}, {""date"": ""20231208090030"", ""headline"": ""Merck suffers bad week as three Keytruda combination trials fail"", ""summary"": ""The three setbacks for Merck demonstrate the challenges drug developers face in improving on Keytruda, which has brought in at least $18 billion so far this year for its maker.""}, {""date"": ""20231208091922"", ""headline"": ""Merck Announces KEYLYNK-008 Trial Evaluating KEYTRUDA Plus LYNPARZA for Patients with Metastatic Squamous Non-Small Cell Lung Cancer to Stop for Futility"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced that it will stop the Phase 3 KEYLYNK-008 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, in combination...""}, {""date"": ""20231208091924"", ""headline"": ""Merck Announces Findings from Phase 2 KeyVibe-002 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced full results from the non-registrational Phase 2 KeyVibe-002 trial evaluating vibostolimab/pembrolizumab, an...""}, {""date"": ""20231208111400"", ""headline"": ""Biotech Deals Are Heating Up. Why 2024 Could Be Even Hotter for M&A."", ""summary"": ""The year-end spurt of biopharma mergers and acquisitions bodes well for the sector in 2024.""}, {""date"": ""20231208114500"", ""headline"": ""Merck and Eisai Provide Update on Phase 3 LEAP-001 Trial Evaluating (pembrolizumab) Plus LENVIMA\u00ae (lenvatinib) as First-Line Treatment for Patients with Advanced or Recurrent Endometrial Carcinoma"", ""summary"": ""RAHWAY, N.J., & NUTLEY, N.J., December 08, 2023--Merck and Eisai Provide Update on LEAP-001 Trial Evaluating KEYTRUDA + LENVIMA as First-Line Treatment for Advanced or Recurrent Endometrial Carcinoma""}, {""date"": ""20231208144500"", ""headline"": ""Company News for Dec 8, 2023"", ""summary"": ""Companies In The Article Are: CIEN,MRK,VRNT,OXM""}, {""date"": ""20231208153221"", ""headline"": ""SPMO: Simple And Efficient Momentum ETF"", ""summary"": ""Invesco S&P 500 Momentum has a unique investment strategy, strong performance, and superior quality. Click here to read an analysis on SPMO ETF now.""}, {""date"": ""20231208163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Merck & Co. Inc. dropped 0.13% to $103.75 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231208164400"", ""headline"": ""Merck's (MRK) Keytruda-Lynparza Combo Fails Lung Cancer Study"", ""summary"": ""After a late-stage study fails to show any improvement in its primary endpoints, Merck (MRK) decides to stop evaluating the Keytruda-Lynparza combination in metastatic squamous NSCLC.""}, {""date"": ""20231209090000"", ""headline"": ""How To Invest $100,000 Today In A Sleep Well Portfolio"", ""summary"": ""The economic cycles have always been with us. But the frequency of boom and bust cycles has certainly increased in the last couple of decades. Read more here.""}, {""date"": ""20231209121653"", ""headline"": ""Income Investors Should Know That Merck & Co., Inc. (NYSE:MRK) Goes Ex-Dividend Soon"", ""summary"": ""Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...""}, {""date"": ""20231210082239"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 10"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the December 10 weekly update.""}, {""date"": ""20231210104103"", ""headline"": ""United Therapeutics: Cheap With Litigation Headwinds"", ""summary"": ""United Therapeutics' treprostinil products are also facing challenges from generics and clinical aspirants. Read why I'm neutral on UTHR stock.""}, {""date"": ""20231210164030"", ""headline"": ""12 Healthcare Stocks Billionaires Like the Most"", ""summary"": ""In this article, we will take a look at the 12 healthcare stocks billionaires like the most. To skip our analysis of the recent market trends and activity, you can go directly to see the 5 Healthcare Stocks Billionaires Like the Most. The healthcare sector includes companies ranging from pharmaceuticals, medical equipment and device manufacturers, [\u2026]""}, {""date"": ""20231210180746"", ""headline"": ""12 Dow Stocks Billionaires Like The Most"", ""summary"": ""In this piece, we will take a look at the 12 Dow stocks that billionaires like the most. If you don\u2019t want to learn more about the Dow Jones Industrial Average (DJIA), its history, and recent performance, then skip ahead to 5 Dow Stocks Billionaires Like The Most. In its current form today, the Dow [\u2026]""}]",{}
23,2023-12-10,103.00415802001953,2023-12-17,105.11000061035156,0.02044424837609715,U3,"[{""date"": ""20231210082239"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 10"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the December 10 weekly update.""}, {""date"": ""20231210104103"", ""headline"": ""United Therapeutics: Cheap With Litigation Headwinds"", ""summary"": ""United Therapeutics' treprostinil products are also facing challenges from generics and clinical aspirants. Read why I'm neutral on UTHR stock.""}, {""date"": ""20231210164030"", ""headline"": ""12 Healthcare Stocks Billionaires Like the Most"", ""summary"": ""In this article, we will take a look at the 12 healthcare stocks billionaires like the most. To skip our analysis of the recent market trends and activity, you can go directly to see the 5 Healthcare Stocks Billionaires Like the Most. The healthcare sector includes companies ranging from pharmaceuticals, medical equipment and device manufacturers, [\u2026]""}, {""date"": ""20231210180746"", ""headline"": ""12 Dow Stocks Billionaires Like The Most"", ""summary"": ""In this piece, we will take a look at the 12 Dow stocks that billionaires like the most. If you don\u2019t want to learn more about the Dow Jones Industrial Average (DJIA), its history, and recent performance, then skip ahead to 5 Dow Stocks Billionaires Like The Most. In its current form today, the Dow [\u2026]""}, {""date"": ""20231211043200"", ""headline"": ""Biotech Is Coming Back, Can The Run Last?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231211054900"", ""headline"": ""Merck Animal Health receives positive CVMP opinion for injectable BRAVECTO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231211055100"", ""headline"": ""Merck, Moderna initiat INTerpath-002 phase 3 study of V940"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231211062000"", ""headline"": ""Merck, Moderna begin new Phase 3 trial for mRNA-based cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231211064402"", ""headline"": ""A Milestone: The S&P 500's 4,600 Level On The Bull Plateau"", ""summary"": ""The S&P 500 reaches new highs as the strong bull plateau continues, extending its duration and offering opportunities for gains to traders. Click here for more.""}, {""date"": ""20231211072702"", ""headline"": ""Merck, Moderna Expand Phase 3 Keytruda/V940 Combo Work"", ""summary"": ""By Colin Kellaher Merck and Moderna have launched a second late-stage study of the combination of Merck's blockbuster cancer drug Keytruda with V940, an individualized neoantigen therapy they...""}, {""date"": ""20231211083603"", ""headline"": ""Merck : start of phase III clinical trial with Moderna"", ""summary"": ""Merck and Moderna announced on Monday the launch of their Phase III clinical trial to evaluate the combination of immunotherapy and messenger RNA technology in the treatment of lung cancer.The two...""}, {""date"": ""20231211095425"", ""headline"": ""Merck and Eisai Provide Update on Phase 3 LEAP-001 Trial Evaluating KEYTRUDA plus LENVIMA as First-Line Treatment for Patients with Advanced or Recurrent Endometrial Carcinoma"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, and Eisai today announced that the Phase 3 LEAP-001 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, plus LENVIMA, the...""}, {""date"": ""20231211114500"", ""headline"": ""Merck Animal Health Receives Positive CVMP Opinion for an Injectable Formulation of BRAVECTO\u00ae (Fluralaner) for Use in Dogs"", ""summary"": ""RAHWAY, N.J., December 11, 2023--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency\u2019s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for BRAVECTO\u00ae (fluralaner) 150 mg/ml powder and solvent for suspension for injection for dogs. The CVMP recommends the product for approval for the treatment and persistent killing of f""}, {""date"": ""20231211114500"", ""headline"": ""Merck and Moderna Initiate INTerpath-002, a Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA\u00ae (pembrolizumab) for Adjuvant Treatment of Patients with Certain Types of Resected Non-Small Cell Lung Cancer"", ""summary"": ""RAHWAY, N.J. & CAMBRIDGE, Mass., December 11, 2023--Merck and Moderna Initiate INTerpath-002 Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA for Certain Types of Resected NSCLC""}, {""date"": ""20231211122013"", ""headline"": ""UPDATE 1-Moderna, Merck begin late-stage study for mRNA cancer therapy"", ""summary"": ""Moderna and Merck & Co said on Monday they have started a late-stage trial of their experimental personalized mRNA cancer treatment in combination with blockbuster drug Keytruda for patients with a type of lung cancer.  Moderna and Merck started a late-stage study in July testing the combination therapy in patients with melanoma, the most deadly form of skin cancer.""}, {""date"": ""20231211124900"", ""headline"": ""Merck & Company: A Strong Buy on Diverse Portfolio and Promising Pipeline"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231211125600"", ""headline"": ""Merck reports mixed updates for cancer treatment, Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231211144600"", ""headline"": ""AbbVie and Big Pharma Have Floundered. How That Could Change in 2024."", ""summary"": ""Goldman Sachs still sees headwinds for the sector next year, but AbbVie could be an outlier.""}, {""date"": ""20231211163500"", ""headline"": ""Merck & Co. Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.60% higher to $104.37 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""20231211165900"", ""headline"": ""Merck's (MRK) Keytruda, Lenvima Endometrial Cancer Study Fails"", ""summary"": ""The combination of Merck's (MRK) Keytruda and Eisai's Lenvima for the first-line treatment of advanced/recurrent endometrial carcinoma fails to meet dual primary endpoints in late-stage study.""}, {""date"": ""20231211210800"", ""headline"": ""Top Research Reports for Merck, Equinor & Illinois Tool Works"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Equinor ASA (EQNR) and Illinois Tool Works Inc. (ITW).""}, {""date"": ""20231212060300"", ""headline"": ""C4 Therapeutics announces license, research collab with Merck"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212062224"", ""headline"": ""Merck and Moderna Initiate INTerpath-002, a Phase 3 Study Evaluating V940 in Combination with KEYTRUDA for Adjuvant Treatment of Patients with Certain Types of Resected Non-Small Cell Lung Cancer"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, and Moderna, Inc. , today announced the initiation of INTerpath-002, a pivotal Phase 3 randomized clinical trial evaluating V940...""}, {""date"": ""20231212062225"", ""headline"": ""Merck Animal Health Receives Positive CVMP Opinion for an Injectable Formulation of BRAVECTO for Use in Dogs"", ""summary"": ""RAHWAY - Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA , today announced that the European Medicines...""}, {""date"": ""20231212063800"", ""headline"": ""C4 Therapeutics stock rallies on Merck deal to develop cancer antibodies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212063800"", ""headline"": ""Merck price target lowered by $2 at Morgan Stanley, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212073000"", ""headline"": ""Moderna CEO to lead sales and marketing as commercial chief departs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212082200"", ""headline"": ""Morning Brew: CPI Data Surprises Ahead of Fed Decision, Epic Wins Antitrust Case Against Google"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212091800"", ""headline"": ""Why Is C4 Therapeutics (CCCC) Stock Up 72% Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212101200"", ""headline"": ""C4 Therapeutics Shares Jump 77% After Licensing Deal With Merck"", ""summary"": ""By Chris Wack C4 Therapeutics shares were up 77% to $2.09 after the company entered into an exclusive license and collaboration agreement with Merck to...""}, {""date"": ""20231212112500"", ""headline"": ""Wall Street Lunch: No Big Surprises With CPI"", ""summary"": ""November CPI arrives about in line, gives Fed some room to push back on rate cuts. Oracle tumbles on cloud concerns. Chevron doesn't expect hostilities in South America.""}, {""date"": ""20231212115600"", ""headline"": ""Eli Lilly: The Party Is Over"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212141100"", ""headline"": ""The Zacks Analyst Blog Highlights Merck, Equinor, Illinois Tool Works, Arthur J. Gallagher and Atlassian"", ""summary"": ""Merck, Equinor, Illinois Tool Works, Arthur J. Gallagher and Atlassian are part of the Zacks top Analyst Blog.""}, {""date"": ""20231212163500"", ""headline"": ""Merck & Co. Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. slid 0.01% to $104.36 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20231212181700"", ""headline"": ""Moderna (MRNA), Merck Start 2nd Late-Study on Cancer Therapy"", ""summary"": ""The second late-stage study will evaluate Moderna (MRNA)/Merck's investigational cancer combination therapy in certain lung cancer patients. A late-stage study in melanoma indication is ongoing.""}, {""date"": ""20231213031400"", ""headline"": ""Dow Jones Skyrockets To Record Heights, Shatters 37,000 Mark, Fueled By Fed's Dovish Stance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213100908"", ""headline"": ""Merck & Co Inc's Dividend Analysis"", ""summary"": ""Merck & Co Inc (NYSE:MRK) recently announced a dividend of $0.77 per share, payable on 2024-01-08, with the ex-dividend date set for 2023-12-14.  As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.  Using the data from GuruFocus, let's look into Merck & Co Inc's dividend performance and assess its sustainability.""}, {""date"": ""20231213103156"", ""headline"": ""Goldman Sachs Says These 3 Healthcare Giants Look Very Attractive Right Now"", ""summary"": ""Barring some outliers, the US large cap pharmaceutical group has underperformed the broader markets this year. In a setting characterized by formidable macro factors, such as economic growth trends and the trajectory of interest rates, Goldman Sachs\u2019 Chris Shibutani says the group has shown it is \u201cunstable on a defensive basis.\u201d That has led to the overall lackluster performance in the market and has resulted in \u201csteeper than average levels of relative valuation discounts.\u201d For instance, while n""}, {""date"": ""20231213113100"", ""headline"": ""UBS\u2019 Top Global Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213130025"", ""headline"": ""Insiders At Merck Sold US$10m In Stock, Alluding To Potential Weakness"", ""summary"": ""The fact that multiple Merck & Co., Inc. ( NYSE:MRK ) insiders offloaded a considerable amount of shares over the past...""}, {""date"": ""20231213140200"", ""headline"": ""Dow's 150-point rally led by gains for shares of Walgreens Boots, Procter & Gamble"", ""summary"": ""Led by positive growth for shares of Walgreens Boots and Procter & Gamble, the Dow Jones Industrial Average is trading up Wednesday afternoon. The Dow is...""}, {""date"": ""20231213162958"", ""headline"": ""What Are The Best Stocks To Invest In Now? 2 Health Care Stocks To Watch"", ""summary"": ""Health care stocks to check out in the stock market now.""}, {""date"": ""20231213163500"", ""headline"": ""Merck & Co. Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. rallied 2.64% to $107.11 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""20231213215500"", ""headline"": ""Merck Ranks No. 1 on Newsweek\u2019s List of America\u2019s Most Responsible Companies 2024"", ""summary"": ""RAHWAY, N.J. / ACCESSWIRE / December 13, 2023 / Merck (NYSE:MRK), known as MSD outside of the United States and Canada, has earned the top spot on Newsweek's annual list of America's Most Responsible Companies, ranking No. 1 overall for the first ...""}, {""date"": ""20231214013800"", ""headline"": ""Dow hits pause on record-setting rally, S&P 500 and Nasdaq struggle for direction"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214022700"", ""headline"": ""Dow Jones aims for back-to-back record close after Fed pencils in 2024 rates cuts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214030700"", ""headline"": ""Moderna CEO Highlights Promising Cancer Vaccine Data: 'Think About The Number Of Lives That Can Be Impacted'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214031500"", ""headline"": ""Stock market today: Asian markets churn upward after the Dow ticks to another record high"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214031500"", ""headline"": ""Stock market today: Wall Street rises again as the Dow ticks to another record"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214033100"", ""headline"": ""What You Missed On Wall Street On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214033600"", ""headline"": ""MRNA Stock Surges as Moderna Teams Up With Merck to Fight Cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214034605"", ""headline"": ""Merck Ranks No. 1 on Newsweek's List of America's Most Responsible Companies 2024"", ""summary"": ""RAHWAY, N.J.- Merck , known as MSD outside of the United States and Canada, has earned the top spot on Newsweek's annual list of America's Most Responsible Companies, ranking No. 1 overall for the...""}, {""date"": ""20231214053900"", ""headline"": ""Moderna, Merck announc e follow-up data on V940 with Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214055100"", ""headline"": ""Moderna\u2019s stock rallies 7.9% after announcing positive data in trial of melanoma treatment combined with Merck\u2019s Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214060200"", ""headline"": ""FDA approves Merck's Welireg for treatment of patients with advanced RCC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214063000"", ""headline"": ""Moderna Reports More Promising Data on Cancer Treatment. The Stock Jumps."", ""summary"": ""The personalized cancer vaccine is being used with a Merck immunotherapy drug to fight melanoma cancer.""}, {""date"": ""20231214063300"", ""headline"": ""Moderna, Merck post three-year data for mRNA-based skin cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214064500"", ""headline"": ""Moderna CEO Bancel says melanoma vaccine could be available by 2025"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214064800"", ""headline"": ""Moderna's stock buoyed by positive data in trial of melanoma treatment"", ""summary"": ""Moderna's stock was on track for its biggest one-day gain in more than a year.""}, {""date"": ""20231214065200"", ""headline"": ""Moderna\u2019s stock rallies after announcement of positive data from trial of melanoma treatment combined with Merck\u2019s Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214072000"", ""headline"": ""Moderna\u2019s (NASDAQ:MRNA) Positive Melanoma Trial Data Sparks Stock Surge"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214080100"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214082000"", ""headline"": ""5 stocks to watch on Thursday: Moderna, Costco, Live Nation and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214083000"", ""headline"": ""Why Is Moderna (MRNA) Stock Up 11% Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214085300"", ""headline"": ""Dow climbs to fresh record as Fed rate-cut forecasts spur global markets rally"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214092100"", ""headline"": ""Top contributors to the S&P 500 from the past 2 years - UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214093300"", ""headline"": ""Biggest stock movers today: Moderna, Foot Locker, Adobe, Ocular Therapeutix and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214102600"", ""headline"": ""Leerink skeptical on sustainability of Moderna rally given eroding fundamentals"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214113000"", ""headline"": ""Moderna And Merck Announce mRNA-4157 (V940) In Combination with Keytruda(R) (Pembrolizumab) Demonstrated Continued Improvement in Recurrence-Free Survival and Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Complete Resection Versus Keytruda at Three Years"", ""summary"": ""At a median planned follow-up of approximately three years, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% (HR=0.510 [95% CI, 0.288-0.906]; one-sided nominal p=0.0095) and the risk of distant metastasis ...""}, {""date"": ""20231214113000"", ""headline"": ""Benefits of Moderna and Merck melanoma vaccine plus Keytruda extend to three years"", ""summary"": ""An experimental messenger RNA cancer vaccine developed by Moderna and Merck & Co paired with Merck's Keytruda cut the chance of recurrence or death from melanoma by half after three years, showing that benefits demonstrated a year ago have held up over time.  The combination of the personalized cancer vaccine and Merck's blockbuster immunotherapy cut the risk of recurrence or death of the most deadly skin cancer by 49% compared with Keytruda alone in the midstage trial, the companies said.""}, {""date"": ""20231214115800"", ""headline"": ""New Moderna cancer vaccine data spurs share rally"", ""summary"": ""Shares climbed by\u00a0double digits after new evidence led to speculation among analysts that Moderna and partner Merck could seek an approval before completing Phase 3 testing.""}, {""date"": ""20231214121600"", ""headline"": ""Moderna, Rivian rise; Apellis, Adobe fall, Thursday, 12/14/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214123300"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214125700"", ""headline"": ""S&P 500 clings to gain, Nasdaq turns negative and Dow hits pause on record-setting rally"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214131848"", ""headline"": ""Merck-Moderna Vaccine Cuts Return of Skin Cancer by Half"", ""summary"": ""(Bloomberg) -- A personalized vaccine developed by Merck & Co. and Moderna Inc. helped prevent the recurrence of severe skin cancer for three years in promising new results from a study.Most Read from BloombergCitigroup Offers Partial Early Bonuses to Encourage Staff DeparturesWall Street Traders Go All-In on Great Monetary Pivot of 2024Elon Musk Is Planning a New University in AustinOwner of the Philippines\u2019 Largest Malls Says China Feud May Hurt BusinessesJPMorgan Is in a Fight Over Its Client""}, {""date"": ""20231214134545"", ""headline"": ""UPDATE 2-Benefits of Moderna and Merck melanoma vaccine plus Keytruda extend to three years"", ""summary"": ""An experimental messenger RNA cancer vaccine developed by Moderna and Merck & Co paired with Merck's Keytruda cut the chance of recurrence or death from melanoma by half after three years, showing that benefits demonstrated a year ago have held up over time.  Moderna shares rose 11.1% to $87.20 premarket, while Merck shares were up marginally at $106.70 before the bell.  The combination of the personalized cancer vaccine and Merck's blockbuster immunotherapy cut the risk of recurrence or death of the most deadly skin cancer by 49% compared with Keytruda alone in the midstage trial, the companies said.""}, {""date"": ""20231214145600"", ""headline"": ""Moderna Stock Surges After Positive Trial Results"", ""summary"": ""Moderna shares rose more than 15% after the company and partner Merck [disclosed positive trial results](https://www.merck.com/news/moderna-and-merck-announce-mrna-4157-v940-an-investigational-personalized-mrna-cancer-vaccine-in-combination-with-keytruda-pembrolizumab-met-primary-efficacy-endpoint-in-phase-2b-keynote-94/) for an experimental mRNA-based treatment for skin cancer.""}, {""date"": ""20231214163500"", ""headline"": ""Merck & Co. Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. slid 0.43% to $105.88 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231214173051"", ""headline"": ""Moderna: Stock soars on cancer vaccine data; CEO Bancel takes on commercial role."", ""summary"": ""Shares of Moderna (MRNA) soared around 14% on Thursday on the news that a personalized cancer vaccine, in partnership with Merck (MRK), reduced the risk of late-stage melanoma by 49%""}, {""date"": ""20231214174626"", ""headline"": ""US FDA approves Merck's drug for kidney cancer"", ""summary"": ""The U.S. Food and Drug Administrationon Thursday approved Merck's drug belzutifan for a typeof kidney cancer. ...""}, {""date"": ""20231214175754"", ""headline"": ""Moderna CEO talks skin cancer vaccine"", ""summary"": ""Moderna (MRNA) shares surged Thursday following positive results from a mid-stage trial for its experimental cancer vaccine. The trial found the vaccine, when used in combination with Merck's (MRK) immunotherapy Keytruda, significantly reduced the risk of death or relapse for patients with advanced melanoma skin cancer. \""We are so happy for patients,\"" Moderna CEO St\u00e9phane Bancel told Yahoo Finance Live, noting the trial showed a roughly 50% survival rate, meaning one in two treated patients were able to live without a relapse. Bancel also highlighted other vaccines in Moderna's pipeline, including its treatment for Respiratory Syncytial Virus (RSV). For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231214210201"", ""headline"": ""Moderna stock sees boost over skin cancer treatment trials"", ""summary"": ""Moderna (MRNA) shares have jumped by over 9% on Thursday in relation to positive trial results in Moderna and Merck's (MRK) collaborative skin cancer treatment that utilizes both a vaccine and the drug Keytruda. Additionally, Pfizer (PFE) disappointed investors this week over the pharmaceutical company's 2024 guidance. Yahoo Finance Health Reporter Anjalee Khemlani details the top stories and biggest drivers behind pharmaceutical stocks Thursday. For more expert insight and the latest market action, click\u00a0here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231215000000"", ""headline"": ""FDA Approves Merck\u2019s WELIREG\u00ae (belzutifan) for the Treatment of Patients With Advanced Renal Cell Carcinoma (RCC) Following a PD-1 or PD-L1 Inhibitor and a VEGF-TKI"", ""summary"": ""RAHWAY, N.J., December 15, 2023--WELIREG FDA Approval""}, {""date"": ""20231215021600"", ""headline"": ""Merck gets FDA approval for kidney cancer drug Welireg"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231215030000"", ""headline"": ""FDA found control lapses at Moderna plant, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231215034100"", ""headline"": ""Merck gets US FDA nod for Welireg, as trial with Moderna bears fruit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231215040200"", ""headline"": ""Merck announces FDA approval of KEYTRUDA plus Padcev"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231215052500"", ""headline"": ""FDA approves Keytruda/Padcev combo therapy for bladder cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231215075454"", ""headline"": ""FDA Approves Merck's WELIREG for the Treatment of Patients with Advanced Renal Cell Carcinoma Following a PD-1 or PD-L1 Inhibitor and a VEGF-TKI"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration has approved WELIREG, an oral hypoxia-inducible factor-2 alpha ...""}, {""date"": ""20231215090003"", ""headline"": ""Merck : promising trial in melanoma care"", ""summary"": ""In this analysis conducted with a median follow-up of approximately three years, mRNA-4157 + Keytruda demonstrated a clinically significant improvement in recurrence-free survival , reducing the risk...""}, {""date"": ""20231215103718"", ""headline"": ""Trending tickers: Costco | Moderna | Rivian | H&M"", ""summary"": ""The latest investor updates on stocks that are trending on Friday.""}, {""date"": ""20231215111000"", ""headline"": ""FDA widens use of cancer drug Merck acquired for $1B"", ""summary"": ""Welireg, which Merck got through its purchase of Peloton Therapeutics, can now be used to treat an advanced form of kidney cancer, adding to an earlier clearance in a rare genetic disease.""}, {""date"": ""20231215155400"", ""headline"": ""IXJ: Healthcare Dashboard For December"", ""summary"": ""iShares Global Healthcare is a global alternative to Healthcare Select Sector SPDR Fund. Click here to read an analysis on IXJ ETF here.""}, {""date"": ""20231215163500"", ""headline"": ""Merck & Co. Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. slumped 0.73% to $105.11 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20231215172700"", ""headline"": ""Moderna (MRNA) Soars on Upbeat Data From Cancer Therapy Study"", ""summary"": ""Three-year follow up data from a mid-stage study shows that treatment with Moderna (MRNA)/Merck's cancer combination therapy reduces recurrence/death risk in certain melanoma patients by half.""}, {""date"": ""20231215173200"", ""headline"": ""FDA Expands Merck's (MRK) Welireg Label in Renal Cell Carcinoma"", ""summary"": ""Per Merck (MRK), the latest FDA approval to Welireg marks the first time a new treatment has been approved in a novel therapeutic class in advanced renal cell carcinoma since 2015.""}, {""date"": ""20231215173903"", ""headline"": ""Merck, Pfizer, Astellas Get FDA OK For Expanded Use Of Keytruda Plus Padcev"", ""summary"": ""By Ben Glickman Merck & Co., Pfizer and Astellas Pharma have received approval from the U.S. Food and Drug Administration for using Keytruda in combination with Padcev to treat a form of...""}, {""date"": ""20231215220000"", ""headline"": ""FDA Approves Expanded Indication for KEYTRUDA\u00ae (pembrolizumab) Plus Padcev\u00ae (enfortumab vedotin-ejfv) for the First-Line Treatment of Adult Patients With Locally Advanced or Metastatic Urothelial Cancer"", ""summary"": ""RAHWAY, N.J., December 15, 2023--FDA Approves Expanded Indication for KEYTRUDA Plus Padcev for the First-Line Treatment of Adult Patients With Locally Advanced or Metastatic UC""}, {""date"": ""20231216020500"", ""headline"": ""Contaminated Vaccines: FDA Reportedly Finds Cleaning And Expiry Lapses At Moderna's Massachusetts Facility"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231216173033"", ""headline"": ""12 Best Slow Growth Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we will take a detailed look at the 12 Best Slow Growth Stocks To Buy According To Hedge Funds. For a quick overview of such stocks, read our article 5 Best Slow Growth Stocks To Buy According To Hedge Funds. It would be interesting to see how markets react to the latest events after a statement [\u2026]""}, {""date"": ""20231217104301"", ""headline"": ""SCHD: A Long-Term Dividend Play With Potential To Generate Additional 'Income'"", ""summary"": ""Discover SCHD, a low-cost ETF that offers diversification to dividend-paying stocks and has shown respectable returns for passive income investors.""}, {""date"": ""20231217112700"", ""headline"": ""3 Ways To Buy The Boeing Boom, Without Buying Boeing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231217120056"", ""headline"": ""Merck & Co., Inc. (NYSE:MRK) is largely controlled by institutional shareholders who own 77% of the company"", ""summary"": ""Key Insights Institutions' substantial holdings in Merck implies that they have significant influence over the...""}, {""date"": ""20231217213447"", ""headline"": ""Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q3 2023 Update"", ""summary"": ""Prem Watsa's 13F portfolio value decreased slightly to $1.86B this quarter. Click here to read more about Fairfax Financial's holdings and trades for Q3 2023.""}]",{}
24,2023-12-17,105.11000061035156,2023-12-24,107.69999694824219,0.024640817456484276,U3,"[{""date"": ""20231217104301"", ""headline"": ""SCHD: A Long-Term Dividend Play With Potential To Generate Additional 'Income'"", ""summary"": ""Discover SCHD, a low-cost ETF that offers diversification to dividend-paying stocks and has shown respectable returns for passive income investors.""}, {""date"": ""20231217120056"", ""headline"": ""Merck & Co., Inc. (NYSE:MRK) is largely controlled by institutional shareholders who own 77% of the company"", ""summary"": ""Key Insights Institutions' substantial holdings in Merck implies that they have significant influence over the...""}, {""date"": ""20231217213447"", ""headline"": ""Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q3 2023 Update"", ""summary"": ""Prem Watsa's 13F portfolio value decreased slightly to $1.86B this quarter. Click here to read more about Fairfax Financial's holdings and trades for Q3 2023.""}, {""date"": ""20231218002358"", ""headline"": ""3 Ways To Buy The Boeing Boom, Without Buying Boeing"", ""summary"": ""Boeing stock has been soaring temporarily, but it may be too late to buy. Check out the three other stocks that should catch up with BA.""}, {""date"": ""20231218055500"", ""headline"": ""Merck announcesEC approves two new indications for KEYTRUDA in GI cancers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231218060400"", ""headline"": ""Astellas, Merck, Pfizer celebrate US approval for Keytruda plus Padcev"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231218065037"", ""headline"": ""Merck - FDA Approves Expanded Indication for KEYTRUDA plus Padcev for the First-Line Treatment of Adult Patients with Locally Advanced or Metastatic Urothelial Cancer"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration has approved KEYTRUDA, Merck's anti-PD-1 therapy, in combination with...""}, {""date"": ""20231218070000"", ""headline"": ""IN BRIEF: Astellas \""proud\"" as EU regulator recommends arpraziquantel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231218094325"", ""headline"": ""13 Most Profitable Pharmaceutical Stocks Now"", ""summary"": ""In this article, we discuss the 13 most profitable pharmaceutical stocks to buy. You can skip our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read the 5 Most Profitable Pharmaceutical Stocks Now. The healthcare sector encompasses a diverse range of companies, spanning pharmaceuticals, medical equipment and device [\u2026]""}, {""date"": ""20231218104003"", ""headline"": ""Merck : EU approves 2 new indications for Keytruda"", ""summary"": ""Merck announced today that the European Commission has approved two new indications for Keytruda in the treatment of gastrointestinal cancers. The first concerns the combination of Keytruda with...""}, {""date"": ""20231218111108"", ""headline"": ""XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector"", ""summary"": ""XLV comprises major healthcare industry players and offers a convenient and cost-effective way to invest in the sector. Find out my analysis of XLV ETF.""}, {""date"": ""20231218114500"", ""headline"": ""European Commission Approves Merck\u2019s KEYTRUDA\u00ae (pembrolizumab) Plus Chemotherapy for New First-Line Indications in Advanced HER2-Negative Gastric or GEJ Adenocarcinoma in Tumors Expressing PD-L1 (CPS \u22651) and Advanced Biliary Tract Cancer"", ""summary"": ""RAHWAY, N.J., December 18, 2023--KEYTRUDA Approved in the EU for use in Gastric and Biliary Tract Cancers""}, {""date"": ""20231218163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.88% higher to $106.04 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""20231219014900"", ""headline"": ""EU approves Merck's Keytruda to treat form of biliary tract cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219055000"", ""headline"": ""Merck's new BLA for pneumococcal conjugate vaccine granted priority review"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219071503"", ""headline"": ""Merck Gets FDA Priority Review For New Pneumococcal Vaccine"", ""summary"": ""By Will Feuer Merck said the Food and Drug Administration has accepted for priority review the company's V116 investigational pneumococcal conjugate vaccine. Merck said the FDA has set...""}, {""date"": ""20231219081602"", ""headline"": ""Merck : priority review for pneumococcal vaccine"", ""summary"": ""Merck announced Tuesday that the U.S. Food and Drug Administration has granted a priority review to the registration dossier for its pneumococcal conjugate vaccine.A priority review means that the...""}, {""date"": ""20231219082900"", ""headline"": ""Evaxion Biotech prices 9.73M shares at 54.4c in private placement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219114500"", ""headline"": ""FDA Grants Priority Review to Merck\u2019s New Biologics License Application for V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed to Protect Adults"", ""summary"": ""RAHWAY, N.J., December 19, 2023--FDA Grants Priority Review to Merck\u2019s New Biologics License Application for V116, an Investigational, 21-valent PCV Designed to Protect Adults""}, {""date"": ""20231219115500"", ""headline"": ""Merck gets FDA decision date for new pneumococcal vaccine"", ""summary"": ""The company\u2019s shot targets 21 strains of pneumococcal bacteria and, if approved, would compete with Pfizer\u2019s Prevnar 20.""}, {""date"": ""20231219152700"", ""headline"": ""Merck (MRK) Gets EU Nod for Expanded Use in Gastric Cancer"", ""summary"": ""Following these approvals, Merck's (MRK) Keytruda is approved for seven gastrointestinal cancers in the European Union. Overall, the drug is approved for 26 indications in the region.""}, {""date"": ""20231219160348"", ""headline"": ""13 Most Promising Growth Stocks According to Analysts"", ""summary"": ""In this piece, we will take a look at the 13 most promising growth stocks according to analysts. If you want to skip our coverage of the latest stock market news, then you can take a look at the 5 Most Promising Growth Stocks According to Analysts. The primary reason most folks are attracted to [\u2026]""}, {""date"": ""20231219163500"", ""headline"": ""Merck & Co. Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.42% higher to $106.49 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""20231220001108"", ""headline"": ""C4 Therapeutics: Merck News Does Not Make It A Buy Yet, But Upgrading To Hold"", ""summary"": ""C4 Therapeutics' partnership with Merck doubled its share price. Read why this is still not enough evidence for me to rate CCCC stock a Buy.""}, {""date"": ""20231220033100"", ""headline"": ""Merck says FDA issues CRL regarding gefapixant NDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231220040200"", ""headline"": ""FDA rejects Merck's application for chronic cough treatment gefapixant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231220110000"", ""headline"": ""Consider These 3 SWAN Stocks To Collect Dividends Almost Monthly"", ""summary"": ""Discover three high-quality stocks that offer monthly dividend payments, making them a valuable addition to any investment portfolio. Click here to read more.""}, {""date"": ""20231220110513"", ""headline"": ""FDA Grants Priority Review to Merck's New Biologics License Application for V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed to Protect Adults"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration has accepted for priority review a new Biologics License Application for...""}, {""date"": ""20231220114500"", ""headline"": ""Merck to Participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference"", ""summary"": ""RAHWAY, N.J., December 20, 2023--Merck to Participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference""}, {""date"": ""20231220163500"", ""headline"": ""Merck & Co. Inc. stock falls Wednesday, still outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. slipped 1.06% to $105.36 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""20231220163900"", ""headline"": ""FDA Accepts Merck's (MRK) BLA for 21-Valent Pneumococcal Jab"", ""summary"": ""The FDA grants priority review to Merck's (MRK) filing seeking approval for its 21-valent pneumococcal conjugate vaccine in adults. A final decision is expected in June 2024.""}, {""date"": ""20231220171302"", ""headline"": ""FDA Says Merck's Chronic Cough Treatment Didn't Show Substantial Evidence of Effectiveness"", ""summary"": ""By Ben Glickman Merck's candidate to treat chronic cough didn't show substantial evidence of effectiveness, according to the Food and Drug Administration. The Rahway, N.J.-based...""}, {""date"": ""20231220213000"", ""headline"": ""Merck Provides U.S. Regulatory Update on Gefapixant"", ""summary"": ""RAHWAY, N.J., December 20, 2023--Merck Provides U.S. Regulatory Update on Gefapixant""}, {""date"": ""20231220214655"", ""headline"": ""XLV Likely Back To Outperforming"", ""summary"": ""The Health Care Select Sector SPDR Fund ETF (XLV) historically outperformed the S&P 500 but underperformed this year.""}, {""date"": ""20231221065603"", ""headline"": ""Merck : negative response from FDA for gefapixant"", ""summary"": ""Merck announced last night that it had received a Complete Response Letter from the U.S. Food and Drug Administration regarding the New Drug Application for gefapixant as a treatment for chronic...""}, {""date"": ""20231221075500"", ""headline"": ""Merck's Chronic Cough Treatment Candidate Receives Second Time FDA Rejection"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231221114719"", ""headline"": ""SCD: Add Diversification To Your Portfolio With This High-Yielding Fund At A Discount"", ""summary"": ""LMP Capital and Income Fund offers a high yield of 9.94% and exposure to common stocks, making it appealing to income-focused investors. Read more here.""}, {""date"": ""20231221120500"", ""headline"": ""KEYTRUDA\u00ae (pembrolizumab) Plus LENVIMA\u00ae (lenvatinib) Receive Public Listing for Patients with Advanced Endometrial Carcinoma (EC) that is not MSI-H or dMMR"", ""summary"": ""Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai announce that KEYTRUDA\u00ae, Merck's anti-PD-1 therapy, plus LENVIMA\u00ae, an orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, is now reimbursed with clinical criteria and conditions under the British Columbia, Alberta, Saskatchewan, Ontario, Quebec, Nova Scotia, New Brunswick, and Newfoundland drug plans, for adult patients with advanced endometrial carcinoma (EC) that is not microsatellite""}, {""date"": ""20231221141205"", ""headline"": ""7 Best Dow Jones Stocks to Buy for Conservative Investors"", ""summary"": ""With the Federal Reserve seemingly open to the idea of interest rate cuts next year, the narrative for the best Dow Jones stocks for conservative investors appears overly cautious. Don\u2019t get me wrong \u2013 you generally can\u2019t go wrong with targeting individual securities under the venerable index. Still, if you\u2019re looking for growth opportunities, the Dow is a bit tame to put it diplomatically. Nevertheless, you\u2019ve got to ask yourself a question: how sure are you that the Fed will actually lower bor""}, {""date"": ""20231221163500"", ""headline"": ""Merck & Co. Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.98% higher to $106.39 Thursday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20231222032200"", ""headline"": ""7 Small-Cap Stocks That Wall Street Loves for Good Reason"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231222083200"", ""headline"": ""IN BRIEF: Merck's patritumab deruxtecan given US FDA priority review"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231222094800"", ""headline"": ""Walgreens Boots, Amgen share gains contribute to Dow's 100-point jump"", ""summary"": ""Shares of Walgreens Boots and Amgen are trading higher Friday morning, sending the Dow Jones Industrial Average into positive territory. The Dow is trading...""}, {""date"": ""20231222113602"", ""headline"": ""For Those Investors Stuck On Yield, 2023 Was Opportunistic"", ""summary"": ""Discover the power of active stock picking and contrarian investing in today's volatile market. Click here to read what investors need to know.""}, {""date"": ""20231222130000"", ""headline"": ""Patritumab Deruxtecan Granted Priority Review in the U.S. for Certain Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer"", ""summary"": ""BASKING RIDGE, N.J. & RAHWAY, N.J., December 22, 2023--Daiichi Sankyo (TSE: 4568) and Merck (known as MSD outside of the United States and Canada) (NYSE: MRK) announced today that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the Biologics License Application (BLA) for patritumab deruxtecan (HER3-DXd) for the treatment of adult patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) previously treated with two or more""}, {""date"": ""20231222140548"", ""headline"": ""12 Best Undervalued Stocks to Buy According to Reddit"", ""summary"": ""In this article, we discuss the 12 best undervalued stocks to buy according to Reddit. If you want to read about some more undervalued stocks, go directly to 5 Best Undervalued Stocks to Buy According to Reddit. Retail investors who often discuss their investment strategies on platforms like Reddit have become a dominant market force [\u2026]""}, {""date"": ""20231222163500"", ""headline"": ""Merck & Co. Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. rose 1.23% to $107.70 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20231223120300"", ""headline"": ""SCHD: Dividend ETF That Delivers Consistent Dividend Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231224112900"", ""headline"": ""Merck: One Of The Best - Unveiling The Trifecta Of Safety, Dividends, And Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231224140000"", ""headline"": ""January Effect: 3 Under-the-Radar Stocks Poised for a New Year Jump"", ""summary"": ""As the world bids adieu to one year and eagerly ushers in the next, the financial landscape comes alive with whispers of a phenomenon known as the January Effect. It\u2019s a time when astute investors set their sights on uncovering hidden treasures poised for a leap into the spotlight of profitability. Amidst this captivating speculation, three enigmatic entities loom on the edge of anticipation. The first one, a retail juggernaut, exerts a strategic blend that caters to the demands of do-it-yoursel""}]",{}
25,2023-12-24,107.69999694824219,2023-12-31,109.0199966430664,0.01225626492318832,U2,"[{""date"": ""20231224140000"", ""headline"": ""January Effect: 3 Under-the-Radar Stocks Poised for a New Year Jump"", ""summary"": ""As the world bids adieu to one year and eagerly ushers in the next, the financial landscape comes alive with whispers of a phenomenon known as the January Effect. It\u2019s a time when astute investors set their sights on uncovering hidden treasures poised for a leap into the spotlight of profitability. Amidst this captivating speculation, three enigmatic entities loom on the edge of anticipation. The first one, a retail juggernaut, exerts a strategic blend that caters to the demands of do-it-yoursel""}, {""date"": ""20231225002404"", ""headline"": ""Merck: One Of The Best - Unveiling The Trifecta Of Safety, Dividends, And Growth"", ""summary"": ""Merck & Co. is a drug manufacturer that has outperformed the healthcare ETF and the S&P 500 over the past decade. Read more about MRK stock here.""}, {""date"": ""20231225073000"", ""headline"": ""Merck: An Excellent Dividend Grower With Strong Annual Total Return Potential"", ""summary"": ""Merck posted healthy sales and non-GAAP EPS growth in the third quarter. Learn why MRK stock appears slightly undervalued.""}, {""date"": ""20231225092000"", ""headline"": ""Merck: Smart Value For Potentially Strong Total Returns"", ""summary"": ""Merck remains undervalued with a strong set of growing drugs and new indications in its pipeline. Read more about MRK stock here.""}, {""date"": ""20231225100302"", ""headline"": ""Capital Gain/Loss On Holdings And Trading Gain/Loss With Cash Cows"", ""summary"": ""I highlight the importance of trade income, capital gains, dividend collection, and tax harvesting in my investment approach. Read more here.""}, {""date"": ""20231225123300"", ""headline"": ""Looking Into Merck & Co's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231226060400"", ""headline"": ""JN.1 Omicron strain becomes dominant COVID variant in U.S."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231226120600"", ""headline"": ""What the Options Market Tells Us About Merck & Co"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231226140000"", ""headline"": ""Rethinking Immunotherapy for Cancer: When Is the Best Time to Stop?"", ""summary"": ""Immune-boosting drugs extend cancer patients\u2019 lives and deliver billions in sales to drugmakers, but some patients might be getting more of the drugs than they need.""}, {""date"": ""20231226163500"", ""headline"": ""Merck & Co. Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. slipped 0.06% to $107.63 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20231227075000"", ""headline"": ""Fusion Pharma climbs as  radiopharmaceutical company flagged as potential merger target"", ""summary"": ""Targeted-oncology specialist draws upgrade at Raymond James after big premium paid is for Rayze Bio.""}, {""date"": ""20231227235924"", ""headline"": ""20 Most Expensive Drugs in the World"", ""summary"": ""In this article, we will take a look at the 20 most expensive drugs in the world. If you want to skip our discussion on the pharmaceutical industry, you can go directly to the 5 Most Expensive Drugs in the World. The health of the global population is being adversely affected due to numerous factors, [\u2026]""}, {""date"": ""20231228021000"", ""headline"": ""Pharma and biotech deal values spike 35% in 2023: report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231228030700"", ""headline"": ""Market Today: Pharma and Biotech Deal Values Surge Amid Patent Cliffs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231228072800"", ""headline"": ""Common Investing Mistake: Income Obsession (& More)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231228082600"", ""headline"": ""Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231228095400"", ""headline"": ""Merck (MRK) Shares Cross Above 200 DMA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231228104400"", ""headline"": ""Interesting MRK Put And Call Options For February 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231228110020"", ""headline"": ""Merck & Co., Inc. (NYSE:MRK) Shares Could Be 50% Below Their Intrinsic Value Estimate"", ""summary"": ""Key Insights Using the 2 Stage Free Cash Flow to Equity, Merck fair value estimate is US$215 Merck is estimated to be...""}, {""date"": ""20231228121214"", ""headline"": ""Vaxcyte: Looking Fully Valued"", ""summary"": ""Vaxcyte is a rising star in the stock market with a promising pneumococcal vaccine. Click here to find out if PCVX stock is a good value here.""}, {""date"": ""20231228130000"", ""headline"": ""5 Biggest Lawsuits in 2023 That Could Hit Your Wallet"", ""summary"": ""From the resumption of student loan repayments to charges against the world's largest cryptocurrency exchange, several 2023 court cases could affect consumers.""}, {""date"": ""20231228154500"", ""headline"": ""Nike, 3M share gains contribute to Dow's 119-point jump"", ""summary"": ""Powered by positive gains for shares of Nike and 3M, the Dow Jones Industrial Average is climbing Thursday afternoon. Shares of Nike and 3M are contributing...""}, {""date"": ""20231228163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.73% higher to $108.77 Thursday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""20231229022800"", ""headline"": ""Can Moderna shares rebound in 2024?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231229060800"", ""headline"": ""Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231229133628"", ""headline"": ""15 Best Dow Stocks To Buy Now"", ""summary"": ""In this article, we discuss the 15 best Dow stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Dow Stocks To Buy Now. The Dow Jones Industrial Average, also known as Dow Jones or Dow, is one of the oldest and most followed equity [\u2026]""}, {""date"": ""20231229134746"", ""headline"": ""11 Best Psychedelic Stocks to Buy in 2024"", ""summary"": ""In this article, we discuss 11 of the best psychedelic stocks to buy in 2024. If you want to see more stocks in this selection, check out 5 Best Psychedelic Stocks to Buy. Unlike substances like marijuana or cocaine, psychedelics are potent and serve as a form of gateway to an \u2018alternate reality\u2019 for those [\u2026]""}, {""date"": ""20231229163500"", ""headline"": ""Merck & Co. Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.23% higher to $109.02 Friday, on what proved to be an all-around dismal trading session for the stock market, with the...""}, {""date"": ""20231231024947"", ""headline"": ""Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation"", ""summary"": ""Bristol-Myers Squibb is a well-known blue-chip stock with a dividend yield exceeding 4.6%. Read why I'm rating BMY stock a Buy at this point.""}, {""date"": ""20231231102603"", ""headline"": ""Chevron, Kimberly-Clark Among 14 Companies To Announce Dividend Increases In January"", ""summary"": ""Investors celebrate double-digit increases for Mastercard and Broadcom.""}, {""date"": ""20231231102841"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 31"", ""summary"": ""Stay updated on dividend activity with this weekly summary for Dividend Champions, Contenders, and Challengers.""}, {""date"": ""20231231104821"", ""headline"": ""MDA Breakouts In Best Year Ever: New Picks For Week 1 - 2024"", ""summary"": ""Discover the remarkable success of the MDA Breakout model, with impressive annual returns and advancements in algorithm for enhanced results in 2024.""}]",{}
26,2023-12-31,109.0199966430664,2024-01-07,117.22000122070312,0.07521560108356717,U5+,"[{""date"": ""20231231024947"", ""headline"": ""Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation"", ""summary"": ""Bristol-Myers Squibb is a well-known blue-chip stock with a dividend yield exceeding 4.6%. Read why I'm rating BMY stock a Buy at this point.""}, {""date"": ""20231231102603"", ""headline"": ""Chevron, Kimberly-Clark Among 14 Companies To Announce Dividend Increases In January"", ""summary"": ""Investors celebrate double-digit increases for Mastercard and Broadcom.""}, {""date"": ""20231231102841"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 31"", ""summary"": ""Stay updated on dividend activity with this weekly summary for Dividend Champions, Contenders, and Challengers.""}, {""date"": ""20231231104821"", ""headline"": ""MDA Breakouts In Best Year Ever: New Picks For Week 1 - 2024"", ""summary"": ""Discover the remarkable success of the MDA Breakout model, with impressive annual returns and advancements in algorithm for enhanced results in 2024.""}, {""date"": ""20240101063312"", ""headline"": ""IGA: Trading At A Discount For A Very Good Reason"", ""summary"": ""Voya Global Advantage and Premium Opportunity Fund offers high level income through its equities and dividend-paying stock portfolios. Read my analysis of IGA.""}, {""date"": ""20240101110023"", ""headline"": ""Those who invested in Merck (NYSE:MRK) five years ago are up 77%"", ""summary"": ""When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...""}, {""date"": ""20240102100000"", ""headline"": ""Anticompetitive Behavior At United Therapeutics"", ""summary"": ""United Therapeutics calls itself a Public Benefit company; in reality, it is a cynical monopolist about to lose its monopoly. Click here to read more.""}, {""date"": ""20240102113000"", ""headline"": ""PH and TXT are added to Goldman\u2019s Jan 2024 Conviction List Directors\u2019 Cut"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240102124000"", ""headline"": ""Amgen, Merck share gains lead Dow's 100-point jump"", ""summary"": ""Behind strong returns for shares of Amgen and Merck, the Dow Jones Industrial Average is climbing Tuesday afternoon. The Dow was most recently trading 100...""}, {""date"": ""20240103021500"", ""headline"": ""Accelerating topline growth stocks - Goldman"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240103030400"", ""headline"": ""Revenge of the Boring Stocks! Dividends Are Sexy Again."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240103053900"", ""headline"": ""Merck price target raised by $5 at Citi, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240103060400"", ""headline"": ""Moderna price target raised by $10 at BofA, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240103070000"", ""headline"": ""Biotech Bonanza: 2024 Biotech Outlook As The Fed Turns Dovish"", ""summary"": ""Biotechnology is well-positioned to outperform the broader indexes in 2024, provided the 10-year yield remains below 4%, with potential gains of 20%-25% and likely higher. Read more here.""}, {""date"": ""20240103074000"", ""headline"": ""Cocrystal Pharma price target lowered by $2 at H.C. Wainwright, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240103081000"", ""headline"": ""Organon: What I'm Looking For In This 8% Yield In 2024"", ""summary"": ""Discover Organon, a pharmaceutical company with a diverse portfolio in women's health and biosimilars. Click here to read our analysis of the stock.""}, {""date"": ""20240103081700"", ""headline"": ""Vaxcyte price target raised by $8 at Guggenheim, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240103093400"", ""headline"": ""Tech Sell-Off Triggers Market Reset: Value Stocks Reach 7-Month High Versus Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240103094800"", ""headline"": ""The biopharmaceuticals stocks to own in 2024, according to BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240103114500"", ""headline"": ""Merck to Participate in the 42nd Annual J.P. Morgan Healthcare Conference"", ""summary"": ""RAHWAY, N.J., January 03, 2024--Merck to Participate in the 42nd Annual J.P. Morgan Healthcare Conference""}, {""date"": ""20240103125829"", ""headline"": ""What The Fed Will Do After The December Jobs Report"", ""summary"": ""The markets widely expect the Federal Reserve to cut interest rates this year. Find out why investors should prepare for obstacles in a soft landing scenario.""}, {""date"": ""20240103142300"", ""headline"": ""Company News for Jan 3, 2024"", ""summary"": ""Companies in The News Are: MRNA, RCL, NVDA, MRK""}, {""date"": ""20240103163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. rose 1.35% to $114.77 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20240103185900"", ""headline"": ""Pharma Stocks Are on a Health Kick"", ""summary"": ""Stocks are down Wednesday, but big pharma shares are bucking the trend. + Shares of Eli Lilly, one of last year's darling stocks, were up nearly 4%, + Amgen, which is a Dow Jones Industrial Average component, and Merck also advanced.""}, {""date"": ""20240104011200"", ""headline"": ""Merck stock poised for sixth straight gain, Cowen upgrades on valuation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104033600"", ""headline"": ""Merck & Co. Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104050100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Immunome (IMNM) and Simulations Plus (SLP)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104062100"", ""headline"": ""5 FDA decisions to watch in the first quarter"", ""summary"": ""The agency could soon clear important new drugs from Eli Lilly and Merck, as well as the first treatment for a common liver disease.""}, {""date"": ""20240104062800"", ""headline"": ""Merck just upgraded at TD Cowen, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104063400"", ""headline"": ""AMD To Rally Over 25%? Here Are 10 Top Analyst Forecasts For Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104072300"", ""headline"": ""2024 And Beyond \u2013 Exploring Six Investment Megatrends With Tema ETFs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104080000"", ""headline"": ""Merck KGaA, Darmstadt, Germany, Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104081600"", ""headline"": ""McDonald's Revenues Expected To Increase, Plus Merck And More On CNBC's 'Final Trades'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104084000"", ""headline"": ""Unusually active option classes on open January 4th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104085300"", ""headline"": ""Apple downgraded, Micron upgraded: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104090200"", ""headline"": ""Merck, Verizon share gains lead Dow's nearly 150-point jump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104101500"", ""headline"": ""Dow's nearly 250-point rally led by gains for Merck, JPMorgan Chase shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104111900"", ""headline"": ""Stocks Edge Higher, Nasdaq Looks To Snap Skid"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104112500"", ""headline"": ""Dow rallies 150 points on gains in Merck, JPMorgan Chase shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104113900"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104115700"", ""headline"": ""Merck stock poised for sixth straight gain"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104122100"", ""headline"": ""Merck CEO says M&A focus 'tends to be more' in small and midsized deals"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104124900"", ""headline"": ""Johnson & Johnson: Rock Solid 3% Yield With Over 10% Annual Return Potential (Rating Upgrade)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104125500"", ""headline"": ""Masking returns to some U.S. hospitals amid rising COVID, flu cases"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104132938"", ""headline"": ""Johnson & Johnson: Rock Solid 3% Yield With Over 10% Return Potential (Rating Upgrade)"", ""summary"": ""Johnson & Johnson offers a safe and attractive investment opportunity with solid growth, a strong balance sheet, and a +3% dividend yield. Learn more on JNJ stock here.""}, {""date"": ""20240104140748"", ""headline"": ""TD Cowen Upgrades Merck (MRK)"", ""summary"": """"}, {""date"": ""20240104161210"", ""headline"": ""Merck & Co., Inc. (MRK) Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript)"", ""summary"": ""Merck &amp; Co., Inc. (NYSE:NYSE:MRK) Goldman Sachs Healthcare C-Suite Unscripted Conference January 4, 2024 ETCompany ParticipantsPeter Dannenbaum - Head,...""}, {""date"": ""20240104170000"", ""headline"": ""TAKING AIM: Marks Electrical to report \""good sales momentum\"" \u2014 Shore"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104201749"", ""headline"": ""Merck seeks GLP-1 drugs with benefits beyond weight loss - CEO"", ""summary"": ""Merck & Co's Chief Executive Officer Robert Davis said on Thursday the company is seeking GLP-1 treatments with benefits beyond weight loss.  The drugmaker is looking for therapies aimed at providing benefits for diabetes and other disorders along with weight loss, Davis said at a conference.  Bloomberg was the first to report on the news on Thursday.""}, {""date"": ""20240104205910"", ""headline"": ""UPDATE 1-Merck seeks GLP-1 drugs with benefits beyond weight loss - CEO"", ""summary"": ""Merck & Co is seeking GLP-1 treatments with benefits beyond weight loss, CEO Robert Davis said on Thursday at a conference.  Newer diabetes and weight-loss drugs of the GLP-1 class like Novo Nordisk's Wegovy and Ozempic and Eli Lilly's Mounjaro and Zepbound are expected to together generate annual sales of over $100 billion by the end of the decade.  Merck's experimental drug efinopegdutide, which belongs to the GLP-1 class and is being developed as a treatment for non-alcoholic steatohepatitis (NASH), also showed a \""compelling\"" weight-loss benefit.""}, {""date"": ""20240105014100"", ""headline"": ""Buy/Sell: Wall Street's top 10 stock calls this week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105015700"", ""headline"": ""Strides Toward Lower Drug Costs: Florida Becomes First To Receive Nod To Import Prescription Drugs from Canada"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105034600"", ""headline"": ""Merck looks to tap into obesity drug market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105054800"", ""headline"": ""Merck initiates Phase 3 trials for four investigational candidates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105063200"", ""headline"": ""Merck price target raised by $8 at Mizuho, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105070003"", ""headline"": ""Merck : launch of four pivotal phase 3 trials"", ""summary"": ""Merck today announced the launch of pivotal Phase 3 trials for four of its investigational drug candidates against hematological malignancies and solid tumors. These global studies involve: -...""}, {""date"": ""20240105081200"", ""headline"": ""Florida to become first state to win FDA nod for mass drug imports from Canada: NYT"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105090000"", ""headline"": ""AbbVie: Still Expensive Despite The Great M&A Acumen"", ""summary"": ""ABBV's Humira erosion balanced by robust Skyrizi and Rinvoq growth, but mixed balance sheet and limited growth prospects may impact the rally. Click here to read.""}, {""date"": ""20240105092300"", ""headline"": ""Florida wins FDA nod for mass drug imports from Canada (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105092500"", ""headline"": ""Merck begins phase 3 trials for four investigational drug candidates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105110021"", ""headline"": ""Merck (NYSE:MRK) Has A Pretty Healthy Balance Sheet"", ""summary"": ""Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...""}, {""date"": ""20240105111800"", ""headline"": ""P/E Ratio Insights for Merck & Co"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105112400"", ""headline"": ""Dry January Investing: Trading Pints For Portfolio Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105114500"", ""headline"": ""Merck Announces Phase 3 Trial Initiations for Four Investigational Candidates From its Promising Hematology and Oncology Pipeline"", ""summary"": ""RAHWAY, N.J., January 05, 2024--Merck Announces Phase 3 Trial Initiations for Four Investigational Candidates From its Promising Hematology and Oncology Pipeline""}, {""date"": ""20240105123600"", ""headline"": ""Strong Buy: Merck\u2019s Growth, Pipeline, and Financial Stability Highlighted by Analyst Chris Shibutani"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105163500"", ""headline"": ""Merck & Co. Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.18% higher to $117.22 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""20240105180709"", ""headline"": ""How I Beat The Market Again In 2023"", ""summary"": ""I express frustration with the constant negativity surrounding the idea that beating the market is impossible for the average investor. Click here to read more.""}, {""date"": ""20240105200623"", ""headline"": ""Healthcare Champions Kick Off 2024"", ""summary"": ""Surprisingly, it is not Big Tech that kicked off 2024 but healtchare champions. Moderna Inc (NASDAQ: MRNA) shares rose after Oppenheimer upgraded the stock due to the Covid-19 vaccine star possibly marketing as many as five products by 2026. Merck & CO Inc (NYSE: MRK) shares also rose 7.3% this year so far with the pharma giant announcing it is kicking off its phase 3 trial for four of its investigational candidates from its diverse and promising hematology and oncology pipeline. 2023 Was A Dism""}, {""date"": ""20240105203800"", ""headline"": ""Top Analyst Reports for Merck, Salesforce & Philip Morris"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Salesforce, Inc. (CRM) and Philip Morris International Inc. (PM).""}, {""date"": ""20240106081200"", ""headline"": ""7 Rock-Solid Healthcare Dividend Stocks to Buy in January"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240106081627"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Spotify.""}, {""date"": ""20240106082000"", ""headline"": ""Wall Street's Top 10 Stock Calls This Week - Saturday, Jan. 6"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240106093000"", ""headline"": ""5 Relatively Secure And Cheap Dividend Stocks To Invest In - January 2024"", ""summary"": ""Discover five large-cap dividend-paying companies offering significant discounts.""}, {""date"": ""20240107110700"", ""headline"": ""J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240107233147"", ""headline"": ""Johnson & Johnson: Overblown Stelara Concerns Distract From Value"", ""summary"": ""Johnson & Johnson's Stelara is nearing the end of its exclusivity, which will likely slow down the growth of EPS. Click here to read why JNJ stock is a Buy.""}]",{}
27,2024-01-07,117.22000122070312,2024-01-14,118.62999725341797,0.012028630080459513,U2,"[{""date"": ""20240107110700"", ""headline"": ""J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240107233147"", ""headline"": ""Johnson & Johnson: Overblown Stelara Concerns Distract From Value"", ""summary"": ""Johnson & Johnson's Stelara is nearing the end of its exclusivity, which will likely slow down the growth of EPS. Click here to read why JNJ stock is a Buy.""}, {""date"": ""20240108003323"", ""headline"": ""Merck in talks to buy Harpoon Therapeutics for around $700 mln - Bloomberg News"", ""summary"": ""Merck & Co is in advancedtalks to buy cancer drugmaker Harpoon Therapeutics Incfor around $700 million, Bloomberg News reported on Sunday,citing people familiar with the matter. Merck...""}, {""date"": ""20240108013200"", ""headline"": ""Merck reportedly in talks to buy drugmaker for more than double Friday\u2019s price"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108014400"", ""headline"": ""Merck in talks to acquire Harpoon Therapeutics for around $700M - Bloomberg"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108015500"", ""headline"": ""Dow rises as yields fall, while tech buoys S&P 500, Nasdaq"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108034800"", ""headline"": ""Dow ends higher after third session of gains, as bond yields pull back"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108035000"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108043500"", ""headline"": ""Biggest stock movers today: Boeing, Harpoon Therapeutics, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108050100"", ""headline"": ""M & A: Merck (NYSE:MRK) Bolsters Oncology Portfolio With Harpoon Deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108063305"", ""headline"": ""Harpoon Therapeutics Shares Take Flight Premarket on Report of Merck Deal Talks"", ""summary"": ""By Colin Kellaher Shares of Harpoon Therapeutics doubled in premarket trading Monday after Bloomberg reported that the clinical-stage immunotherapy company is near a deal to be acquired by...""}, {""date"": ""20240108064000"", ""headline"": ""Merck to acquire Harpoon Therapeutics for $23.00 per share in cash"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108064900"", ""headline"": ""Wall Street\u2019s most celebrated bear is not a bull yet. Here\u2019s Mike Wilson\u2019s stock-market playbook for three economic scenarios."", ""summary"": ""Morgan Stanley strategist outlines three playbooks for what could hit the U.S. economy.""}, {""date"": ""20240108065156"", ""headline"": ""Wall Street Breakfast Podcast: Shares Of Boeing, Spirit AeroSystems Plunge"", ""summary"": ""Shares of Boeing and Spirit AeroSystems plunge after mid-air blowout. Merck in talks to acquire Harpoon Therapeutics for around $700M - Bloomberg. Audacy files for Chapter 11.""}, {""date"": ""20240108065400"", ""headline"": ""Merck to pay 118% premium to buy cancer drugmaker Harpoon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108071000"", ""headline"": ""Why Is Harpoon Therapeutics (HARP) Stock Up 111% Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108071700"", ""headline"": ""Merck to buy Harpoon in $680M all-cash deal (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108075100"", ""headline"": ""Dow futures down 100 points, pressured by Boeing, Fed trajectory"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108075225"", ""headline"": ""Boeing, Alaska Air, Spirit AeroSystems fall premarket; Nvidia, Moderna rise"", ""summary"": ""Investing.com -- U.S. futures retreated Monday, with investors cautious ahead of the release of the key monthly inflation data later in the week, which could determine risk appetite going forward.""}, {""date"": ""20240108075900"", ""headline"": ""4 stocks to watch on Monday: Boeing, J&J and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108080109"", ""headline"": ""Merck's Soaring Stock: Examining The Euphoria Amidst Potential Pitfalls"", ""summary"": ""Merck is known worldwide for Keytruda, its star cancer medication that generates tens of billions of dollars annually. See why I rate MRK stock a Hold now.""}, {""date"": ""20240108080600"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108081000"", ""headline"": ""Moderna posts $6.7B COVID-19 vaccine sales for 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108083152"", ""headline"": ""Healthcare Outlook 2024"", ""summary"": ""The healthcare sector was flat in 2023 year as a result of some unique issues. Check out the healthcare outlook for 2024.""}, {""date"": ""20240108083400"", ""headline"": ""Biggest stock movers today: Boeing, American Eagle Outfitters, Harpoon Therapeutics, Ambrx, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108083605"", ""headline"": ""Merck acquires Harpoon to strengthen its position in oncology"", ""summary"": ""Merck announced on Monday that it would acquire California-based biotech company Harpoon Therapeutics for an enterprise value of $680 million, in order to diversify its oncology portfolio.The...""}, {""date"": ""20240108084100"", ""headline"": ""Dow dragged down by Boeing shares after snapping streak of 9 straight weekly wins"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108090400"", ""headline"": ""M & A News: Merck (NYSE:MRK) Acquires Harpoon for $680 Million"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108091100"", ""headline"": ""Health Care Company Merck & Co Announces Acquisition of Harpoon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108092000"", ""headline"": ""Merck to buy Harpoon Therapeutics for about USD680 million"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108102900"", ""headline"": ""Merck and J&J\u2019s Biotech Deals Are More Good News for a Troubled Sector"", ""summary"": ""Merck and Johnson & Johnson are paying big premiums to acquire companies with promising biotech targets.""}, {""date"": ""20240108102958"", ""headline"": ""Drugmakers kick off industry conference with two cancer deals"", ""summary"": ""Johnson & Johnson and Merck on Mondayannounced plans to buy cancer therapy developers on the firstday of a major U.S. healthcare conference, igniting whatindustry participants hope will be a strong...""}, {""date"": ""20240108105200"", ""headline"": ""One Put, One Call Option To Know About for Merck & Co (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108105200"", ""headline"": ""M & A News: Merck (NYSE:MRK) to Acquire Harpoon for $680 Million"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108105500"", ""headline"": ""Dow dragged down by Boeing shares as tech buoys S&P 500, Nasdaq"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108105800"", ""headline"": ""Novartis to acquire Calypso Biotech for $250M upfront, up to $175M in milestones"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108113300"", ""headline"": ""Merck on track to snap its seven-day win streak"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108114700"", ""headline"": ""Harpoon Therapeutics downgraded to Neutral from Buy at H.C. Wainwright"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108120000"", ""headline"": ""Merck pays $680M for struggling cancer biotech Harpoon"", ""summary"": ""The acquisition will build out Merck\u2019s pipeline of immunotherapies as its top-seller Keytruda nears the end of U.S. market exclusivity.""}, {""date"": ""20240108121700"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108121900"", ""headline"": ""Boeing, Alaska Air Group fall; Harpoon Therapeutics, Axonics rise, Monday, 1/8/2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108123000"", ""headline"": ""Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline"", ""summary"": ""RAHWAY, N.J. & SOUTH SAN FRANCISCO, Calif., January 08, 2024--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Harpoon Therapeutics, Inc. (Nasdaq: HARP) today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Harpoon for $23.00 per share in cash for an approximate total equity value of $680 million.""}, {""date"": ""20240108124700"", ""headline"": ""Dow edges lower as Boeing falls, while tech buoys S&P 500, Nasdaq"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108125329"", ""headline"": ""Johnson & Johnson: EPS Growth Returns In 2024, JPM Healthcare Conference On Tap"", ""summary"": ""Investors are showing interest in Johnson & Johnson as they move away from glamour growth stocks. Read more to see our analysis on JNJ stock.""}, {""date"": ""20240108125546"", ""headline"": ""Merck Is in Advanced Talks to Buy Cancer Drugmaker Harpoon Therapeutics"", ""summary"": ""(Bloomberg) -- Merck & Co. has agreed to acquire cancer drugmaker Harpoon Therapeutics Inc. for $680 million as it seeks to solidify its leadership position in the profitable oncology space.Most Read from BloombergMusk\u2019s Drug Use Concerns Tesla, SpaceX Leaders, WSJ SaysKey Piece of Boeing 737 Found in Hunt for Clues on Plane BlowoutChina Says It Caught Foreign Consultant Spying for UK\u2019s MI6The drugmaker will pay $23 a share for South San Francisco-based Harpoon, it said in a statement on Monday""}, {""date"": ""20240108130000"", ""headline"": ""Merck to Buy Harpoon Therapeutics for $680 Million"", ""summary"": ""Merck has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680 million.""}, {""date"": ""20240108142305"", ""headline"": ""Merck Stock Has Been A Laggard For Seven Months. Is It Staging A Comeback?"", ""summary"": ""Merck stock is shrugging off seven months of underperformance, shooting more than 7% higher in the first week of 2024.""}, {""date"": ""20240108143600"", ""headline"": ""The Zacks Analyst Blog Highlights Merck, Salesforce, Philip Morris International, Novartis and CME Group"", ""summary"": ""Merck, Salesforce, Philip Morris International, Novartis and CME Group are part of the Zacks top Analyst Blog.""}, {""date"": ""20240108144009"", ""headline"": ""Trending : Johnson & Johnson and Merck & Co. Announce Acquisitions"", ""summary"": ""1422 ET -- Johnson & Johnson and Merck & Co. are two of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. J&J will acquire Ambrx...""}, {""date"": ""20240108151100"", ""headline"": ""Merck (MRK) Begins Pivotal Studies on Four Cancer Candidates"", ""summary"": ""Merck (MRK) begins global pivotal studies on bomedemstat, nemtabrutinib, MK-2870 and MK-5684.""}, {""date"": ""20240108153435"", ""headline"": ""How To Build A Dividend Growth Portfolio As A 'Young Investor' With $100,000"", ""summary"": ""Number of years left before retirement is an important factor to consider when planning investments. Click here to read what young investors should focus on.""}, {""date"": ""20240108161700"", ""headline"": ""NEW YORK MARKET CLOSE: Boeing nosedives but stocks jump as tech shines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108163046"", ""headline"": ""Merck to acquire Harpoon Therapeutics in $680M deal"", ""summary"": ""Pharmaceutical company Merck (MRK) will acquire cancer drugmaker Harpoon Therapeutics (HARP) in a deal valued at $680 million. The closing of the acquisition is currently pending, awaiting approval from Harpoon shareholders. Yahoo Finance Anchors Seana Smith and Brad Smith break down the latest development for the two companies and what it could mean for them going forward. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Nicholas Jacobino""}, {""date"": ""20240108163500"", ""headline"": ""Merck & Co. Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.14% higher to $117.38 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20240108195555"", ""headline"": ""Merck Stock's Rally Could Extend to Record Highs"", ""summary"": ""A bull note is flashing for the pharmaceutical giant""}, {""date"": ""20240108203956"", ""headline"": ""Merck-Harpoon deal, Twilio, Crocs: Trending Tickers"", ""summary"": ""Merck (MRK) is set to acquire Harpoon Therapeutics (HARP) in a deal valued at $680 million. Twilio (TWLO) Co-Founder Jeff Lawson steps down as CEO amid pressures from activist investor groups. Lastly, shares of footwear brand Crocs (CROX) have soared by over 20% on Monday after updating its guidance and full-year revenue forecasts for 2023. For more expert insight and the latest market action, click\u00a0here\u00a0to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.""}, {""date"": ""20240109003905"", ""headline"": ""Merck & Co., Inc. (MRK) Presents at JPMorgan 42nd Annual Healthcare Conference (Transcript)"", ""summary"": ""Start Time: 19:30 January 1, 0000 8:10 PM ETMerck &amp; Co., Inc.""}, {""date"": ""20240109004310"", ""headline"": ""Merck & Co., Inc. (MRK) JPMorgan 42nd Annual Healthcare Conference (Slides)"", ""summary"": ""The following slide deck was published by Merck &amp; Co., Inc.""}, {""date"": ""20240109042000"", ""headline"": ""Merck & Co: A Strong Buy on Robust Performance and Promising Growth Prospects"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109060700"", ""headline"": ""Medicenna Therapeutics commences ABILITY-1 study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109061800"", ""headline"": ""Cantor Fitzgerald Sticks to Its Buy Rating for Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109072700"", ""headline"": ""Buy Rating for Merck on Strategic Acquisition of Harpoon Therapeutics and Promising Drug Efficacy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109090400"", ""headline"": ""Harpoon Therapeutics could see interest from other parties, Oppenheimer says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109090500"", ""headline"": ""Demystifying Merck & Co: Insights From 9 Analyst Reviews"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109091300"", ""headline"": ""Here are Wall Street\u2019s favorite stocks in the sector expected to grow profits the most in 2024"", ""summary"": ""It may be better for you as an investor to look beyond quarterly earnings season that begins this week""}, {""date"": ""20240109110020"", ""headline"": ""Are Robust Financials Driving The Recent Rally In Merck & Co., Inc.'s (NYSE:MRK) Stock?"", ""summary"": ""Most readers would already be aware that Merck's (NYSE:MRK) stock increased significantly by 13% over the past three...""}, {""date"": ""20240109112400"", ""headline"": ""FDA warned Merck drug could induce 'despair,' many weren't told, NY Times says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109122900"", ""headline"": ""NGM Biopharma gains on Phase 1 data update for cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109124600"", ""headline"": ""2024 Marks a New Era Of Pharmaceutical Innovation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109131500"", ""headline"": ""Company News for Jan 9, 2024"", ""summary"": ""Companies In The News Are: HELE, CMC, NVDA, MRK, HARP.""}, {""date"": ""20240109163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.89% higher to $118.43 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P...""}, {""date"": ""20240110020500"", ""headline"": ""Smart Money Is Betting Big In MRK Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110024000"", ""headline"": ""LONDON BRIEFING: Sainsbury's grocery sales drive festive growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110054600"", ""headline"": ""Marks Electrical ups market share but gross margins rise disappointing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110054600"", ""headline"": ""AIM WINNERS & LOSERS: Great Western completes mill construction"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110070000"", ""headline"": ""LONDON MARKET MIDDAY: FTSE 100 falls as investors await rates clarity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110071734"", ""headline"": ""AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approval of PREVYMIS for Prevention of CMV Infection in High-Risk Adult Kidney Transplant Recipients"", ""summary"": ""Germany - AiCuris Anti-infective Cures AG, a leading clinical-stage pharmaceutical company developing novel, therapeutic candidates for the prevention and treatment of severe and potentially...""}, {""date"": ""20240110080112"", ""headline"": ""iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must Watch"", ""summary"": """"}, {""date"": ""20240110081900"", ""headline"": ""Peering Into Merck & Co's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110115100"", ""headline"": ""LONDON MARKET CLOSE: Tepid trade as investors await US inflation data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110122000"", ""headline"": ""5 questions facing pharma in 2024"", ""summary"": ""Many drugmakers hope to compete\u00a0in obesity, while others seek to win oncology\u2019s next era. In the background, a contentious drug pricing law looms.""}, {""date"": ""20240110163500"", ""headline"": ""Merck & Co. Inc. stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.36% higher to $118.86 Wednesday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""20240110175232"", ""headline"": ""SCHD Vs. SPHD: Only One Is A Worthy Passive Income Snowball"", ""summary"": ""Investors can look at two popular dividend ETFs to see which one makes for a better passive income snowball. Learn more about the SCHD and SPHD ETFs here.""}, {""date"": ""20240110200218"", ""headline"": ""JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market"", ""summary"": ""Several big pharma companies are rushing into the GLP-1 obesity space, which currently has two market leaders. How they plan to take some of that market share will be the story of the drug class for 2024.""}, {""date"": ""20240110230456"", ""headline"": ""The 3 Best Blue-Chip Stocks to Buy in January 2024"", ""summary"": ""Investing in the best blue-chip stocks offers some benefits, especially lower volatility. Typically, these stocks are stable companies with a lower beta than their peers. So, they minimize drawdowns during periods of market turmoil. Below, we highlight some of the best blue-chip stocks to buy in 2024. First, these established global companies have proven their resilience across all economic environments. Over the years, they have successfully navigated downturns such as the Global Financial Cris""}, {""date"": ""20240111084000"", ""headline"": ""Unusually active option classes on open January 11th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240111105000"", ""headline"": ""Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240111120300"", ""headline"": ""Biotech Alert: Searches spiking for these stocks today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240111120500"", ""headline"": ""2023 Year-End Sector Review - Part 2"", ""summary"": ""While most renewables face a challenging environment, not all renewable energy utilities are such precarious positions.""}, {""date"": ""20240111163500"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Merck & Co. Inc. slumped 0.36% to $118.43 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""20240112034500"", ""headline"": ""Q2 2023 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q1 2023 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q4 2022 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q3 2022 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q2 2022 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q3 2023 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q4 2021 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q3 2021 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q2 2021 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q1 2021 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q4 2020 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q3 2020 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q2 2020 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q1 2020 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q4 2019 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q3 2019 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q2 2019 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q1 2019 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q4 2018 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112034500"", ""headline"": ""Q1 2022 Merck & Co Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112043300"", ""headline"": ""Merck: FDA approves Keytruda in combination with chemoradiotherapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112051200"", ""headline"": ""FDA approves Merck's Keytruda for FIGO 2014 cervical cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112091308"", ""headline"": ""Merck-Settlement Of $1.4 Billion Coverage Dispute Over NotPetya Cyberattack Places Renewed Spotlight On War Exclusions In 2024"", ""summary"": ""Last week, Merck & Co. filed documents with the Supreme Court of New Jersey indicating that it reached a settlement with its all risk property insurers in a long-running coverage dispute involving...""}, {""date"": ""20240112113600"", ""headline"": ""See Which Of The Latest 13F Filers Holds Merck"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112163500"", ""headline"": ""Merck & Co. Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.17% higher to $118.63 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""20240112164749"", ""headline"": ""Merck's Keytruda combo gets FDA nod for expanded use in cervical cancer"", ""summary"": ""The U.S. Food and Drug Administration on Friday approved the expanded use of Merck & Co'sblockbuster immunotherapy Keytruda in combination withchemoradiotherapy to treat patients with a type of...""}, {""date"": ""20240112173000"", ""headline"": ""Merck & Co., Inc. Announces FDA Approves Merck's KEYTRUDA\u00ae (Pembrolizumab) Plus Chemoradiotherapy as Treatment for Patients with FIGO 2014 Stage III-IVA Cervical Cancer"", ""summary"": ""Merck & Co., Inc. announced the U.S. Food and Drug Administration has approved KEYTRUDA, Merck?s anti-PD-1 therapy, in combination with chemoradiotherapy for the treatment of patients with FIGO ...""}, {""date"": ""20240112175908"", ""headline"": ""Merck's Keytruda Combined with Chemoradiotherapy Gets FDA Approval to Treat Cervical Cancer"", ""summary"": ""By Denny Jacob Merck received approval from the Food and Drug Administration for cancer drug Keytruda in combination with chemoradiotherapy as a treatment for patients with FIGO 2014 Stage...""}, {""date"": ""20240112220553"", ""headline"": ""UPDATE 2-Merck's Keytruda combo gets FDA nod for expanded use in cervical cancer"", ""summary"": ""The U.S. Food and Drug Administration (FDA) on Friday approved the expanded use of Merck & Co's blockbuster immunotherapy Keytruda in combination with chemoradiotherapy to treat newly diagnosed patients with a type of advanced cervical cancer.  The Keytruda combination was approved for patients with cervical cancer who had not previously received surgery, radiation, or systemic therapy, FDA said.  This makes Keytruda plus chemoradiotherapy the first anti-PD-1-based immunotherapy combination approved in the U.S. as a treatment for newly diagnosed patients with a certain type of cervical cancer, Merck said.""}, {""date"": ""20240112223000"", ""headline"": ""FDA Approves Merck\u2019s KEYTRUDA\u00ae (pembrolizumab) Plus Chemoradiotherapy as Treatment for Patients With FIGO 2014 Stage III-IVA Cervical Cancer"", ""summary"": ""RAHWAY, N.J., January 12, 2024--FDA Approves Merck\u2019s KEYTRUDA\u00ae (pembrolizumab) Plus Chemoradiotherapy as Treatment for Patients With FIGO 2014 Stage III-IVA Cervical Cancer""}, {""date"": ""20240113120026"", ""headline"": ""Insiders At Merck Sold US$10m In Stock, Alluding To Potential Weakness"", ""summary"": ""Many Merck & Co., Inc. ( NYSE:MRK ) insiders ditched their stock over the past year, which may be of interest to the...""}, {""date"": ""20240114115900"", ""headline"": ""7 Healthcare Stocks Taking Medicine to the Next Level"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
28,2024-01-14,118.62999725341797,2024-01-21,118.88999938964844,0.002191706501307955,U1,"[{""date"": ""20240114115900"", ""headline"": ""7 Healthcare Stocks Taking Medicine to the Next Level"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240115014900"", ""headline"": ""Merck's Keytruda wins third approval in cervical cancer from US FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240115040000"", ""headline"": ""Merck (NYSE:MRK): FDA Approves Expanded Use of Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240115073127"", ""headline"": ""FDA Approves Merck's KEYTRUDA plus Chemoradiotherapy as Treatment for Patients with FIGO 2014 Stage III-IVA Cervical Cancer"", ""summary"": ""RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration has approved KEYTRUDA, Merck's anti-PD-1 therapy, in combination with...""}, {""date"": ""20240116080015"", ""headline"": ""Merck Animal Health's Fourth Veterinary Wellbeing Study Indicates Progress in Addressing Mental Health Challenges among Veterinary Teams"", ""summary"": ""RAHWAY - Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA , today released findings of its comprehensive...""}, {""date"": ""20240116091000"", ""headline"": ""Citi\u2019s top 20 large-cap recommendation list"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240116114000"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240116163500"", ""headline"": ""Merck & Co. Inc. stock falls Tuesday, still outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. slid 0.12% to $118.49 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20240116181012"", ""headline"": ""Merck's Crown Jewel Cancer Drug Keytruda Scores FDA Approval For Third Indication In Cervical Cancer"", ""summary"": ""Friday, the FDA approved Merck & Co Inc\u2019s (NYSE:MRK) Keytruda (pembrolizumab) in combination with chemoradiotherapy (CRT) for FIGO (International Federation of Gynecology and Obstetrics) 2014 Stage III-IVA cervical cancer. The approval is based on data from the Phase 3 KEYNOTE-A18 trial, in which Keytruda plus CRT demonstrated an improvement in progression-free survival (PFS), reducing the risk of disease progression or death by 41% compared to placebo plus CRT. The trial enrolled 1,060 patients""}, {""date"": ""20240116225018"", ""headline"": ""Merck (MRK) Stock Moves -0.12%: What You Should Know"", ""summary"": ""The latest trading day saw Merck (MRK) settling at $118.49, representing a -0.12% change from its previous close.""}, {""date"": ""20240117030000"", ""headline"": ""10 Stocks That Show Why Healthcare Stocks Are Hot in 2024"", ""summary"": ""The sector has seen one of the best starts to the year in decades, Goldman says.""}, {""date"": ""20240117030000"", ""headline"": ""10 Stocks That Show Why Healthcare Is Hot in 2024"", ""summary"": ""The sector has seen one of the best starts to the year in decades, Goldman says.""}, {""date"": ""20240117073000"", ""headline"": ""Adagene falls after trial data for cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240117095000"", ""headline"": ""The 3 Best Dividend Growth Stocks to Buy in January 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240117101700"", ""headline"": ""Adagene falls after presenting interim results from study of ADG126"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240117104100"", ""headline"": ""Why Is Cancer Focused Adagene Stock Plummeting Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240117163500"", ""headline"": ""Merck & Co. Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. dropped 0.30% to $118.13 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20240118100900"", ""headline"": ""Medicare drug price negotiations hit critical phase"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240118110027"", ""headline"": ""With 77% ownership of the shares, Merck & Co., Inc. (NYSE:MRK) is heavily dominated by institutional owners"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Merck's stock price might be vulnerable to their...""}, {""date"": ""20240118163500"", ""headline"": ""Merck & Co. Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.35% higher to $118.54 Thursday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20240119030900"", ""headline"": ""S&P 500 Shatters Records: The Top-Performing Stocks In January 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240119062900"", ""headline"": ""IN BRIEF: Arix Bioscience eyes USD19 million return from Harpoon sale"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240119071100"", ""headline"": ""Senate panel to consider subpoenas for J&J and Merck CEOs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240119080000"", ""headline"": ""IYH: Healthcare Dashboard For January"", ""summary"": ""The healthcare sector is overvalued currenty, but with promising value scores. Click for my review of iShares U.S. Healthcare ETF (IYH).""}, {""date"": ""20240119114500"", ""headline"": ""Merck to Hold Fourth-Quarter and Full-Year 2023 Sales and Earnings Conference Call Feb. 1"", ""summary"": ""RAHWAY, N.J., January 19, 2024--Merck to Hold Fourth-Quarter and Full-Year 2023 Sales and Earnings Conference Call Feb. 1""}, {""date"": ""20240119115800"", ""headline"": ""Sanders threatens to subpoena J&J, Merck CEOs over drug prices"", ""summary"": ""The Senate HELP committee, which is seeking testimony from J&J's Joaquin Duato and Merck's Robert Davis, hasn't issued a subpoena since 1981.""}, {""date"": ""20240119123400"", ""headline"": ""Amgen's Blockbuster Osteoporosis Drug Prolia Flagged With FDA Strictest Warning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240119131000"", ""headline"": ""Wall Street Lunch: Spirit Not Giving Up On Merger"", ""summary"": ""Spirit Airlines confirms commitment to merger along with upbeat guidance. Consumer sentiment hits a 2-1/2 year high. Meta buying up Nvidia AI chips.""}, {""date"": ""20240119163500"", ""headline"": ""Merck & Co. Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. inched 0.30% higher to $118.89 Friday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20240120004932"", ""headline"": ""My Dividend Growth Portfolio - Q4 2023 Summary"", ""summary"": ""As we wrap up Q4 2023, it's clear that while the market will continue to present challenges, it will also provide valuable investment opportunities. Click here to read more.""}, {""date"": ""20240120014100"", ""headline"": ""Week in Review: Lee\u2019s Pharma Signs $138 Million Agreement For China Rights To Heart Failure Therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240120031900"", ""headline"": ""Senate Health, Education, Labor & Pensions Committee holds an executive session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240120141213"", ""headline"": ""Jim Cramer\u2019s 11 Best Dividend Stocks"", ""summary"": ""In this article, we will take a detailed look at Jim Cramer\u2019s 11 Best Dividend Stocks. For a quick overview of such stocks, read our article Jim Cramer\u2019s 5 Best Dividend Stocks. Uncertainty around the future of stock markets remains high, with analysts and investors divided on what plan of action the Federal Reserve would devise to tackle [\u2026]""}, {""date"": ""20240121070000"", ""headline"": ""Our U.S. Stock Portfolio Performance For 2023 And Longer-Term Market Beat"", ""summary"": ""The U.S. market exceeded expectations in 2023, delivering a 26% return for the S&P 500. Click here to read more about the portfolio and our stock picks.""}, {""date"": ""20240121231306"", ""headline"": ""THQ: Investing In A Healthy Future"", ""summary"": ""THQ employs a versatile growth and income strategy across all sub-sectors of the healthcare industry and across the full capital structure. Learn why the Fund is a Hold.""}]",{}
